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ABSTRACT 
 
 The objective of this research was to evaluate select novel, low-digestible 
carbohydrates – pullulans (Pull), soluble fiber dextrins (SFD), and soluble corn fibers (SCF) 
- for properties that could positively impact health outcomes.  Study 1 measured in vitro 
hydrolytic digestion characteristics, glycemic and insulinemic responses, and true 
metabolizable energy (TMEn) content of select SFDs and Pulls.  Soluble fiber dextrins 
varied in digestibility, with all substrates resulting in low to intermediate in vitro 
monosaccharide digestion.  Pullulans were nearly completely hydrolyzed after simulated 
hydrolytic digestion.  The glycemic response with dogs varied widely among SFDs, with all 
but one SFD having a lower glycemic response than maltodextrin (Malt).  The pullulans all 
resulted in low glycemic values. Lower relative insulinemic responses (RIR) compared to 
the Malt control were noted for all SFDs and pullulans.  Pullulans resulted in higher true 
metabolizable energy (TMEn) values than did SFDs.   Study 2 measured in vitro hydrolytic 
digestion, glycemic and insulinemic responses, and TMEn content of SCFs (first and second 
generation products) produced using different methods.  All SCFs had intermediate to low 
amounts of monosaccharides released as a result of in vitro hydrolytic digestion, with 
glucose being the primary sugar component released. Second generation SCFs, on average, 
had lower glycemic responses and TMEn values than did first generation SCFs.  Study 3 
measured in vitro hydrolytic digestion and glycemic and insulinemic responses of select 
carbohydrate blends, all containing SCF and blended with Pull, sorbitol (Sorb), and (or) 
fructose (Fruct).  The addition of higher amounts of Fruct and Sorb increased the free Fruct 
and Sorb concentrations of the blends.  All SCF blends resulted in low glycemic and 
insulinemic responses compared to the Malt control.  Blends containing Fruct and Sorb were 
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most effective in attenuating the glycemic and insulinemic responses.  Study 4 measured 
gastrointestinal health outcomes resulting from supplementation of SFD and SCF to rats. 
Rats were randomly assigned to one of four treatment groups (n=10) for 21 d.  An AIN-93G 
diet with 5% cellulose served as the Control.  The 5% cellulose was replaced with either 5% 
pectin (Pectin, positive control), SFD, or SCF. Consumption of SFD and SCF increased 
cecal weight but not colon weight.  On a per cecum basis, SFD and SCF increased acetate, 
propionate, and total SCFA concentrations, with no effect on butyrate concentrations, 
compared to the Control diet. Cecal branched-chain fatty acids (BCFA) concentrations were 
decreased by SFD and SCF, whereas Pectin increased BCFA concentrations.  
Supplementation of SFD and SCF did not have an effect on cecal microbial populations 
compared to the Control diet. Pectin tended to decrease cecal Escherichia coli 
concentrations.  Gut histomorphology was positively affected by SFD and SCF.  Increased 
crypt depth, goblet cell numbers, and acidic mucin were observed in both the cecum and 
colon of rats supplemented with SFD, SCF, and Pectin. These novel, low-digestible 
carbohydrates appear to have the potential to beneficially impact health through decreased 
hydrolytic digestion, attenuated glycemic and insulinemic response, decreased energy value, 
SCFA production, and modulating gut morphology. 
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CHAPTER 1:  INTRODUCTION 
 
 As consumers are becoming more health conscious, the use of foods and 
ingredients that promote health is increasing.  Dietary carbohydrates especially fibrous 
carbohydrates represent a complex group of food components that have a variety of 
beneficial physiological and nutritional properties (Crittenden and Playne, 1996; Cummings 
et al., 1997; Van Loo et al., 1999).  There is increasing evidence that dietary fiber has 
beneficial influences on health; however, most of the population of the United States 
consumes less than half of the recommended concentration of dietary fiber daily (Anderson 
et al., 2009).  This has led to a demand for the development of novel carbohydrates that have 
functional properties similar to those of dietary fiber but that may be incorporated more 
easily into a wider array of solid and liquid food matrices.   
     One class of carbohydrates, low-digestible carbohydrates, are becoming popular 
as food ingredients, not only due to their potential to improve both the physical and 
chemical properties of foods, but also due to the possible health benefits associated with 
their consumption (they act similarly to dietary fiber; Murphy, 2001).  Low-digestible 
carbohydrates are low molecular weight carbohydrates that resist the hydrolytic activity of 
human digestive enzymes (Crittenden and Playne, 1996; Roberfroid and Slavin, 2000; 
Mussatto and Mancilha, 2007).  Low-digestible carbohydrates include polyols, resistant 
starch, fructooligosaccharides, and other oligosaccharides (Marteau and Flourie, 2001).  
Factors restricting digestion and absorption of low-digestible carbohydrates are the 
impaired hydrolysis of constitutive bonds by enzymes and the degree of absorption in the 
small intestine (Marteau and Flourie, 2001).  Possessing a low hydrolytic digestibility makes 
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these oligosaccharides suitable for use in sweet, low-calorie diet foods, and for consumption 
by individuals with diabetes because of their ability to attenuate glycemic and insulinemic 
responses. The management of diabetes is becoming more important as diabetes is a 
growing health concern in the general population.  There is also evidence that low-digestible 
carbohydrates may affect risk factors associated with diseases such as obesity, non-insulin 
dependent diabetes mellitus, hyperlipidemia, and hypertension, and cardiovascular disease 
although the underlying mechanisms are not well understood (Scheppach et al., 2001).   
Low-digestible carbohydrates pass into the colon where they are substates for 
fermentation by colonic microbiota.  Fermentation yields short-chain fatty acids (SCFA) 
that provide colonic cells with energy and lower the pH of luminal contents.  Van Loo et al. 
(1999) concluded that there was consistent evidence that non-digestible carbohydrates 
resulted in a fecal bulking effect and a normalization of stool frequency.  The stool bulking 
effect is due to increases in microbial mass from the fermentation of the low-digestible 
carbohydrates.  Low-digestible carbohydrates also have the potential to alter the 
composition of the colonic microflora, especially by stimulating growth of bifidobacteria 
and beneficially modulating intestinal morphology.  Health benefits associated with 
bifidogenesis include displacement of detrimental bacteria, strengthening of gut barrier 
function, and prevention of pathogen invasion (Van Loo et al., 1999; Scheppach et al., 
2001).   
Low-digestible carbohydrates have effects that beneficically affect host health, so 
they may be considered as functional foods (defined as ingredients that affect physiological 
function (s) of the body in a targeted way so as to have a positive effect (s) that may, in due 
course, justify health claims; Roberfroid, 1996).  The advantageous physicochemical and 
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physiological properties that low-digestible carbohydrates possess make them of interest to 
food manufacturers, health professionals, and consumers. 
The major objectives of the research reported in this thesis were to evaluate select 
novel, low-digestible carbohydrates - pullulans, soluble fiber dextrins, and soluble corn 
fibers - for physiological outcomes that could positively impact health indices. Properties 
evaluated included hydrolytic digestion, glycemic and insulinemic responses, true 
metabolizable energy content, fermentation characteristics, modulation of microbiota 
populations, and gut morphological characteristics utilizing in vitro, canine, avian, and 
rodent models.  
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CHAPTER 2:  LITERATURE REVIEW 
 
Characteristics of Low-Digestible Carbohydrates 
In recent years, the demand for functional foods that contain novel ingredients and 
provide specific health benefits has increased (Murphy, 2001).  The identification of dietary 
fiber as a promoter of healthy gut function and other health benefits has led to the search for 
other food components with similar properties (Cummings et al., 2004).  Substrates having 
physiological properties such as reduced energy value, bifidogenic properties, laxation 
effects, fecal bulking properties, and reduced glycemic response are being sought (Murphy, 
2001).  This has led to an expansion in the demand for carbohydrates that have functional 
properties similar to dietary fiber. 
Low-digestible carbohydrates represent a heterogeneous group of oligosaccharides 
that are partially unavailable to digestive enzymes so are either incompletely or not 
absorbed from the small intestine (Murphy, 2001; Scheppach et al., 2001; Grabitske and 
Slavin, 2008).  These oligosaccharides are low molecular weight carbohydrates containing 
three to ten sugar moieties (Crittenden and Playne, 1996; Mussatto and Mancilha, 2007). 
The nondigestibility of these carbohydrates is due to the anomeric C atom of the 
monosaccharide units having a configuration that makes linkages unable to be hydrolyzed 
by digestive enzymes.  The majority of low-digestible carbohydrates presently available as 
food ingredients are made from different types of monosaccharides in which the 
monosaccharide unit is fructose, galactose, glucose, and (or) xylose (Roberfroid and Slavin, 
2000; Mussatto and Mancilha, 2007).   
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In general, food-grade oligosaccharides are not pure products, and differences in 
production methods can affect chain length, monosaccharide composition, degree of 
branching, and purity (Crittenden and Playne, 1996; Roberfroid and Slavin, 2000).  
Industrial production of low-digestible carbohydrates includes extraction of 
oligosaccharides from natural sources, hydrolysis of polysaccharides, and enzymatic or 
chemical synthesis from carbohydrate substrates.  Enzymatic synthesis of low-digestible 
carbohydrates can occur through two basic processes.  They can be produced from simple 
sugars, such as sucrose, where enzymatic transglycosylation reactions build an 
oligosaccharide, or they can be formed by controlled enzymatic hydrolysis of starch (Sako 
et al., 1999).  Production of low-digestible carbohydrates using these processes usually 
results in a range of oligosaccharides differing in their degree of polymerization and 
position of glycosidic attachments.  Unreacted substrates and monosaccharides also can be 
present after oligosaccharide formation.  Purification methods such as membrane filtration 
or chromatographic procedures are applied to remove contaminating sugars so as to produce 
purer oligosaccharides.  Low-digestible carbohydrates include polyols, resistant starch, 
fructooligosaccharides, and other oligosaccharides (Marteau and Flourie, 2001; Murphy, 
2001; Scheppach et al., 2001; Grabitske and Slavin, 2008).  One of the most widely used 
and studied low-digestible carbohydrates is inulin-type fructans composed of β-D-
fructofuranoses attached by β-2,1 linkages. 
Low-digestible carbohydrates possess important physicochemical properties that 
make them valuable ingredients for incorporation into foodstuffs.  They are readily water-
soluble and exhibit some sweetness, typically 0.3 – 0.6 times as sweet as sucrose 
(Roberfroid and Slavin, 2000; Mussatto and Mancilha, 2007).  The sweetness depends on 
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the chemical structure, the degree of polymerization of the oligosaccharides present, and the 
concentrations of mono- and disaccharides in the mixture (Crittenden and Playne, 1996; 
Voragen, 1998; Mussatto and Mancilha, 2007).  These products often are used as fat 
replacers and texture modifiers for processed foods.  The relatively low sweetness makes 
low-digestible carbohydrates useful in food production when a bulking agent with reduced 
sweetness is desirable to enhance other food flavors.  In the case of very sweet foods, they 
may be used as bulking agents in conjunction with artificial sweeteners in order to mask the 
aftertastes produced by some of the intense sweeteners such as aspartame (Mussatto and 
Mancilha, 2007).   
Compared with mono- and disaccharides, the higher molecular weight of 
oligosaccharides provides increased viscosity that allows for improved body and mouth feel 
(Crittenden and Playne, 1996).  Low-digestible carbohydrates also can be incorporated into 
food products to alter the freezing temperature of frozen foods, and to control the intensity 
of browning due to Maillard reactions in heat-processed foods (Mussatto and Mancilha, 
2007).  They also provide a high moisture-retaining capacity, prevent excessive drying, and 
result in a low water activity that helps control microbial contamination (Crittenden and 
Playne, 1996).  The caloric value of low-digestible carbohydrates has been estimated to be 
1.5 – 2.0 kcal/g, approximately 40 – 50% of the value for digestible carbohydrates such as 
sucrose (Sako et al., 1999). 
Health Benefits of Low-Digestible Carbohydrates 
 Evidence for the possible physiological and health benefits associated with 
low-digestible carbohydrate consumption is substantial and has led to an increased 
 8 
 
awareness among consumers (Murphy, 2001). Many benefits of low-digestible carbohydrate 
consumption exist but of major interest is their effect on energy content, glycemic response, 
and on fermentation and gastrointestinal health. 
 Modulation of Bone Health by Increasing Bioavailability of Minerals 
 There is increasing evidence that low-digestible carbohydrates improve the 
bioavailability of minerals.  Several studies in rats have shown increased Ca, Mg, and Fe 
absorption following consumption of low-digestible carbohydrates, inulin-type fructans in 
particular (Younes et al., 1996).  Evidence indicates that the increased absorption originates 
mainly at the level of the large intestine and effectively results in increased bone mineral 
density (Van Loo et al., 1999).  Consumption of low-digestible carbohydrates to increase 
bone mineral density could have potential use for reducing the risk of osteoporosis. 
Modulation of Lipid Metabolism 
Supplementation of low-digestible fructans has been reported to lower serum 
triacylglycerols in rats (Fiordaliso et al., 1995; Delzenne et al., 2002).  A review of human 
studies by Van Loo et al. (1999) found inconsistent results from the supplementation of low-
digestible fructans, but indicate that the intake of moderate concentrations of inulin or 
oligofructose may positively affect lipid metabolism. The hypotriglyceridemia is due mostly 
to a decrease in the concentration of plasma very-low density lipoproteins (Fiordaliso et al., 
1995; Roberfroid and Slavin, 2000).  The hypotriacylglycerolemic effect of low-digestible 
carbohydrate consumption is due to a decrease in hepatic triacylglycerol synthesis 
(Roberfroid and Delzenne, 1996).  This results mainly from a lower rate of lipogenesis that 
results from a down-regulation of fatty acid synthase, a key hepatic lipogenic enzyme (Kok 
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et al., 1996; Roberfroid and Delzenne, 1996).  Low-digestible carbohydrates may possibly 
modulate lipid metabolism by increasing the gut peptides, glucose-dependent insulinotropic 
polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) (Delzenne et al., 2002).  These 
peptides influence lipid metabolism by promoting insulin-induced glucose uptake and de 
novo lipogenesis in adipose tissue (Delzenne et al., 2002). 
Anti-Carcinogenic Properties 
 A reduced risk of experimentally induced carcinogenesis has been observed in rats 
fed low-digestible carbohydrate diets.  This anti-carcinogenic effect appears to be related to 
a reduction in the production of carcinogenic substances by decreasing the amount of 
pathogenic bacteria in the colon and by increasing cellular immunity (Tungland and Meyer, 
2002; Mussatto and Mancilha, 2007).  In studies where low-digestible fructans were 
supplemented and a carcinogenic compound, azoxymethane, administered, a reduction in 
the numbers of colonic aberrant crypt foci was observed (Rowland et al., 1998).  Aberrant 
crypt foci are early indicators of future risk of tumor development.  A comparable effect is 
induced upon administration of bifidobacteria.  Combining a low-digestible carbohydrate 
simultaneously with bifidobacteria was shown to have a synergistic effect (Gallaher et al., 
1996; Rowland et al., 1998).   
Increasing butyrate production can potentially contribute to the anti-carcinogenic 
properties of low-digestible carbohydrates.  There is growing evidence that butyric acid has 
a protective role in the development of colorectal cancer (Murphy, 2001).    Butyrate has 
been shown to arrest cell division through its ability to regulate gene expression (Siavoshian 
et al., 2000).  Growth of normal cells and promotion of DNA repair in damaged cells has 
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been stimulated by butyrate (Topping et al., 2008).  Induced apoptosis in colorectal tumor 
cell lines and stimulation of immunogenicity in cancer cells has been shown with increased 
butyrate (Wong et al., 2006).    Low-digestible carbohydrates also can decrease ammonia, p-
cresol, and indole concentrations.  There are fecal metabolites considered as risk factors for 
colon cancer (Mussatto and Mancilha, 2007).  
Glycemic Response and Glycemic Index (GI)  
Glycemic response is an indication of how rapidly carbohydrates are digested.  The 
extent to which bioavailable carbohydrates increase postprandial blood glucose is influenced 
by the rate and extent of carbohydrate digestion and absorption in the gastrointestinal tract 
(Wolever, 2006). Carbohydrates in the diet include a wide range of different compounds 
including monosaccharides, disaccharides, oligosaccharides, and polysaccharides that elicit 
different glycemic responses.  Different dietary carbohydrates may influence blood glucose 
by the nature of the monosaccharide absorbed, the amount of carbohydrate absorbed, and 
the rate of absorption (Wolever, 2003). 
In the small intestine, only monosaccharides can be absorbed; thus, disaccharides, 
oligosaccharides, and polysaccharides must be hydrolyzed to their monosaccharide units.  
The majority of the carbohydrate in the diet enters the bloodstream as glucose, which is 
transported through the body to the tissues (Lunn and Buttriss, 2007). Once in the tissues, 
glucose has several fates: it can be used for energy, stored as glycogen in the liver or 
muscles, or converted to fat (Lunn and Buttriss, 2007).  The fate of the glucose circulating 
in the bloodstream is determined by the relative concentrations of insulin.  Insulin is 
released from the  cells of the pancreas in response to glucose absorption, and triggers 
glucose uptake into the muscle and liver cells where it is either utilized for energy or stored 
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as glycogen (Lunn and Buttriss, 2007). The amount of glycogen that the body can store is 
limited so excess glucose will be converted to fat.  Insulin suppresses the metabolic 
pathways in the liver that synthesize glucose, so provided the body is sensitive to insulin, 
blood glucose concentrations will fall.  Postprandial glucose and insulin responses can be 
reduced by decreasing available carbohydrate intake, which can be achieved by replacing 
available carbohydrates with low-digestible carbohydrates (Wolever, 2003).   
The GI concept is, in many ways, an extension of the dietary fiber hypothesis of 
Burkitt and Trowell who suggested that dietary fiber may have metabolic benefits related to 
diabetes, reduction of coronary heart disease risk, and colon cancer (Jenkins et al., 2002; 
Wolever, 2006).  Interest in the GI concept is becoming increasingly widespread as 
evidence is gathered showing it to be relevant in many areas of human health and 
performance (Wolever, 2006).   A ranking system for carbohydrates, GI was first introduced 
by Jenkins et al. (1981).  The GI is a quantitative assessment of foods based on postprandial 
blood glucose response expressed as a percentage of the response to an equivalent 
carbohydrate portion of a reference food (Augustin et al., 2002).  The glycemic index is 
defined as the incremental area under the blood glucose response curve of a 50 g available 
carbohydrate portion of a test food expressed as a percentage of the response to the same 
amount of carbohydrate from a standard food taken by the same subject (Wolever, 2003; 
Venn and Green, 2007).   A common GI classification system for foods is categorizing GI 
values as low (<55), medium (55-69), or high (>70) (Venn and Green, 2007).   
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Factors Involved in Determining Glycemic Index 
 Several factors must be considered in determining the GI of a carbohydrate:  amount 
of carbohydrate tested, method of blood sampling and glucose measurement, and 
characteristics of the subjects being studied.  All can contribute to variation in determining 
the GI of a test ingredient (Granfeldt et al., 1995; Wolever, 2003; Brouns et al., 2005; 
Wolever, 2006). 
Calculation of Area Under the Curve (AUC) 
The AUC is estimated based on measures of blood glucose concentration obtained at 
various points in time after carbohydrate is ingested.  Glucose is usually measured at 15 to 
30 minute intervals over 2 to 3 hours after intake of the carbohydrate being tested.  Area 
under the curve can be calculated in several different ways that, depending on how 
calculated, can lead to major differences in results and interpretation of results of the same 
data (Wolever, 2003).  One of the major considerations in determining AUC is 
determination of which area to be included in the AUC.  The GI is based on the incremental 
area under the curve (IAUC), defined as the area beneath the curve above the fasting level 
only (Wolever, 2006).  Area beneath the fasting level is ignored.  Incremental area under the 
curve is used because it indicates the amount that the carbohydrate raises blood glucose 
above the fasting concentration (Wolever, 2006). 
Other common methods of calculating the AUC include AUCcut and total AUC 
(TAUC).  AUCcut is calculated in the same way as IAUC, but includes area before the 
blood glucose concentration drops below the baseline fasting concentration (Wolever, 
2006).  Total area under the curve is the area under the curve when the blood glucose 
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concentration is zero and measures the average blood glucose concentration during the 
period of the test (Wolever, 2003).  Total area under the curve for blood glucose will result 
in a value much greater than that for IAUC because TAUC is determined based on the 
concentration of fasting glucose (Wolever, 2006).   
Amount of Carbohydrate Tested 
Given that blood glucose responses differ depending on the amount of carbohydrate 
consumed, the portion size of food used to determine the GI is critical (Wolever, 2003).  
The GI is intended to be an index of “blood glucose raising potential” of available or 
absorbable carbohydrates in food.  Only carbohydrate sources assumed to be fully 
digestible, absorbable, and glycemic are included in the calculation of dosed carbohydrates 
in the 50 g portion size in the classical GI concept (Brouns et al., 2005).  This is difficult in 
practice since available carbohydrate is difficult to measure accurately and the definitions 
and methods used to measure dietary carbohydrates vary in different parts of the world 
(Wolever, 2003). 
 If a portion size less than 50 g is to be used, then the amount of carbohydrate in the 
reference food needs to be reduced so that both are supplying equal amounts of available 
carbohydrate. Test foods were fed at concentrations of 25, 50, and 100 g and the glycemic 
responses of the foods relative to that of control bread containing the same amount of 
carbohydrate did not differ significantly (Wolever and Bolognesi, 1996).  This suggests that 
the relative responses of foods are the same at different concentrations of available 
carbohydrate intake.  However, a larger dose of carbohydrate might be preferred as this 
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study also found that variability of the results increased as the portion size became smaller 
(Wolever and Bolognesi, 1996). 
Method of Blood Sampling and Glucose Measurement  
Blood obtained from a vein, artery, or capillary bed can be used to determine glucose 
concentration.  Glucose concentrations also can be measured using whole blood or serum or 
plasma.  The concentration of glucose in venous plasma is less than that in arterial plasma 
because the glucose is taken up by tissues from the blood as it passes from the arteries 
(Wolever, 2006).  Capillary blood glucose concentrations have been found to be greater than 
venous when measuring GI of various products so that the AUC was 33-40% lower for 
venous blood glucose (Granfeldt et al., 1995).  The measurements of GI were not affected 
since both the test and control measurements ended up being affected (Granfeldt et al., 
1995).  An inter-laboratory study examined the difference in glucose responses in venous 
plasma versus capillary blood.  Measuring glucose responses in venous plasma resulted in 
greater within-subject variation in GI values than measuring glucose in capillary blood 
(Wolever et al., 2003), the coefficient of variation of capillary measurements being 23.4 +/- 
2.1% compared to venous measurements with a coefficient of variation of 56.8% +/- 4.4% 
(Wolever et al., 2003).  These findings suggest that capillary blood sampling may be the 
preferred method of determining blood glucose concentrations for GI. 
Subject Characteristics 
Glycemic index values have been found not to be significantly affected by subject 
variables such as age, sex, ethnicity, glucose tolerance status, or presence of type 1 or type 2 
diabetes, making GI values from these groups comparable to each other (Wolever, 2003).  
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However, the within-subject variation of glycemic responses is significant and accounts for 
most of the variation in GI values (Wolever, 2006).   
Health Aspects 
The GI was originally designed as a food selection guide for people with diabetes 
(Jenkins et al., 2002).  However, GI and glycemic response of carbohydrates have more 
recently been widely recommended as factors important in chronic diseases including 
diabetes, obesity, cancer, and heart disease and in the treatment of cardiovascular risk 
factors, especially dyslipidemia (Jenkins et al., 2002; Wolever, 2003; Han and BeMiller, 
2007; Venn and Green, 2007).  High blood glucose concentrations create oxidative stress 
and affect cellular function, lipid oxidation, protein glycosylation, clotting tendency, and 
inflammatory processes (Brand-Miller, 2007).    
A popular application of GI is for body weight management. A low-GI diet is 
thought to promote weight loss through reduced food intake, reduced fat storage, and 
increased fat oxidation (Wolever, 2006).  Low-GI diets may aid in weight management by 
increasing food residence time in the gut and may influence the response of such satiety 
hormones as gastric inhibitory peptide, glucagon-like peptide, and cholecystokinin (Brand-
Miller, 2007; Slavin et al., 2009).   High-glycemic diets may result in hormonal changes that 
limit availability of metabolic fuels in the postprandial state and stimulate increased 
voluntary food intake (Raatz et al., 2005).   
Foods with a low-GI or glycemic response have been shown to be most beneficial in 
the management of diabetes.  Epidemiological studies suggest that reduced postprandial 
glucose peaks, reduced episodes of hypoglycemia, and greater insulin sensitivity are 
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beneficial for diabetes management (Lehmann and Robin, 2007).  Several studies have 
shown that calorie for calorie, high-GI meals stimulate more insulin secretion than low-GI 
meals because of relative postprandial hyperglycemia (Ludwig, 2002).  High-GI diets also 
may impair  -cell function through the direct effect of elevated blood glucose and free fatty 
acid concentrations that high-GI diets are known to cause (Ludwig, 2002). 
Energy Content 
Evaluation of Energy Content 
The increased interest in low-calorie foods has increased the use of low-digestible 
carbohydrates in foodstuffs and, thus, increased the importance of determining the energy 
value of these carbohydrates.  Particular needs for information in this area are from 
manufacturers attempting to design foods of lower caloric value and from governing bodies 
who assign energy values for the purpose of food labeling (Livesey, 1990; Livesey et al., 
2000).  The use of correct energy values for low-digestible carbohydrates is also essential 
for consumers.  
When evaluating the energy of a diet where the energy value of ingredients is not 
known, indirect calculations are used to estimate the energy contribution of the individual 
components.  There are several commonly used equations for energy assessment for 
predicting metabolizable energy such as the Atwater system and British system (Livesey, 
1990).  The equations include the intakes of protein, fat, and carbohydrate using caloric 
conversion factors; however, these equations often either overpredict or underpredict the 
available energy from low-digestible carbohydrates depending on the conversion factor used 
in the equation (Livesey, 1990).  In the past, low-digestible carbohydrates often were 
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assigned an energy value of 0 kcal/g, but research has indicated that a more appropriate 
value to be used in calculations would be 2 kcal/g (Livesey, 1990; Livesey et al., 2000).  
The use of energy conversion factors in determining the caloric value of novel low-
digestible carbohydates may not accurately reflect their energy value and can be misleading. 
More accurate energy evaluation is conducted by examining the digestible energy 
(DE) and metabolizable energy (ME) of diets and individual ingredients.  Digestible energy 
and ME values are used extensively in energy evaluation of ingredients and complete diets.  
The direct method for determining DE involves measuring the intake of ingredient (s) of a 
known gross energy (GE) content and measurement of energy in the feces (Livesey et al., 
2000).  Metabolizable energy is measured similarly to DE, but also takes into account losses 
of energy in urine.  Metabolizable energy can be expressed as either apparent (AME) or true 
(TME) metabolizable energy, the difference being that TME takes into account endogenous 
fecal and urinary energy losses (Sibbald, 1976; Miller and Reinecke, 1984).  A more 
advanced system for energy evaluation is net energy (NE).  Net energy was developed to 
provide more accurate estimates of energy that is available to the host for use in 
maintenance and production (i.e., growth, gestation, lactation, etc.).  The main difference 
between the NE system and the DE and ME systems is that the NE system considers the 
amount of heat lost during digestion and subsequent deposition of nutrients in protein and 
adipose tissue (Livesey et al., 2000). 
Roosters can be utilized for ME assays to evaluate the energy content of individual 
ingredients.  The rooster can be used to simulate the conditions in the digestive tract of 
humans for determining the energy content of foodstuffs.  Use of roosters allows for a better 
representation of the digestive process than does in vitro assays for determining 
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metabolizable energy.  Also, rooster assays allow for shorter, easier, and more accurate 
collection of data than using human subjects where total collection of feces and urine can be 
difficult. 
Low-Digestible Carbohydrates as Low-Calorie Ingredients 
A major health concern facing today’s human and pet animal population is obesity 
and its related metabolic diseases.  This has led to consumer demand for low-calorie 
ingredients and reduced-calorie versions of many foods without compromise in taste 
(Stowell, 2006).  In response to consumer demand, development and production of new 
low-calorie food ingredients and additives has increased.  The three major categories of low-
calorie ingredients include fat substitutes, high-intensity sweeteners, and low-calorie 
bulking agents. 
Low-calorie bulking ingredients are defined as natural or novel food ingredients that 
provide foods and drinks with such organoleptic properties as body, texture, flavor, mouth-
feel, and taste (Annison et al., 1994).  Often, low-calorie bulking ingredients are dietary 
fibers (e.g., pectins, gums, and lignins; Annison et al., 1994; Auerbach et al., 2006).  These 
materials come from a variety of sources and often are complex mixtures of carbohydrates 
that are chemically not well defined and have limitations as sugar replacements (Annison et 
al., 1994; Auerbach et al., 2006).  This emphasizes the need for novel, high-quality, bulking 
agents that allow for a greater flexibility when replacing sugar in formulations and that 
complement the use of high-intensity sweeteners.   
 Metabolic effects of carbohydrates are dependent on their rate of absorption from 
the small intestine.  The rate of absorption can be reduced by a number of factors including 
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the molecular structure of the carbohydrate and other inherent properties such as viscosity, 
gel-forming properties, and water-holding capability (Annison et al., 1994).  Diets 
containing low-digestible carbohydrates will have lower energy content due to their 
decreased rate of small intestinal carbohydrate absorption.  Non- and low-digestible 
polysaccharides and oligosaccharides are good candidates for use as food ingredients in 
low-calorie products because they resist digestion in the small intestine and may be partially 
or totally fermented in the colon.  As a result, they have lower caloric content of 
approximately 1 to 3 kcal/g for low-digestible carbohydrates compared with 4 kcal/g for 
completely digestible carbohydrates (Sako et al., 1999; Roberfroid and Slavin, 2000; 
Grabitske and Slavin, 2008). 
Gastrointestinal Health and Fermentation 
 While the physiological effects of fiber depend on numerous variables, the majority 
of the beneficial effects originate from its fermentative action in the colon.  The 
gastrointestinal tract is heavily populated with bacteria, with the large bowel being the most 
heavily colonized region.  The bacteria are mainly strictly anaerobic.  This microbial 
community is complex in terms of numbers of organisms and their diversity.  There are 
approximately 10
13 
anerobic bacteria for every gram of intestinal content (Tungland and 
Meyer, 2002; Mussatto and Mancilha, 2007).  Through the use of sequencing of the highly 
conserved 16S region of ribosomal RNA, it is estimated that there are approximately 800 – 
1,000 different bacterial species with over 7,000 strains (O’Keefe, 2008; Qin et al., 2010).  
Through the process of fermentation, colonic bacteria produce a wide variety of compounds 
that may affect the gut as well as systemic physiology of the host (Roberfroid and Slavin, 
2000).  The rate of carbohydrate fermentation is dependent upon factors including degree of 
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polymerization, glycosidic linkage and degree of branching, bacteria present, and 
saccharolytic capacity (Voragen, 1998).  Due to their chemical structure, low-digestible 
carbohydrates are substrates that can be fermented only by a limited number of bacteria.  
Among the groups of bacteria present in the gastrointestinal tract, the bifidobacteria and 
lactobacilli are those that best utilize oligosaccharides.  These microorganisms appear to be 
benefical to host health (Bielecka et al., 2002; Mussatto and Mancilha, 2007). 
 Short-Chain Fatty Acids 
Low-digestible carbohydrates are substrates for fermentation by anaerobic colonic 
microflora since they are partially resistant to hydrolysis and digestion in the stomach and 
small intestine and eventually enter the colon for fermentation (Wong et al., 2006). 
Fermentation yields ME for microbial growth and maintenance, and metabolic end-products 
for use by the host (Wong et al., 2006).  The major end-products of fermentation are SCFA, 
carbon dioxide, methane, hydrogen, and heat (Wong et al., 2006). Short-chain fatty acids are 
mainly found in the proximal colon where fermentation is most active, and the amount 
produced is reflective of the supply of carbohydrate in the diet (Nugent, 2005).  The major 
SCFA produced by fermentation are acetate, propionate, and butyrate, although other SCFA 
such as formate, valerate, and caproate are produced in lesser amounts (MacFarlane and 
MacFarlane, 2003).  Much of the hydrogen produced is converted to methane by bacteria, 
and both hydrogen and methane are excreted in breath and flatus (Elia and Cummings, 
2007).  Lactate also is produced from fermentation of oligosaccharides.  Both D- and L-
lactate are produced, and both are absorbed. 
The generation of SCFA from fermentation has several effects on colonic function 
and health.  Short-chain fatty acids are rapidly absorbed and provide colonic cells with 
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substrate for energy production, with butyrate being the preferred energy source for the 
colonic epithelial cells (Wong et al., 2006; Elia and Cummings, 2007).  Propionate passes to 
the liver where it is taken up and metabolized aerobically to glucose (Topping and Clifton, 
2001; Elia and Cummings, 2007). Acetate is the major SCFA produced in all types of 
fermentation.  The molar ratio of acetate:propionate:butyrate is approximately 60:20:20 
(Elia and Cummings, 2007).  Acetate is rapidly absorbed, stimulating sodium absorption, 
and passes to the liver and into the peripheral tissues to be oxidized by skeletal and cardiac 
muscles as an energy source (Topping and Clifton, 2001).   
Along with providing fuels for maintaining normal colonic function, SCFA can 
regulate colonocyte gene expression, induce arrest of cell division and apoptosis, and can 
exert trophic effects on colonic epithelium (Mentschel and Claus, 2003).  It has been 
reported that butyrate can inhibit inflammation responses by down-regulating the activity of 
the transcription factor nuclear factor kappa β (NF-kβ) (Segain et al., 2000). Nuclear factor 
kappa β is a major regulator of inflammation and many immune responses.  The ability of 
butyrate to affect NF-kβ expression and activity may have beneficial effects on colonic 
function, particularly in inflammatory bowel disease (Nugent, 2005).   
Low-digestible carbohydrates increase SCFA production that leads to a lower 
colonic pH and potential modification of the metabolism of bile acids.  A decrease in 
colonic pH might reduce the risk of developing colonic cancer because an inverse 
correlation between stool pH and colon cancer risk has been observed (Bouhnik et al., 
2004).  A lowered pH also inhibits the transformation of primary to secondary bile acids.  
Secondary bile acids are cytotoxic to colonic cells and may promote the formation of tumors 
(Young and Le Leu, 2004).  Lower pH is thought to control the overgrowth of potentially 
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pathogenic bacteria, limit absorption of potentially cytotoxic agents, and lower the risk of 
infectious diarrhea (Topping et al., 2008). 
Microbiota Modulation 
Microbiota are present throughout the gastrointestinal tract, but the majority are 
located in the large intestine and consist of a wide variety of bacterial genera, species, and 
strains that are thought to be either beneficial (e.g., bifidobacteria and lactobacilli) or 
detrimental (e.g., Clostridium spp.) to host health (Bouhnik et al., 2004).  Diet can have an 
impact on many microbiota-associated activities and, thus, may impact host health. 
  Microbial populations present in the gut are able to produce a range of compounds 
through the process of fermentation.  These compounds can have both positive and negative 
effects on gut physiology.  Competition for nutrients, production of antimicrobial 
compounds, lowering of intestinal pH, and stimulation of the immune system all may play a 
role in providing an efficient barrier for invading pathogens and all are affected by the 
microbial population present (Macfarlane, 2008; Adam-Perrot, 2009).  Evidence is 
emerging supporting the concept that the maintenance of a healthy gut microflora may 
provide protection against gastrointestinal disorders including gastrointestinal infections, 
inflammatory bowel disease, and colon cancer (Puupponen-Pimia et al., 2002).   
Bifidobacteria are thought to stimulate the immune system, produce B vitamins, inhibit 
pathogen growth, reduce blood ammonia and blood cholesterol concentrations, and help 
restore the normal flora after antibiotic therapy (Gibson and Roberfroid, 1995; Wang, 2009).  
Lactobacilli may aid digestion of lactose in lactose-intolerant individuals, reduce 
constipation and infantile diarrhea, help resist infections such as salmonella, and help to 
relieve irritable bowel syndrome (Manning and Gibson, 2004; Wang, 2009). 
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Selectively fermented ingredients that allow specific changes, both in the 
composition and (or) activity of the gastrointestinal microbiota that confer benefits upon 
host health, are termed prebiotics (Gibson et al., 2004).  They provide benefits by producing 
SCFA that lower the pH of the contents of the large intestine.  A reduced pH is beneficial by 
creating an environment that stimulates the growth of certain bacteria like bifidobacteria and 
lactobacilli and by attenuating growth of harmful bacteria such as Clostridium perfringens 
(Topping and Clifton, 2001).   
The genera, bifidobacteria and lactobacilli, are considered beneficial because they do 
not contain any strains known to be pathogenic, and they are primarily carbohydrate-
fermenting bacteria, unlike other groups such as bacteroides and clostridia that are also 
proteolytic and amino acid-fermenting (Guarner, 2007).   The products of protein 
breakdown and amino acid fermentation, which include ammonia, phenols, indoles, thiols, 
amines, and sulfides, are not beneficial to gut and host health, and actually can be 
detrimental. 
 Bifidobacteria and lactobacilli also play a significant role in the maintenance of 
colonization resistance and have potential health benefits in strengthening the gut barrier 
against infection (Gibson et al, 2005).  Viruses, protozoa, fungi, and bacterial can all cause 
acute gastroenteritis. The gut microbiota produce SCFA that lower gut pH to levels below 
those at which such pathogens can effectively compete.  Also, many lactobacilli and 
bifidobacterial species are able to excrete natural antibiotics (Manning and Gibson, 2004).  
Prebiotic bacteria may be able to stimulate both non-specific host defense mechanisms and 
specific immune responses.  The result often is increased phagocytic activity and (or) 
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elevated concentrations of immunological molecules such as secretory IgA, which may 
negatively affect pathogens such as salmonella and rotovirus (Manning and Gibson, 2004).    
The effective bifidogenic doses vary among the different low-digestible 
carbohydrate types.  Many studies have been performed using daily doses ranging from 3–
15 g of the low-digestible carbohydrates for 1-3 weeks, and most oligosaccharides have 
been demonstrated to increase bifidobacteria numbers in the colon at these doses (Crittenden 
and Playne, 1996; Roberfroid and Slavin, 2000).  Inulin-type fructans have been extensively 
studied, and their bifidogenic effect has been shown at doses as low as 4 g/day, but there is 
some consensus that larger doses, preferentially 8-15 g/day, would be needed to increase 
bifidobacteria and lactobacilli cell numbers in the colon (Bouhnik et al., 2004; Manning and 
Gibson, 2004; Roberfroid, 2005).  Bifidogenic effects noted at lower doses of inulin-type 
fructans have been attributed to the host baseline bifidobacteria level being low (Mussatto 
and Mancilha, 2007). 
Gut Morphology 
 Dietary fiber ingestion is associated with changes in the structure of the 
gastrointestinal tract.  Changes include alterations in length and weight and modifications in 
the morphology of the mucosa such as higher villi, deeper crypts, increased number of 
goblet cells, and a thicker mucus layer on the colonic epithelium (Sigelo et al., 1984; Kim, 
2002).  These modifications may impact barrier function and elements of immune function 
of the large intestine since it encompasses a significant portion of the human immune 
system (Tungland and Meyer, 2002).  The fermentation of low-digestible carbohydrates 
may be important in modulating the barrier function by increasing the number of 
bifidobacteria and lactobacilli in the epithelial mucosa of the colon (Guarner, 2007).   
 25 
 
Ingestion of inulin-type fructans and other low-digestible carbohydrates have 
resulted in increased cecum weights when supplemented in diets of rats (Levrat et al., 1991; 
Campbell et al., 1997; Lu et al., 2000; Kim, 2002).  Length of the small intestine also can be 
increased through dietary supplementation of low-digestible carbohydrates (Chun et al., 
1989).  Low-digestible carbohydrates also have been reported to increase villus height 
throughout the small intestinal tract of rats and piglets (Chun et al., 1989; Kim, 2002; Xu et 
al., 2002; Van Nevel et al., 2003; Rossi et al., 2008).  Along with increased villus height, 
another beneficial morphological effect of low-digestible carbohydrate supplementation is 
increased crypt depth (Jin et al., 1994; Kleessen et al., 2003).  The crypts contain intestinal 
stem cells, the principal site of cell proliferation in the intestinal mucosa, and increased 
depth may be associated with increased rate of turnover of intestinal mucosal cells. 
Low-digestible carbohydrates can affect the mucosal architecture by affecting goblet 
cell numbers and mucin types secreted.  Mucins are high molecular mass glycoproteins that 
are synthesized and secreted by the goblet cells. They form a gel-like layer on the mucosal 
surface and provide ideal conditions for the colonization of residental microbiota (Forstner, 
1978; Kleessen et al., 2003).  Mucins are assumed to provide lubrication and protection of 
the underlying epithelium against potentially injurious chemicals, enzymes, bacteria, and 
dietary constituents.  The amount and composition of the mucus layer reflects an 
equilibrium between mucus secretion on the one hand and its erosion and degradation by 
bacteria on the other (Deplancke and Gaskins, 2001).   
Mucins are classified into neutral and acidic subtypes.  Acidic mucins are further 
classified as sulfated (sulfomucins) or non-sulfated (sialomucins) groups.  It is suggested 
that acidic mucins protect against bacterial translocation because sulfated mucins in 
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particular appear to be less degradable by bacterial glycosidases and host proteases 
(Deplancke and Gaskins, 2001).  Increases in goblet cell numbers have been reported in rats 
fed dietary fiber, including inulin-type fructans (Satchithanandam et al., 1990; Meslin et al., 
1993; Fontaine et al., 1996; Schmidt-Wittig et al., 1996; Kim, 2002). Rat studies with diets 
supplemented with inulin-type fructans have been shown to modulate mucins in the 
intestinal tract by increasing acidic mucins, especially the protective sulfomucins (Fontaine 
et al., 1996; Delzenne, 2003; Kleessen et al., 2003).  Alterations in the mucosal architecture 
and amounts of sulfomucins and sialomucins could have important effects on the gut 
mucosal barrier and health maintenance of the gut. 
Health Detriments of Low-Digestible Carbohydrates 
Low-digestible carbohydrates offer many potential benefits, but these benefits can be 
offset by tolerance issues when consumed.  Low-digestible carbohydrates are generally well 
tolerated but since they may increase the rate of fermentation in the colon, they may result 
in abdominal pain, excessive flatus, and diarrhea (Livesey, 2001; Marteau and Flourie, 
2001; Grabitske and Salvin, 2008). Due to differences in degree of absorption and 
fermentation, and to differences in osmotic effects, there is variation in tolerance of low-
digestible carbohydrates.  Also, there is inter-individual variability in tolerance, perhaps due 
to differences in absorption capacities, motility patterns, and colonic responses among 
individuals (Marteau and Flourie, 2001).   
Undesirable outcomes often are caused by altered osmotic responses that 
unabsorbed, low-digestible carbohydrates exert in the intestinal lumen.  This osmotic effect 
increases water flow rate and may induce borborygmi, abdominal pain, and diarrhea 
(Marteau and Flourie, 2001).  Diarrhea resulting from low-digestible carbohydrate 
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consumption may be associated with the fermentation process.  The rapid fermentation of 
low-digestible carbohydrates can yield lactate and SCFA at a faster rate than can be 
absorbed, thus temporarily inducing diarrhea (Livesey, 2001).  When low-digestible 
carbohydrates are ingested, they also may lead to an elevated water load entering the colon.  
This occurs because additional water may be drawn into the small intestine to maintain 
osmolality (Livesey, 2001).   
When low-digestible carbohydrates enter the colon, they are subjected to anaerobic 
fermentation that leads to gaseous end-products, carbon dioxide, hydrogen, and methane 
(Livesey, 2001).  High rates of gas production may cause discomfort and pain in some 
people.   It is not clear whether individuals can adapt to the higher rates of gas production 
that low-digestible carbohydrates cause (Livesey, 2001). 
Besides tolerance issues, there is some research that inulin-type fructans can 
negatively affect the epithelial barrier in the gut by increasing intestinal permeability.  Ten 
Bruggencate et al. (2005) found that inulin supplementation of rats on a low-calcium diet 
increased translocation of salmonella in infection studies.  Also, inulin supplementation was 
associated with increased fecal water cytotoxicity, increased excretion of nitrates, and 
increased excretion of mucins after the rats were inoculated with salmonella (Ten 
Bruggencate et al., 2003).   Supplementing inulin to humans showed signs of mucosal 
irritation through increased mucin excretion, but adverse effects on resistance to intestinal 
infections were not observed as in rats (Ten Bruggencate et al., 2006).    The rapid 
fermentation of low-digestible carbohydrates can result in overproduction of organic acids 
which may lead to epithelial injury and increased intestinal permeability; however, the 
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mechanisms responsible for this adverse effect of inulin-type fructan consumption is unclear 
(Ten Bruggencate et al., 2005; Guarner, 2007) 
Novel Low-Digestible Carbohydrates 
Pullulan 
Pullulans are  naturally occurring, fungal polysaccharides produced by 
Aureobasidium pullulans, a black yeast found throughout all ecological niches including 
forest soils, fresh and sea water, and plant and animal tissues (Wolf et al., 2003; Shingel, 
2004). Pullulans are linear polysaccharides consisting of three  -(1-4) linked glucose 
molecules that are repeatedly polymerized by  -(1-6) linkages on the terminal glucose, 
resulting in a stair-step structure (Leathers, 2003; Shingel, 2004).  The stair-step structure 
resulting from glycosidic linkages in pullulans hinders hydrolysis by enzymes, making them 
low-digestible carbohydrates (Wolf et al., 2003).      
Commercially produced pullulan has been available since 1976 from the 
Hayashibara Company Ltd., Okayama, Japan (Shingel, 2004).  It is produced by 
fermentation of a food-grade hydrolyzed starch using a strain of A. pullulans that is non-
toxin producing (Kimoto et al., 1997; Shingel, 2004).  Upon completion of fermentation, the 
fungal biomass, pigments, and other impurities are removed.   Pullulans are stable in 
aqueous solutions over a wide pH range and dissolve readily in water to form viscous 
solutions.  Upon drying, pullulans form transparent, water-soluble, fat-resistant, odorless, 
and flavorless films (Leathers, 2003). 
The unique linkage pattern of pullulans gives them distinctive characteristics like the 
capacity to form fibers, compression moldings, and strong oxygen-impermeable films 
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(Leathers, 2003).  Pullulans are stable in aqueous solutions over a wide pH range and 
dissolve readily in water to form viscous solutions.  Upon drying, pullulans form 
transparent, water-soluble, fat-resistant, odorless, and flavorless films (Leathers, 2003). 
Pullulans possess many characteristics that make them ideal for numerous 
applications in food and pharmaceutical manufacturing.  Their consistency, dispersibility, 
and moisture retention characteristics are similar to those of starch, so they are commonly 
used as a starch replacement in certain foods (Singh et al., 2008).  A popular application for 
pullulans is for films that are thin, clear, readily dissolved, and highly oxygen-impermeable, 
making them ideal for edible food coatings (Singh et al., 2008).  Pharmaceutical uses for 
pullulan include use in sustained-release formulations, in coatings of pills for strength and 
shelf life, and as films for oral care products (Singh et al., 2008).   
Pullulan also has been evaluated for its potential to attenuate glycemic response. 
Spears et al. (2005) evaluated two pullulans in dogs, one high molecular weight (MW 
100,000) and one low molecular weight (MW 6,300).  Authors reported that, although not 
statistically significant, the low-MW pullulan had a numerically lower glycemic response 
for the first 60 min postprandial compared to maltodextrin.  Wolf et al. (2003) evaluated the 
glycemic response of  a low-MW pullulan  (MW 100,000) in humans and found that it 
reduced (P<0.01) the glucose AUC by 50% compared to maltodextrin.   
Soluble Fiber Dextrin 
Components in starch hydrolysates, such as dextrins, maltodextrin, and corn syrup, 
may be rendered at least partially indigestible.  These products are termed resistant 
maltodextrins, indigestible dextrins, or soluble fiber dextrins (SFD) and are produced when 
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a starch source is treated with heat and acid.  This treatment causes the starch molecules to 
undergo hydrolysis and produce short-chain oligosaccharides that randomly re-arrange 
during cooling, forming a highly branched structure (Laurentin and Edwards, 2004; 
Lefranc-Millot et al., 2009).  During this treatment, formation of random linkages occurs 
including the digestible α-1-4 linkages and the non-digestible linkages such as β-1-4, α and 
β-1-6, α and β-1-3, 1-2 (Laurentin et al., 2003).  Due to their structural characteristics, SFD 
are only partially hydrolyzed by human digestive enzymes and absorbed in the small 
intestine (van den Heuvel et al., 2005).   
The dextrinization process generates compounds with a broad molecular weight 
range that can be narrowed by eliminating the higher molecular weight fractions, leading to 
a dextrin with a reduced viscosity (Joshi and Neves, 2006).   Eliminating low molecular 
weight fractions can make the dextrin sugar-free, improve its digestive tolerance, and reduce 
hygroscopicity (Joshi and Neves, 2006).   The dextrininization process also leaves the 
product with a discoloration and an off-taste.  The heat-treated starch then goes through a 
purification step with amylases to remove undesirable odors and tastes, and this is followed 
by decolorizing and demineralization (Joshi and Neves, 2006).   The amylase purification 
step also can slightly increase digestibility of the SFD. 
Soluble fiber dextrins possess characteristics that allow them to be easily 
incorporated into a wide variety of foods (Ohkuma and Wakabayashi, 2001) such as high 
solubility, low viscosity, stability under numerous processing steps, and neutral taste 
(Ohkuma and Wakabayashi, 2001). Soluble fiber dextrins also have been shown to have a 
high digestive tolerance allowing them to be incorporated into foodstuffs at sufficient 
concentrations to induce beneficial health outcomes (Pasman et al., 2006). 
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Slavin et al. (2009) reported in a review that wheat dextrin had a GI of 25% and 
insulin response of 13% compared with dextrose when evaluated in healthy human subjects.  
Kendall et al. (2008) evaluated the glycemic response in humans of 25 g of a SFD that was 
incorporated into a beverage.  Authors reported an AUC of 50.1 mmol/L for SFD that was 
lower compared to the glucose control (103.7 mmol/L).  The same trend was noted for the 
insulin response. 
Fibersol-2
®
 is a commercially available SFD that has been found to have a caloric 
value of 1.0-1.5 kcal/g (Ohkuma and Wakabyashi, 1998).  Tsuji and Gordon (1998) 
measured the caloric value of Fibersol-2
®
 in rats and calculated a caloric value of 1.2 kcal/g.  
Goda et al. (2006) measured net metabolizable energy of Fibersol-2
®
 in humans using 
indirect calorimetry and calculated a caloric value of 1.5 kcal/g.   
Nutriose
®
 FB is a commercially available low-digestible carbohydrate produced 
from wheat starch.  Caloric values of 2 and 1.7 kcal/g have been reported for Nutriose
®
 FB 
(Auerbach et al., 2006; Lefranc-Millot et al., 2009)  The degree of resistance to digestion of 
modified starches depends not only on structural differences, but also on starch source and 
manufacturing processes used. 
Lefranc-Millot et al. (2009) reported that supplementation of 15 g per day of a wheat 
dextrin (Nutriose
®
) over two weeks decreased fecal pH and significantly reduced 
Clostridium perfringens from 5.9 to 5.6 log CFU/g in human feces.  Fastinger et al. (2008) 
evaluated the consumption of 7.5 and 15 g/d of Fibersol-2® in 38 humans.  Over the 3 wk 
period, Fibersol-2® supplementation tended to increase the molar proportion of butyrate 
produced (16.5 %) and bifidobacteria populations (10.4 log CFU/g dry feces)  with the 15 
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g/d treatment over baseline values (molar butyrate proportion 14.1%; 9.62 log CFU/g dry 
feces). 
Soluble Corn Fiber 
 Another novel, low-digestible carbohydrate is soluble corn fiber (SCF) obtained by 
isolating an oligosaccharide-rich fraction from partially hydrolyzed corn syrup.  During corn 
starch hydrolysis, an aqueous stream comprised of dextrose, fructose, and a mixture of 
oligosaccharides is formed (Harrison and Hoffman, 2007).  This stream undergoes several 
additional processes including nanofiltration and use of enzymes to create a compound with 
increased glycosidic α-1,6 and other non-digestible bonds (Harrison and Hoffman, 2007).  
These processing methods yield an oligosaccharide with approximately 72% total dietary 
fiber (AOAC method 2001.03; Adam-Perrot et al., 2009).  Soluble corn fibers function like 
glucose syrup and are incorporated easily into many food formulations (Adam-Perrot et al, 
2009).  They may be aded to cereal bars, breakfast cereals, cookies, biscuits, beverages, 
yogurts, ice creams, sauces, confections, and processed meats. 
Increased dietary fiber intake often is associated with adverse gastrointestinal 
symptoms; thus, the type of dietary fiber should be taken into consideration before being 
incorporated into the diet.  Stewart et al. (2010) found SCF to be well-tolerated when 
supplemented at 12 g/day. Low scores in bloating, cramping, flatulence, and borborygmi 
were observed (Stewart et al., 2010). Sanders et al. (2008) also reported SCF to be well 
tolerated by healthy humans at daily dosages of 5, 15, and 25 g. 
Soluble corn fibers may possess beneficial glycemic properties due to their increased 
glycosidic bonds and ability to resist hydrolytic digestion and be fermented.  Kendall et al. 
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(2008) evaluated the in vitro digestibility of a SCF and it was calculated to be 14.5%.    
Kendall et al. (2008) also evaluated the glycemic response in humans of 25 g of SCF 
incorporated in a beverage.  Authors reported an AUC of 28.5 mmol/L for SCF which was 
lower compared to the glucose control (103.7 mmol/L).  The insulin response of SCF was 
only 13% of the glucose control (Kendall et al., 2008).   
A significant portion of SCF will enter the colon and have the potential to be 
fermented by the microbiota.  Maathuis et al. (2009) evaluated the prebiotic activity of SCF 
using a validated dynamic computer-controlled in vitro model of the human proximal large 
intestine (TIM-2).  The fiber was first pre-digested using an in vitro hydrolytic digestion 
assay and then inoculated with intestinal inoculum in TIM-2 (Maathuis et al., 2009).  
Soluble corn fiber and other low-digestible carbohydrates tested resulted in higher SCFA 
production (168.8 mmol) compared with a cellulose control (94.6 mmol) after 72 hours 
(Maathuis et al., 2009).  Soluble corn fiber was noted to increase bifidobacteria, but not 
lactobacilli concentrations, as measured using a DNA microarray chip (Maathuis et al., 
2009). 
Soluble corn fiber has been reported to benefit bone health in rats.  Supplementation 
of SCF was shown to increase whole body bone mineral content and density, cortical 
thickness and area, and peak breaking strength of the distal femur compared with a cellulose 
control and several other low-digestible carbohydrates (Weaver et al., 2010). Immunity 
modulation properties of SCF also have been evaluated using rodent models.  Bassaganya-
Riera et al. (2010) used interleukin-10-deficient mice as a model of inflammatory bowel 
disease and found supplementation of SCF to have preventive effects as regards 
spontaneous colitis and ileitis and ameliorated disease activity.  Soluble corn fiber decreased 
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cytokine IFN-γ production by cells from the Peyer’s patches (Bassaganya-Riera et al., 
2010).  Soluble corn fiber, therefore, may have the potential to minimize gut inflammation. 
Summary 
With increased awareness of the potential health benefits associated with dietary 
fibers, the demand for carbohydrates with functional properties similar to dietary fiber is 
growing.  Low-digestible carbohydrates with properties similar to dietary fiber are of 
interest because they can be incorporated into a variety of foodstuffs more easily.  Beneficial 
properties associated with low-digetible carbohydrates include diminished hydrolytic 
digestion, attenuated glycemic and insulinemic responses, reduced energy content, 
fermentation to produce SCFA, the ability to stimulate the growth of beneficial bacteria in 
the colon, and beneficial modulation of intestinal morphology.  A group of novel low-
digestible carbohydrates, including pullulan, soluble fiber dextrin, and soluble corn fiber, 
will be evaluated for these characteristics.  The information gained from this research will 
provide insight into the physiological characteristics of select carbohydrates that could 
positively impact human health. 
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CHAPTER 3: SOLUBLE FIBER DEXTRINS AND PULLULANS VARY IN 
EXTENT OF HYDROLYTIC DIGESTION IN VITRO AND IN ENERGY VALUE 
AND ATTENUATE GLYCEMIC AND INSULINEMIC RESPONSES IN DOGS 
 
ABSTRACT: The objective of this research was to measure in vitro hydrolytic digestion 
characteristics, glycemic and insulinemic responses, and true metabolizable energy (TMEn) 
content of select soluble fiber dextrins (SFDs) and pullulans.  The SFDs were derived either 
from tapioca starch or from corn starch.  The pullulans were of low, intermediate, and high 
molecular weight.  Soluble fiber dextrins varied in digestibility, with all substrates resulting 
in low to intermediate in vitro monosaccharide digestion.  Pullulans were nearly completely 
hydrolyzed after simulated hydrolytic digestion.  The glycemic response with dogs varied 
widely among SFDs, with all but one SFD substrate having lower glycemic response than 
maltodextrin (Malt).  The pullulans all resulted in low glycemic values. Lower relative 
insulinemic responses (RIR) compared to the Malt control were noted for all SFDs and 
pullulans.  True metabolizable energy (TMEn) values for SFDs obtained using roosters were 
lower than for Malt, with tapioca-based SFDs having numerically higher values than corn-
based SFDs.  Pullulans resulted in higher TMEn values than did SFDs.  Soluble fiber 
dextrins and pullulans may be suitable candidates for reduced calorie and glycemic 
foodstuffs. 
INTRODUCTION 
In recent years, the demand for functional ingredients that provide specific health 
benefits has increased (Murphy, 2001).  There are several reasons why consumption of 
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functional foods is increasing, including a concern about the high cost of prescription drugs, 
a quest for more natural remedies to improve health, engagement in preventative health 
measures, and an interest in overall health improvement (Burdock et al., 2006).  The global 
trend in rising levels of chronic diseases such as obesity, diabetes, heart disease, and cancer 
is also increasing demand for functional ingredients that can be utilized to control, prevent, 
or ameliorate these diseases. 
Dietary fibers differ widely in chemical and physical properties and exert a variety of 
physiological and nutritional properties in humans (van Loo et al., 1999).  Dietary fibers 
have been shown to promote healthy gut function and other beneficial effects such as 
laxation, reduction in blood cholesterol concentrations, modulation of blood glucose 
concentration, and bifidogenic properties (Murphy, 2001).  Substrates possessing properties 
similar to dietary fiber are being sought for potential incorporation into foodstuffs.  This has 
led to an expansion in the demand for carbohydrates that have functional properties similar 
to those of dietary fiber, but that may be incorporated more easily into a wider array of solid 
and liquid food matrices.  A class of carbohydrates that may prove to be suitable are low-
digestible carbohydrates. 
Some carbohydrates are unavailable to digestive enzymes, so are either only partially 
absorbed or not absorbed in the small intestine, and vary in fermentability upon reaching the 
large intestine.  These low-digestible carbohydrates possess many physiological properties 
that may provide potential human health benefits including a role in prevention of obesity, 
diabetes, colon cancer, and irritable bowel syndrome (Scheppach et al., 2001).  Both soluble 
fiber dextrins (SFD) and pullulans are low-digestible carbohydrates that have physiological 
attributes resembling dietary fiber and may result in physiological benefits.   
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Components in starch hydrolysates, such as dextrin, maltodextrin, and corn syrup, 
may be rendered at least partially indigestible.  These products are termed resistant 
maltodextrins, indigestible dextrins, and soluble fiber dextrins and are produced when a 
starch source is treated with heat and acid.  This treatment causes the starch molecules to 
undergo hydrolysis and produce short-chain oligosaccharides that randomly rearrange 
during cooling, forming a highly branched structure (Laurentin and Edwards, 2004; 
Lefranc-Millot et al., 2009).  During this treatment, the formation of random linkages occurs 
including the digestible linkages of α 1 - 4 and α 1 - 6, and nondigestible linkages such as β 
1 - 4, β 1 - 6, α and β 1 - 3, 1 - 2.(Laurentin et al., 2003; Lefranc-Millot et al., 2009).  Due to 
their structural characteristics, SFDs are only partially hydrolyzed by human digestive 
enzymes and absorbed in the small intestine (van den Heuvel et al., 2005).   
The dextrinization process generates a product with a broad molecular weight range 
(Joshi, 2006) that can be narrowed by eliminating the higher molecular weight fractions, 
leading to a dextrin with a reduced viscosity (Joshi, 2006).   Eliminating low molecular 
weight fractions can make the dextrin sugar-free, improve its digestive tolerance, and reduce 
hygroscopicity  (Joshi, 2006).  The dextrininization process also leaves the product with a 
discoloration and an off-taste.  The heat-treated starch then goes through a purification step 
with amylases to remove undesirable odors and tastes, and this is followed by decolorizing 
and subsequent demineralization (Joshi, 2006).  This amylase purification step can affect the 
digestible and indigestible components of the SFD. 
Soluble fiber dextrins possess characteristics that allow them to be easily 
incorporated into a wide variety of foods(Ohkuma et al., 2001; Lefranc-Millot et al., 2009) 
such as solubility, low viscosity, stability under numerous processing steps, and neutral taste 
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(Ohkuma et al., 2001; Lefranc-Millot et al., 2009).  Soluble fiber dextrins also have been 
shown to have a high digestive tolerance allowing them to be incorporated into foodstuffs at 
sufficient concentrations to induce beneficial health outcomes (Pasman et al., 2006). 
Pullulans are naturally occurring fermentation products produced by Aureobasidium 
pullulans, a black yeast found throughout all ecological niches including forest soils, fresh 
water and seawater, and plant and animal tissues (Wolf et al., 2003; Shingel, 2004). 
Pullulans are linear polysaccharides consisting of three  -(1-4) linked glucose molecules 
that are repeatedly polymerized by  -(1-6) linkages on the terminal glucose, resulting in a 
stair-step structure (Kimoto et al., 1997; Leathers, 2003). The stair-step structure resulting 
from glycosidic linkages in pullulans hinders hydrolysis by enzymes, making them low-
digestible carbohydrates (Wolf et al., 2003).      
Commercially produced pullulans have been available since 1976 from the 
Hayashibara Company Ltd. (Shingel, 2004).  They are produced by fermentation from a 
food-grade hydrolyzed starch using a strain of A. pullulans that is non-toxin producing 
(Kimoto et al., 1997; Shingel, 2004).  Upon completion of fermentation, the fungal biomass, 
pigments, and other impurities are removed. 
The unique linkage pattern of pullulans gives them distinctive characteristics like the 
capacity to form fibers, compression moldings, and strong oxygen-impermeable films 
(Leathers, 2003).  Pullulans are stable in aqueous solutions over a wide pH range and 
dissolve readily in water to form viscous solutions.  Upon drying, pullulans form 
transparent, water-soluble, fat-resistant, odorless, and flavorless films (Leathers, 2003). 
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Pullulans possess many characteristics that make them ideal for numerous 
applications in food and pharmaceutical manufacturing.  Pullulans’ consistency, 
dispersibility, and moisture retention characteristics are similar to those of starch, so they 
are commonly used as a starch replacement in certain foods (Leathers, 2003; Singh et al., 
2008).  A popular application for pullulans is for films that are thin, clear, readily dissolved, 
and highly oxygen-impermeable making them ideal for edible food coatings (Singh et al., 
2008).  Pharmaceutical uses for pullulan include use in sustained-release formulations, in 
coatings of pills for strength and shelf life, and as films for oral care products (Singh et al., 
2008).    
The objective of this study was to evaluate select soluble fiber dextrins and pullulans 
for physiological properties that could positively impact human health.  Properties evaluated 
included in vitro hydrolytic digestion characteristics, glycemic and insulinemic responses 
using a dog model, and true metabolizable energy (TMEn) using an avian model. 
MATERIALS AND METHODS 
Substrates: 
 Carbohydrates studied included six soluble fiber dextrins (SFDs) and three 
pullulans.  Six SFDs were evaluated and were produced using two different starch sources.  
All SFDs were produced using a standard process of treating starch with heat, acid, and 
enzymes.     Three SFDs were prepared from tapioca starch:  tapioca-based SFD1 (T1), 
tapioca-based SFD2 (T2), and tapioca-based SFD that was hydrogenated (TH).  The other 
three substrates were commercially available SFDs prepared from corn starch: corn-based 
SFD1 (C1), corn-based SFD2 (C2), and corn-based SFD3 (C3).  Tapioca-based SFD1 (T1) 
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and T2 were produced under similar conditions, but with differences in the purification 
method, and TH underwent a hydrogentation process.  Hydrogenation of the tapioca-based 
SFD involved subjecting the starch solution to hydrogen in the presence of a catalyst (e.g., 
nickel or platinum (Boyers, 1959)) in which monosaccharides were converted to alcohols 
such as sorbitol.  The corn-based SFDs varied in total dietary fiber content (AOAC Method 
2001.03) with C1 containing 90% fiber, C2, 85% fiber, and C3, 70% fiber, as stated by the 
manufacturers.  Tapioca-based SFDs were prepared by Tate & Lyle (Decatur, IL).  Corn-
based SFD1 is Fibersol-2 from Matsutani America Inc. (Clinton, IA).  Corn-based SFD2 
and C3 are Nutriose products (Nutriose
  
FM06 and Nutriose 
 
FM10, respectively) from 
Roquette (Keokuk, IA).   
Pullulans evaluated were of varying molecular weights: a low MW pullulan (Pull 
LMW) (MW 100,000),  an intermediate MW pullulan (Pull IMW) (MW 250,000), and a 
high MW pullulan (Pull HMW) (MW 500,000).  Pull LMW and Pull HMW were prepared 
by Tate & Lyle (Decatur, IL). IMW pullulan is produced by Hayashibara Company Ltd. 
(Okayama, Japan). 
Chemical Analyses:   
Carbohydrates were analyzed for dry matter (DM) and organic matter (OM) 
according to AOAC (2000), and for free and hydrolyzed monosaccharide concentrations.  
Test carbohydrates were hydrolyzed using the procedure described by Hoebler et al. 
(Hoebler et al., 1989) where carbohydrates were subjected to hydrolysis with H2SO4 acid.  
Free sugars and hydrolyzed monosaccharides were quantified using a Dionex DX500 high 
performance liquid chromatography (HPLC) system (Dionex Corporation, Sunnyvale, CA).  
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Standards for quantification included inositol, fucose, arabinose, rhamnose, galactose, 
xylose, and mannose.  Free monosaccharides were injected at a volume of 25 L .  All 
assays were conducted using a CarboPac PA-1 column and guard column following 
methods cited by Smiricky et al. (Smiricky et al., 2002).   
In Vitro Hydrolytic Digestion:   
Approximately 200 mg of each carbohydrate were weighed in triplicate and 
incubated with 2 mL of a pepsin/hydrochloric acid solution and 2 mL of an enzyme solution 
consisting of amylogucosidase and  -amylase to simulate gastric and small intestinal 
digestion (Muir and O'Dea et al., 1993).  The samples were analyzed for free released 
monosaccharides using HPLC (Smiricky et al., 2002) following the simulated hydrolytic 
digestion procedure.  
 Data were analyzed as a completely randomized design using the Mixed Models 
procedure of SAS (SAS Institute, Inc., Cary, NC). The statistical model included the fixed 
effect of substrate.  Treatment least-squares means were reported and compared using a 
Tukey adjustment to ensure the overall protection level. Differences among means with a P-
value of less than 0.05 were considered significant. 
Glycemic/Insulinemic Responses:   
To determine postprandial glycemic and insulinemic responses to the test carbohydrates, 
five purpose-bred female dogs (Butler Farms, Clyde, NY) with hound bloodlines, a mean 
initial body weight of 25.1 ± 4.8 kg, and a mean age of 5.6 ± 2.4 years were used.  Dogs 
were housed individually in 1.2 x 2.4 m clean floor pens in a climate-controlled room at the 
animal care facility of the Edward R. Madigan Laboratory on the University of Illinois 
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campus. Dogs were provided with nondestructible toys (hard plastic balls, Nyla bones, etc.).  
Pens allowed for nose - nose contact between dogs in adjacent runs and visual contact with 
all dogs in the room.  A 16 h light:8 h dark cycle was used. The University of Illinois 
Institutional Animal Care and Use Committee approved all procedures prior to animal 
experimentation. 
Dogs were orally dosed with 25 g of test carbohydrate (DM basis) in approximately 
240 mL of double distilled/deionized water.  In order to get carbohydrate sources into 
solution, water and carbohydrate were mixed using a stir plate.   Quantity to be dosed was 
measured using a disposable 60 cc syringe (without needle), and all 25 g was consumed by 
the dogs within a 10 min period.  During the trial, all dogs were fed the same commercial 
diet (Iams Weight Control; The Iams Co., Lewisburg, OH).  Water was available ad libitum. 
Five by five Latin square experimental designs were used to evaluate test substrates. 
Maltodextrin served as the control, and in every Latin square conducted, the dogs were 
subjected to four test ingredients and the maltodextrin control. Glycemic tests were 3 h long 
and spaced 4 days apart.  At 1700 h on the evening before each glycemic test, any remaining 
food was removed and dogs were food-deprived for 15 h, during which time they had access 
to water.  Dogs consumed their allotted treatment after the 15 h of food deprivation.   
On the morning of the glycemic test, a blood sample was obtained from dogs before 
being dosed to serve as the baseline value.  Dogs then were dosed with the appropriate 
carbohydrate, and additional blood samples were taken at 15, 30, 45, 60, 90, 120, 150, and 
180 min postprandially.  Approximately 3 mL of blood was collected in a syringe via 
jugular or radial venipuncture.  An aliquot of blood was taken immediately for glucose 
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analysis.  The remaining blood was centrifuged at 1,240g for 10 min and serum stored at - 
20 ºC for subsquent analysis of insulin. 
Immediately following collection, blood samples were assayed for glucose based on 
the glucose oxidase method using a Precision-G Blood Glucose Testing System (Medisense, 
Inc., Bedford, MA).  This system measures blood glucose concentrations from the electrical 
current resulting  from electron transfer when the glucose oxidase on the test strip catalyzes 
the oxidation of glucose to gluconic acid (Cass et al., 1984).  Each glucometer was 
calibrated prior to each glycemic test according to manufacturer’s instructions.  Serum was 
analyzed for insulin using a Rat Insulin Enzyme Immunoassy kit (Cayman Chemical, Ann 
Arbor, MI) (Wisdom, 1976). 
The positive incremental area under the curve (AUC), ignoring any areas below 
baseline, for blood glucose and insulin values was calculated according to the method of 
Wolever et al. (1991) using GraphPad Prism 4 Software (GraphPad Software, Inc., San 
Diego, CA).  The relative glucose response (RGR) and relative insulinemic response (RIR) 
of the test carbohydrates were calculated for each individual dog according to the following 
formula: [(AUC for test carbohydrate) / (AUC for control)] x 100%.   
Data were analyzed by the Mixed Models procedure of SAS (SAS Institute, Cary, 
NC).    The statistical model included the fixed effect of treatment and the random effects of 
animal nested within Latin square and test period nested within Latin square.  Treatment 
least-squares means were compared using single degree of freedom contrast statements to 
compare only the test ingredients of interest in the numerous Latin squares conducted.  A 
probability of P < 0.05 was accepted as being statistically significant.   
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True Metabolizable Energy (TMEn):   
Conventional Single Comb White Leghorn roosters were utilized in this study.  All 
birds were housed individually in cages with raised wire floors. They were kept in an 
environmentally controlled room and subjected to a 16 h light and 8 h dark photoperiod.  
The University of Illinois Institutional Animal Care and Use Committee approved all 
procedures prior to animal experimentation. 
Roosters were deprived of feed for 24 h and then crop-intubated with approximately 
13 - 26 g of each carbohydrate using the precision-fed rooster assay (Sibbald, 1980; Parsons, 
1985). Each carbohydrate was fed to four roosters.  Following crop intubation, excreta 
(urine and feces) were collected for 48 h on plastic trays placed under each cage. Excreta 
samples then were lyophilized, weighed, and analyzed for gross energy using a bomb 
calorimeter (Parr Instrument Co., Moline, IL).  Endogenous corrections for energy were 
made using roosters that had been fasted for 48 h.  The nitrogen-corrected true 
metabolizable energy (TMEn) values, corrected for endogenous energy, were calculated 
using the following equation (Parsons et al., 1992): 
TMEn (kcal/g) =  
(g) intake Feed
(kcal) birds fastedby  excretedenergy   (kcal) birds fedby  excretedenergy   -(kcal) intakeEnergy 
 
 
Data were analyzed as a completely randomized design using the GLM procedure of 
SAS (SAS Institute, Inc., Cary, NC).  Differences among dietary treatments were 
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determined using the least significant difference method.  A probability of P < 0.05 was 
accepted as being statistically significant. 
RESULTS AND DISCUSSION 
Free Sugar and Hydrolyzed Monosaccharide Concentrations:   
Free sugar content of the SFD substrates is presented in Table 3-1.  Overall, the 
SFDs had low free sugar concentrations.  Tapioca SFD1, T2, and C2 had the lowest free 
sugar concentrations, with less than 1% of the substrate being composed of free sugars.  The 
highest free sugar concentration was found for TH, with C1 and C3 having intermediate free 
sugar concentrations. 
For all six substrates, glucose was the free sugar found in the highest concentration.  
Free glucose was highest in TH which also contained the highest amount of sorbitol.  The 
sorbitol found in TH was likely a result of the hydrogenation process.  The corn-based SFDs 
had small amounts of free fructose, whereas the tapioca-based SFDs did not have any free 
fructose.  
All the SFD substrates had high hydrolyzed monosaccharide concentrations (Table 
3-1), with TH having a slightly lower concentration than the rest.  The hydrolyzed 
monosaccharide concentration of T1, C1, C2, and C3 consisted totally of glucose, while a 
small portion of the hydrolyzed monosaccharide concentration of T2, T3, and C1 consisted 
of mannose.  Only TH resulted in a small amount of sorbitol. 
All pullulans had very low free sugar concentrations, with Pull HMW having 
essentially no free sugar present (Table 3-2).  Pull LMW and Pull IMW had similar total 
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free sugar concentrations, with glucose being the free sugar present in the highest 
concentration followed by small amounts of fructose.  A very small amount of sorbitol was 
the only free sugar present in Pull HMW. 
Hydrolyzed monosaccharide concentrations varied slightly among the pullulan 
substrates (Table 3-2).  All three pullulans had high concentrations of hydrolyzed 
monosaccharides, with Pull LMW having a slightly lower concentration.  The majority of 
the hydrolyzed monosaccharide content was from glucose for all three pullulan substrates. 
Small amounts of galactose and mannose were present in Pull LMW and Pull HMW.   
For a complete understanding of novel carbohydrate potential for incorporation into 
foodstuffs, quantification of the free sugar and hydrolyzed monosaccharide contents of the 
test ingredient is essential.  Knowledge of the free sugar content is important for 
carbohydrates that will be incorporated into foodstuffs meant to have a low glycemic 
response and reduced calorie content because these free sugars are readily digested and 
absorbed.  The hydrolyzed monosaccharides constitute the building blocks of carbohydrate 
polymers and the fraction potentially available for digestion, and that also could affect the 
glycemic response and caloric content.  Soluble fiber dextrins had low free sugar 
concentrations but were high in bound glucose concentrations.    Depending on the linkages 
contained in the SFDs, branches composed of glucose units may be readily available to 
enzymes and have impacts on their digestibility, glycemic response, and energy values. 
Like the SFD substrates, pullulans had very low free sugar content but high 
hydrolyzed monosaccharide content, mainly glucose.  Interestingly, Pull IMW and Pull 
HMW had higher hydrolyzed monosaccharide content than that of Pull LMW.  It has been 
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reported that lowering the molecular weight of pullulan makes it more available for 
enzymatic digestion (Spears et al., 2005).  Commerical pullulans are commonly produced 
using sucrose or cornstarch and, thus, can contain fructose and other sugar impurities.   
Some fructose is destroyed during the hydrolyzed monosaccharide assay and, along with 
sugar alcohols, are not included in the hydrolyzed monosaccharide value.  Even though a 
portion of fructose is destroyed during the hydrolyzed monosaccharide assay, Pull LMW 
contained high amounts of fructose.  This accounts for the lower hydrolyzed 
monosaccharide content of Pull LMW.  Since these pullulans are manufactured by different 
companies, production and purification methods likely differ and this could account for 
differences in sugar composition and impurities found in the samples.   
In Vitro Digestion:   
All SFDs had low to intermediate amounts of monosaccharides (mainly glucose) 
released (Table 3-3).  Released glucose concentrations were higher for the tapioca-based 
SFDs than for the corn-based SFDs.  The highest concentration of released monosaccharides 
occurred for TH (~ 63% of DM), while C1 had the lowest concentration of released sugars 
(~ 16% of DM). 
Monosaccharides released from the simulated hydrolytic digestion of pullulans are 
presented in Table 3-4.  High amounts of glucose were released after simulated digestion of 
all pullulans.  Both Pull LMW and Pull HMW released only glucose, while Pull IMW had 
small amounts of fructose released after simulated digestion.  Pull HMW had the lowest 
amount of released monosaccharide (~87 % of DM) while Pull LMW and Pull IMW were 
completely digestible.   
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Carbohydrates with low concentrations of released monosaccharides have low 
digestibility as was noted for the SFD substrates, with the corn-based SFDs being 
approximately 20% digestible and the tapioca-based SFDs 50% digestible.  The digestibility 
of a SFD derived from wheat (Nutriose) was evaluated using three different methods (in 
vitro, TNO intestinal model, and intestinal infusion in rats) (Lefranc-Millot et al., 2009).  
The results indicated an average small intestinal digestibility of 15% with a range of 8.7% to 
19% (Lefranc-Millot et al., 2009).  The two Nutriose
 
SFD (C2 and C3) products evaluated 
in this study resulted in a higher in vitro digestibility (average of 25%).  Carbohydrates that 
are highly digestible would result in little residue left for fermentation; however, these 
carbohydrates that have a lower digestion would contribute substantial substrate for 
potential fermentation in the colon.   
Due to molecular structure and type of glycosidic linkages among monomeric units, 
some dietary carbohydrates are able to resist digestion by mammalian enzymes better than 
others.  Based on the released monosaccharide data from the simulated hydrolytic digestion 
experiment, the SFDs appear to resist digestion and, thus, are potential substrates for 
fermentation by the microbiota in the large intestine.  A comparison of SFDs from different 
starch sources by Laurentin and Edwards (Laurentin and Edwards, 2004) found that the 
portions of SFDs that escaped digestion were extensively fermented.  A variety of starch 
sources can be used to form indigestible dextrins such as those from corn, potato, wheat, 
lentil, cassava, and tapioca.  The enzyme-resistant fractions of indigestible dextrins may 
vary significantly with the botanical source of the starch used (Laurentin et al., 2003).  
 The different starch sources in this experiment varied significantly from each other 
with the SFDs from cornstarch having a lower (P < 0.05) digestibility than the SFDs from 
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tapioca starch.   It also has been documented that dextrinization increases in vitro 
indigestibility of the starch and that, as the degree of dextrinization increases, the extent of 
hydrolysis decreases (Laurentin et al., 2003). It may be the case that the corn-based SFDs 
had a higher degree of dextrinization, more branching, or a higher concentration of 
nondigestible linkages compared to the SFDs derived from tapioca, making them less 
susceptible to digestive enzymes. 
High concentrations of monosaccharides released after simulated hydrolytic 
digestion indicate that the carbohydrate is highly digestible, as was the case for the pullulan 
substrates.   However, other research conducted with pullulans indicates otherwise. Wolf et 
al. (2003) found pullulan (MW 100,000) to be extensively hydrolyzed in vitro, but this 
hydrolysis occurred slowly over time.  They concluded that pullulan was slowly digested 
and would result in a low glycemic response.  Spears et al. (2007) also reported on the 
digestibility of two pullulans (MW 63,000 and MW 100,000). Hydrolytic digestion was 
determined to be ~ 55% (Spears et al., 2007), indicating that the pullulans were not 
completely digested in the small intestine and portions were available to be fermented in the 
large intestine. 
Glycemic and Insulinemic Responses:   
The change in plasma glucose for the SFDs is presented in Figure 3-1, and the 
corresponding values for AUC (mmol/L) and relative glycemic response (RGR) are 
presented in Table 3-5.  Maltodextrin was used as a control in every set of glycemic 
response tests because it is highly digestible and rapidly absorbed, resulting in a consistently 
high glycemic response. Area under the curve for Malt was statistically higher than for the 
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SFDs except for C3.  The SFDs with the lowest AUC were C1 and TH, with T1, T2, and C2 
having intermediate AUC values. 
Since Malt served as the control to which all test carbohydrates were compared, it 
was assigned an RGR value of 100.  Relative glycemic responses are related directly to 
AUC, so test carbohydrates with high AUC values will have correspondingly high RGR 
values.  The RGR is a useful value for interpretation and comparison of glycemic responses 
among test substrates, particularly in this case where the carbohydrates were run in a series 
of tests and were not all evaluated in the same period.  This is the reason Malt was used in 
every period as a control to calculate a relative response to the test carbohydrate in any 
particular period.  The RGR values followed a similar pattern as AUC values for the SFDs.  
Corn-based SFD 3 and C2 had the numerically highest RGR values, with C3 being 
statistically similar to Malt.  All three tapioca-based SFDs had similar intermediate RGR 
values, with a response averaging ~50% of the Malt response.  The lowest RGR response 
was observed for C1, with a RGR value of 27%. 
Varying degrees of resistance to digestion in the small intestine were noted for the 
SFD substrates.  Low amounts of released monosaccharides were noted after simulated 
digestion of C1, and this corresponded to a low RGR for this test carbohydrate.  A similarly 
low RGR was noted for TH, even though it had the highest (P < 0.05) amount of 
monosaccharide released after simulated hydrolytic digestion of all SFDs tested.  However, 
TH had a portion of its free sugar and hydrolyzed monosaccharide content composed of 
sorbitol that would result in a blunting of the glycemic response since sorbitol does not elicit 
a glycemic response.  Both C1 and TH resulted in a similar pattern of blood glucose 
response to carbohydrate ingestion: a peak in blood glucose at 30 min followed by steadily 
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decreasing blood glucose concentrations and, by 90 min, blood glucose concentrations near 
or below baseline values. 
Higher RGRs were noted for C2 and C3 compared to T1 and T2, even though C2 
and C3 resulted in lower (P < 0.05) amounts of monosaccharides released after simulated 
digestion.  The high glycemic responses noted for C2 and C3 are due, in part, to their pattern 
of blood glucose response during digestion.  Peaks in blood glucose concentration during 
the first 45 min of the glycemic response test were larger for T1 and T2 compared to C2 and 
C3, but for the remainder of the test, T1 and T2 resulted in an attenuated glycemic response.  
Higher RGRs were noted for C2 and C3 due, in part, to the fact that they had sustained 
blood glucose values after 90 min whereas the remainder of the SFDs resulted in glucose 
values that were closer to baseline.   
The relative glycemic response (average 84%) of the Nutriose SFDs (C2 and C3) 
evaluated were higher than what has been reported for a wheat Nutriose SFD in humans 
with a lower RGR of 25% (Donazzolo et al., 2003; Lefranc-Millot, 2008).  A tapioca-based 
SFD similar to T1 and T2 was evaluated in humans and resulted in a similar RGR value as 
what was found using the canine model (48.2 and 51.6, respectively) (Kendall et al., 2008). 
The changes in serum insulin for the SFD substrates are presented in Figure 3-2, and 
the corresponding values for AUC (pmol/L) and relative insulinemic response (RIR) are 
presented in Table 3-5.  All SFD substrates resulted in similar and lower (P < 0.05) AUC 
responses for insulin compared to the Malt control.  All SFD substrates had a lower (P < 
0.05) RIR value compared to the Malt control.  Among the SFD substrates, T1, C1, C2, and 
C3 resulted in similar RIR responses with a response averaging ~ 26% of the Malt response.  
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Tapioca-based SFD2 (T2) and TH resulted in the numerically highest RIR values among the 
substrates with a response averaging ~ 50% of Malt.   
All SFDs had small peaks in insulin concentrations at 15, 30, and 45 min time 
points, but these peaks were all considerably lower in comparison to the Malt response. At 
60 and 90 min after dosing, the insulin values for the SFDs had returned to baseline and 
stayed close to baseline for the remainder of the test.  The higher values for T2 and TH 
compared to the rest of the SFD substrates are a result of a low blunted increase in serum 
insulin during later time points (120 and 150 min) of the glycemic response test.  
The insulin responses of the SFDs are reflective of their glycemic responses.  The 
SFDs all consisted of a portion of readily digestible starch that resulted in moderate peaks in 
blood glucose concentrations during the first 30 min of the glycemic response test.  The 
increases in blood glucose concentrations induced insulin secretion and resulted in small 
peaks in insulin during the first 60 min of the test.  Due to the nature of the glycemic curve, 
even SFDs with high RGR values (C2 and C3) resulted in low RIR values (average 25%).  
The higher RGR values result from a blunted response that lasted throughout the entire test 
with no sharp increases in blood glucose concentrations.  These results are in comparison to 
a RIR of 13% reported for a wheat-based SFD in humans (Donazzolo et al., 2003; Lefranc-
Millot, 2008).  A tapioca-based SFD resulted in a somewhat similar RIR in humans as T2 in 
this experiment (40.2 and 50.5, respectively) (Kendall et al., 2008).   The attenuated blood 
glucose peaks do not induce high insulin secretion resulting in low insulin response values 
for the SFDs.  It has been suggested that the low insulinemic responses after ingesting low-
digestible carbohydrates could contribute to a better feeling of satiety (Slavin and Green, 
2007; Bellisle, 2008). 
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 The changes in plasma glucose for the pullulans are presented in Figure 3-3, and the 
corresponding values for AUC (mmol/L) and relative glycemic response (RGR) are 
presented in Table 3-6.  Maltodextrin had the highest (P < 0.05) AUC, with all pullulans 
resulting in lower but statistically similar AUCs for blood glucose.  The RGR data followed 
the same pattern. 
 Spears et al. (2005) evaluated two pullulans in dogs, one of MW 6,300 and the other 
of MW 100,000.  Authors reported that, although not statistically significant, the 6,300 MW 
Pull had a lower glycemic response for the first 60 min postprandial compared to Malt.  
Wolf et al. (2003) evaluated the glycemic response of  a MW 100,000 Pull in humans and 
found that it reduced (P < 0.01) the glucose AUC by 50% compared to Malt.  This result is 
similar to the decrease observed in the present experiment where Pull LMW reduced the 
glucose AUC by approximately 60% compared to the Malt control. 
The data for change in serum insulin for the pullulans are presented in Figure 3-4, 
and the corresponding values for AUC (pmol/L) and relative insulinemic response (RIR) are 
presented in Table 3-6.  All pullulan substrates resulted in lower (P < 0.05) and similar AUC 
and RIR values compared to Malt.  A low blunted curve during the first 60 min of the test 
was noted for Pull LMW, which mirrors the glycemic response and accounts for Pull LMW 
having a numerically higher RGR and RIR among the Pull substrates. In general, the 
pullulans resulted in insulin response values that stayed close to baseline values throughout 
the entire response test.  These responses mirror the glycemic responses where no large, 
sharp peaks resulted and, thus, no sharp increases in insulin were noted.  Spears et al. (2005) 
also evaluated insulin responses in dogs fed pullulans of 6,300 MW and 100,000 MW and 
found the 100,000 MW Pull to significantly reduce serum insulin, but not the 6,300 MW 
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Pull.  However, the 6,300 MW Pull used by Spears et al. (Spears et al., 2005) was a much 
smaller compound than that used in this current study (100,000 MW), explaining in part 
why the latter was capable of significantly reducing both glycemic and insulinemic 
responses compared to Malt. 
Pullulans resulted in low glycemic and insulinemic responses, with an average 
response value of ~24% for both RGR and RIR.  Numerically, Pull LMW had the highest 
glycemic response with a RGR value ~41% of that of the Malt control.  The lower MW of 
this pullulan could make it more readily available for digestion.  The overall glycemic curve 
patterns of the pullulans showed low blunted curves throughout the entire glycemic test, 
indicating that the pullulans are slowly digestible. 
True Metabolizable Energy (TMEn):   
As health complications associated with obesity are a growing problem in today’s 
society, there is an increasing trend for producing reduced calorie foodstuffs. This is 
increasing the demand for low-calorie sweeteners and bulking agents.  One method for 
evaluating the energy value of ingredients is use of the true metabolizable energy (TMEn) 
assay with roosters. This in vivo animal model assay allows for a better representation of the 
digestive process than do in vitro assays for determining metabolizable energy.   
Maltodextrin had a higher (P < 0.05) TMEn value compared to all SFDs (Table 3-7).  
Similar TMEn values were found for T1, T2, and TH.  Also, C1, C2, and C3 had similar 
values, with the tapioca-based SFDs being numerically higher than the corn-based SFDs.  
The corn-based Nutriose SFDs (C2 and C3) resulted in exactly the same energy value (avg 
1.7 kcal/g) as a wheat-based Nutriose SFD (1.7 kcal/g) evaluated in men (Vermorel et al., 
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2004).  Fibersol-2 has been evaluated for its energy content in humans and has been 
reported to have an energy value of 1.5 kcal/g (Goda et al., 2006).  This is similar to the 
energy value of 1.2 kcal/g found when evaluating Fibersol-2
 
(C1) using the precision-fed 
rooster assay.  Metabolizable energy of carbohydrates varies due to the degree to which they 
are digested and absorbed; thus, the results of the TMEn  assay corroborate well with the in 
vitro hydrolytic digestion results.   
True metabolizable energy data for the pullulans are presented in Table 3-8.  Energy 
data were not collected for Pull HMW because, due to its physical properties, sufficient 
substrate could not be provided to the roosters for accurate measurementss.  Low molecular 
weight pullulan resulted in the lowest (P < 0.05) TMEn value (3.33 kcal/g) with Pull IMW 
and Malt having similar values (3.95 and 4.06 kcal/g).  While the glycemic assay shows 
pullulans to have significantly lower responses than Malt, indicative of resistance to 
digestion, that test lasts for 3 h only.  The hydrolytic in vitro digestion and TMEn results 
indicate that the LMW and IMW pullulan substrates are not resistant to digestion but are, 
instead, slowly digestible carbohydrates. 
Few data exist regarding metabolizable energy content of novel carbohydrates fed 
alone.  In those instances where these carbohydates are evaluated, the carbohydrates are part 
of a diet matrix.  The TMEn assay is useful in that the carbohydrate alone can be studied 
without interferences from dietary matrix components.  This is important information when 
developing food products. 
   In summary, the SFDs evaluated varied in sugar composition and physiological 
responses.  The corn-based SFDs resulted in a lower content of released monosaccharides 
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and lower energy content compared to the tapioca- based SFDs after simulated hydrolytic 
digestion, but this did not correspond to lower glycemic responses as was the case for C2 
and C3.  Overall, the SFDs showed varying degrees of resistance to digestion, thus resulting 
in attenuated glycemic responses compared to Malt, making them suitable candidates for 
reduced glycemic and low-calorie foodstuffs.  Low-digestible carbohydrates also may 
promote health benefits due to their potential for colonic fermentation.  Some positive 
effects that have been observed with low-digestible carbohydrates such as SFDs are 
decreases in colon pH, production of short-chain fatty acids, increased absorption of 
minerals, positive impacts on sugar and fat metabolism, and an increase of energy 
expenditure (Slavin et al., 2009).   Even though the pullulans were almost completely 
hydrolyzed after simulated digestion, they resulted in significantly attenuated glycemic 
responses, indicating that pullulans are slowly digestible carbohydrates.  Pullulans could be 
ideal candidates for incorporation into foodstuffs for diabetics as they result in low glycemic 
response without eliciting large peaks in blood glucose or insulin.  Higher MW pullulans 
also would be beneficial in products meant to help sustain low blood glucose concentrations 
over time since they are more slowly digested compared to lower MW pullulans.  The 
differences in physiological responses among carbohydrates can be contributed, in part, to 
individual carbohydrate molecular structure and bonding pattern and how they affect 
digestibilty.  Evaluation of a variety of physiological responses is beneficial as it allows for 
a more complete understanding of the potential functional benefits that select carbohydrates 
possess. 
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Table 3-1.  Free sugar and hydrolyzed monosaccharide concentrations of soluble fiber dextrins  
Test carbohydrate
1
      T1         T2                 TH                     C1                C2 C3 
 
Free sugars, mg/g
2
     
  
Arabinose 0.00 0.17 0.00 0.37 0.00 0.00 
Fructose 0.00 0.00 0.00 0.29 0.80 4.73 
Galactose 0.00 0.00 0.07 0.00 0.00 0.00 
Glucose 0.48 0.63 64.46 11.87 2.37 28.20 
Mannose 0.00 0.00 0.00 0.00 0.20 0.45 
Rhamnose 0.10 0.00 0.00 0.20 0.00 0.00 
Sorbitol 0.04 0.10 27.05 0.48 0.00 0.00 
Sucrose 0.00 0.25 0.00 0.00 0.00 0.00 
Xylose 0.00 0.00 0.00 0.00 0.00 0.00 
Total, mg/g
3
 0.62 1.15 91.59 13.21 3.37 33.38 
     
  
Hydrolyzed monosaccharides, 
mg/g
2,4
     
  
Galactose 0.00 0.00 0.00 0.00 0.00 0.00 
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1 
Abbreviations: T1, tapioca-based SFD1; T2, tapioca-based SFD2; TH, tapioca-based SFD hydrogenated; C1, corn-based 
SFD1; C2, corn-based SFD2; C3, corn-based SFD3. 
2 
Values are expressed on a dry matter basis. 
3 
Values include water added when starches are broken down to monosaccharide units 
4 
Values are correcte for free monosaccharide concentrations. 
  
 
 
Table 3-1 (con’t.) 
    
  
 
Glucose 
 
1,139.67 
 
1,030.29 
 
945.55 
 
1,158.37 
 
1,137.51 
 
1,128.21 
Mannose 0.00 7.26 5.22 2.09 0.00 0.00 
Sorbitol 0.00 0.00 9.83 0.00 0.00 0.00 
Total, mg/g
3
 1,139.67 1,037.55 960.59 1,160.46 1,137.51 1,128.21 
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Table 3-2.  Free sugar and hydrolyzed monosaccharide concentrations of pullulans 
Test carbohydrate
1
 Pull LMW Pull IMW Pull HMW 
 
Free sugars, mg/g
2
    
Arabinose 0.03 0.00 0.00 
Fructose 2.62 0.99 0.00 
Galactose 0.06 0.00 0.00 
Glucose 4.76 6.79 0.00 
Mannose 0.55 0.05 0.00 
Rhamnose 0.00 0.00 0.00 
Sorbitol 0.06 0.24 0.01 
Sucrose 0.00 0.00 0.00 
Xylose 0.09 0.00 0.00 
Total, mg/g
3
 8.17 8.07 0.01 
 
   
Hydrolyzed monosaccharides, mg/g
2,4
 
   
Galactose 28.80 0.43 19.38 
Glucose 840.09 1,112.76 1,081.98 
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1 
Abbreviations: Pull LMW, low molecular weight pullulan; Pull IMW, intermediate molecular weight pullulan; Pull HMW, 
high molecular weight. 
2 
Values are expressed on a dry matter basis. 
3 
Values include water added when starches are broken down to monosaccharide units. 
4 
Values are corrected for free monosaccharide concentrations. 
 
 
 
 
Table 3-2 (con’t.) 
   
 
Mannose 
 
38.32 
 
0.00 
 
26.60 
Sorbitol 0.00 0.00 0.00 
Total, mg/g
3
 907.21 1,113.19 1,127.96 
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Table 3-3. Monosaccharides (including free monosaccharides) released after simulated hydrolytic digestion of soluble fiber dextrins 
 Test carbohydrate
1
  
Released monosaccharides, 
mg/g
2
 
T1 T2 TH C1 C2 C3 SEM 
 
Fructose 
 
0.00
a
 
 
0.00
a
 
 
0.00
a
 
 
0.00
a
 
 
0.80
b
 
 
5.57
c
 
 
0.05 
Galactose 0.00
a
 0.00
a
 0.00
a
 0.00
a
 0.03
b
 0.07
c
 0.01 
Glucosamine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Glucose 427.35
c
 457.46
c
 588.19
d
 164.81
a
 227.63
ab
 279.13
b
 20.57 
Isomaltose 0.00
a
 0.00
a
 8.83
b
 0.00
a
 0.00
a
 0.00
a
 0.32 
Sorbitol 0.00
a
 0.00
a
 33.90
b
 0.00
a
 0.00
a
 0.00
a
 0.59 
Sucrose 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Total, mg/g 3 427.35
c
 457.46
c
 630.92
d
 164.81
a
 228.47
ab
 284.77
b
 15.30 
1
Abbreviations: T1, tapioca-based SFD1; T2, tapioca-based SFD2; TH, tapioca-based SFD hydrogenated; C1, corn-based 
SFD1; C2, corn-based SFD2; C3, corn-based SFD3. 
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2 
Values are expressed on a dry matter basis. 
3
 Values include addition of water added when starches are broken down to monosaccharide units. 
abcd
 Means in the same row with different superscript letters are different (P<0.05). 
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Table 3-4. Monosaccharides (including free monosaccharides) released after simulated hydrolytic digestion of pullulans 
1 
Abbreviations: Pull LMW, low molecular weight pullulan; Pull IMW, intermediate molecular weight pullulan; Pull HMW, 
high molecular weight. 
2 
Values are expressed on a dry matter basis. 
 Test carbohydrate
1
  
Released monosaccharides, 
mg/g
2
 
Pull LMW Pull IMW Pull HMW SEM 
 
Fructose 
 
0.00
a
 
 
6.97
b
 
 
0.00
a
 
 
0.13 
Galactose 0.00 0.00 0.00 0.00 
Glucosamine 0.00 0.00 0.00 0.00 
Glucose 1,041.62
b
 1,041.24
b
 866.16
a
 27.11 
Isomaltose 0.00 0.00 0.00 0.00 
Sorbitol 0.00 0.00 0.00 0.00 
Sucrose 0.00 0.00 0.00 0.00 
Total, mg/g 
3
 1,041.62
b
 1,048.21
b
 866.16
a
 27.12 
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 3 
Values include water that is added when starches are broken down to monosaccharide units. 
ab
 Means in the same row with different superscript letters are different (P<0.05). 
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Table 3-5. Incremental area under the curve (AUC) for glucose and insulin, and relative glycemic response (RGR) and relative 
insulinemic response (RIR) of soluble fiber dextrins. 
 Carbohydrate
1
  
Item T1 T2 TH C1 C2 C3 Malt SEM
2 
 
AUC for glucose, 
mmol/L 
 
91.38
ab
 
 
80.11
ab
 
 
63.75
a
 
 
46.12
a
 
 
82.60
ab
 
 
132.86
bc
 
 
155.52
c
 
 
20.96 
RGR, % 52.85
ab
 50.43
ab
 44.37
a
 27.22
a
 76.47
bc
 90.58
cd
 100.00
d
 10.20 
AUC for insulin, 
pmol/L 
2,115.82
a
 5,353.38
a
 5,007.46
a
 3,774.38
a
 2,206.00
a
 3,162.38
a
 10,561.00
b
 1,156.42 
RIR, % 18.44
a
 50.52
bc
 57.68
c
 37.97
abc
 20.33
a
 30.13
ab
 100
d
 6.94 
 
1
 Abbreviations: T1, tapioca-based SFD1; T2, tapioca-based SFD2; TH, tapioca-based SFD hydrogenated; C1, corn-based 
SFD1; C2, corn-based SFD2; C3, corn-based SFD3; Malt, maltodextrin. 
2 
Pooled standard error of the mean. 
abcd
 Means in the same row with different superscript letters are different (P < 0.05). 
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Table 3-6. Incremental area under the curve (AUC) for glucose and insulin, and relative glycemic response (RGR) and relative 
insulinemic response (RIR) of Pullulans. 
 Test carbohydrate
1
  
Item Pull LMW Pull IMW Pull HMW Malt SEM
2 
 
AUC for glucose, 
mmol/L 
 
60.18
a
 
 
14.73
a
 
 
44.10
a
 
 
153.76
b
 
 
20.81 
RGR, % 40.79
a
 13.33
a
 19.05
a
 100.00
b
 10.13 
AUC for insulin,    
pmol/L 
2,800.34
a
 2,613.04
a
 1,167.08
a
 11,978.00
b
 2,335.66 
RIR, % 38.10
a
 18.27
a
 15.29
a
 100.00
b
 6.84 
1
Abbreviations: Pull LMW, low molecular weight pullulan; Pull IMW, intermediate molecular weight pullulan; Pull HMW, 
high molecular weight pullulan; Malt, maltodextrin. 
2 
Pooled standard error of the mean. 
ab
 Means in the same row with different superscript letters are different (P<0.05). 
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Table 3-7. True metabolizable energy (TMEn) values for soluble fiber dextrins 
1
 Abbreviations: T1, tapioca-based SFD1; T2, tapioca-based SFD2; TH, tapioca-based SFD hydrogenated; C1, corn-based 
SFD1; C2, corn-based SFD2; C3, corn-based SFD3; Malt, maltodextrin. 
2 
Pooled standard error of the mean. 
abcd
 Means in the same row with different superscript letters are different (P < 0.05). 
 
 Test carbohydrate
 1
  
Item T1 T2 TH C1 C2 C3 Malt SEM
2
 
 
Amount dosed,          
g DM basis 
13.47 20.29 26.07 25.68 23.58 17.80 14.27 … 
TMEn, kcal/g 2.19
bc
 2.30
c
 2.57
c
 1.23
a
 1.66
ab
 1.65
ab
 4.06
d
 0.12 
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Table 3-8.  True metabolizable energy (TMEn) values for pullulans 
 
 
 
 
 
 
 
1 
Abbreviations: Pull LMW, low molecular weight pullulan; Pull IMW, intermediate molecular weight pullulan; Pull HMW, 
high molecular weight pullulan; Malt, maltodextrin; NM, not measured. 
2 
Pooled standard error of the mean. 
ab
 Means in the same row with different superscript letters are different (P<0.05). 
 
 
 
 Test carbohydrate
 1
 
 
Item Pull LMW Pull IMW Pull HMW Malt SEM
2 
Amount dosed,         
g DM basis 
14.23 14.40 NM 14.27 … 
TMEn, kcal/g 3.33
a
 3.95
b
 NM 4.06
b
 0.17 
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Figure 3-1. Incremental change from baseline in blood glucose response for dogs consuming 25 g of soluble fiber dextrins.          
Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (0.17), tapioca-based SFD1 (T1) (0.32), tapioca-
based SFD2 (T2) (0.31), tapioca-based SFD hydrogenated (TH) (0.31), corn-based SFD1 (C1) (0.31), corn-based SFD2 (C2) (0.30), 
andcorn-based SFD3 (C3) (0.30). 
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Figure 3-2. Incremental change from baseline in serum insulin response for dogs consuming 25 g of soluble fiber dextrins.         
Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (17.27), tapioca-based SFD1 (T1) (28.33), 
tapioca-based SFD2 (T2) (27.33), tapioca-based SFD hydrogenated (TH) (27.33), corn-based SFD1 (C1) (27.33), corn-based SFD2 
(C2) (27.21), corn-based SFD3 (C3) (27.21). 
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Figure 3-3. Incremental change from baseline in blood glucose response for dogs consuming 25 g of pullulans.                            
Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (0.20), low molecular weight pullulan (Pull 
LMW) (0.30), intermediate molecular weight pullulan (Pull IMW) (0.31), high molecular weight pullulan (Pull HMW) (0.33). 
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Figure 3-4. Incremental change from baseline in serum insulin response for dogs consuming 25 g of pullulans.                              
Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (19.34), low molecular weight pullulan (Pull 
LMW) (26.35), intermediate molecular weight pullulan (Pull IMW) (27.76), high molecular weight pullulan (Pull HMW) (32.74). 
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CHAPTER 4: IN VITRO HYDROLYTIC DIGESTION, GLYCEMIC RESPONSE IN 
DOGS, AND TRUE METABOLIZABLE ENERGY CONTENT OF SOLUBLE 
CORN FIBERS 
 
ABSTRACT: The objective of this research was to measure in vitro hydrolytic 
digestion, glycemic and insulinemic responses, and true metabolizable energy (TMEn) 
content of select soluble corn fibers (SCFs).  The first generation SCFs included 
hydrochloric acid- treated corn syrup (HCl corn syrup); a SCF with an increased total 
dietary fiber (TDF) content (SCF gen 1); a SCF that was spray-dried (SCF spray-dried); and 
a hydrogenated  SCF (SCF hydrogenated).  The second generation SCFs included those 
prepared using phosphoric acid catalyzation in both a liquid (SCF phos (l)) and powder 
(SCF phos (p)) form, and SCFs that were prepared using hydrochloric acid catalyzation in 
both a liquid (SCF HCl (l)) and powder (SCF HCl (p)) form.  Also, in the second generation 
set of samples were SCFs prepared using the same method but in three separate batches.  All 
contained 70% TDF and 15% sugars. Two were in liquid form (SCF 2A and SCF 2B), and 
one in powder form (SCF 2C). A lower sugar form (80% TDF and 5% sugar) SCF also was 
evaluated (SCF low sugar).  Glucose was the major free sugar and bound monosaccharide in 
all SCFs except for SCF hydrogenated that had higher concentrations of sorbitol. All SCFs 
had intermediate to low amounts of monosaccharides released as a result of in vitro 
hydrolytic digestion, with glucose being the primary sugar component released. First 
generation SCFs were more digestible in vitro (~50%) compared to second generation SCFs 
(~ 32%).  All SCFs had attenuated glycemic responses in dogs compared to a maltodextrin 
(Malt) control.  Second generation SCFs, on average, had lower glycemic responses and 
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TMEn values in roosters than first generation SCFs.  All SCFs had low free sugar 
concentrations with varying degrees of resistance to digestion, reduced caloric content, and 
attenuated glycemic  and insulinemic responses. These ingredients are potential candidates 
for inclusion in reduced calorie and low glycemic foodstuffs. 
INTRODUCTION 
 The increasing incidence of chronic diseases such as obesity, diabetes, heart disease, 
cancers, and other metabolic disorders in today’s society is leading to an increased 
awareness of how diet, especially dietary fiber and low-digestible carbohydrates, can play a  
positive role in health maintenance.  As consumers become more aware of the potential 
health benefits associated with ingredients that have reduced energy content, that are 
partially fermented in the colon, and that elicit reduced glycemic and insulinemic responses, 
demand for these ingredients will increase.  A growing body of research indicates that 
dietary fiber may reduce the risk for developing several diseases including coronary heart 
disease, hypertension, diabetes, obesity, and some gastrointestinal disorders (Anderson et 
al., 2009).  However, most of the population of the United States consumes less than half of 
the recommended levels of dietary fiber daily (Anderson et al., 2009).  This has led to a 
demand for the development of novel carbohydrates that have functional properties similar 
to dietary fiber, but that may be incorporated more easily into a wider array of solid and 
liquid food matrices.   
 Novel carbohydrates have the potential to not only increase the fiber content of 
foodstuffs, but also the ability to positively influence postprandial glycemia (Riccardi et al., 
2008).  Low glycemic diets have been shown to help control postprandial glucose and 
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insulin concentrations in diabetics (Livesey et al., 2008; Riccardi et al., 2008).  Decreasing 
the glycemic response also may have a role in improving risk factors associated with heart 
disease and diabetes (Livesey et al., 2008; Riccardi et al., 2008).   
A category of carbohydrate that has the potential to have functional properties and 
benefits similar to dietary fiber is low-digestible carbohydrates.  Low-digestible 
carbohydrates represent a heterogeneous group of compounds that are partially unavailable 
to digestive enzymes so are either incompletely or not absorbed from the small intestine 
(Murphy, 2001; Scheppach et al., 2001; Grabitske et al., 2008).  These low-digestible 
carbohydrates pass into the colon where they are totally or partially fermented by colonic 
microflora.   Low-digestible carbohydrates include polyols, resistant starch, non-starch 
polysaccharides, fructooligosaccharides, and other oligosaccharides (Marteau and Flourie, 
2001; Murphy, 2001; Scheppach et al., 2001; Grabitske et al., 2008).  Factors restricting 
digestion and absorption of low-digestible carbohydrates are the impaired hydrolysis of 
constitutive bonds by enzymes and the degree of absorption in the small intestine (Marteau 
and Flourie, 2001).  Once low-digestible carbohydrates reach the colon, they are totally or 
partially fermented to short-chain fatty acids (SCFA) and gases. 
A type of novel, low-digestible carbohydrate is soluble corn fiber (SCF).  Soluble 
corn fibers are obtained by isolating an oligosaccharide-rich component from partially 
hydrolyzed corn syrup.  During corn starch hydrolysis, an aqueous stream comprised of 
dextrose, fructose, and a mixture of oligosaccharides is formed (Harrison and Hoffman, 
2007).  This stream undergoes several additional processes including nanofiltration and use 
of enzymes to create products with increased glycosidic α-1,6  bonds (Harrison and 
Hoffman, 2007). The different processes utilized to produce these oligosaccharides result in 
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fractions with varying degrees of digestion resistance.  Soluble corn fiber is manufactured in 
a similar manner to type III resistant starch that is often produced using enzymes and 
retrogradation to increase glycosidic linkages. (Haralampu, 2000; Thompson, 2000). 
  Evaluation of a variety of physiological responses to these carbohydrates is 
beneficial as it allows for a better understanding of the potential functional benefits that 
select carbohydrates possess.  The objective of the study was to evaluate SCFs for 
physiological properties that could positively impact human health to include sugar 
composition, in vitro hydrolytic digestion, glycemic and insulinemic responses using a dog 
model, and true metabolizable energy (TMEn) using an avian model. 
MATERIALS AND METHODS 
Substrates: 
Soluble corn fibers resulted from the process of manufacturing oligosaccharides that 
are digestion-resistant or slowly digestible.  The first step in the production of SCFs was to 
isolate an oligosaccharide-rich stream.  During cornstarch hydrolysis, an aqueous stream 
comprised of dextrose, fructose, and a mixture of oligosaccharides results (Harrison and 
Hoffman, 2007).  The aqueous solution is nanofiltered, resulting in a monosaccharide and an 
oligosaccharide-rich stream.  This latter stream is comprised of at least 50% and as much as 
90% by weight (dry solids basis) of oligosaccharides, but still may have up to 50% dextrose 
and fructose present.  
Once oligosaccharide-rich syrup has been formed, it can be treated with an 
isomerization enzyme such that some of the dextrose present in the syrup is converted to 
fructose, producing an isomerized oligosaccharide-rich stream (Harrison and Hoffman, 
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2007).  The oligosaccharide-rich syrup may go through another membrane filtering step to 
remove monosaccharides from the syrup.  The syrup also can be hydrogenated, converting 
some of the monosaccharides to alcohols.  Lastly, in yet another process, the syrup may be 
subjected to a catalyst(s) that creates reversion products where the residual monosaccharides 
in the syrup become covalently bonded to oligosaccharides or other monosaccharides 
present in the syrup, thus increasing glycosidic α-1,6  bond formation  in the structure 
(Harrison and Hoffman, 2007).   
The last steps in the production process include decolorization of the syrup and 
evaporation and drying to produce a powder.   The different processes utilized to produce 
these oligosaccharides result in fractions with varying degrees of resistance to digestion.   
All the SCFs evaluated were produced using the basic steps outlined above, but 
procedures were modified to produce a variety of SCFs.  The SCFs evaluated can be 
classified into first generation and second generation products.  Both generations of SCFs 
rely on the creation of reversion products using different combinations of acid catalysts and 
enzymes to increase number of glycosidic bonds. 
The first generation of SCFs included: one made from corn syrup where 
hydrochloric acid only was used as a catalyst (HCl corn syrup); a SCF using the same 
production methods as for HCl corn syrup but that had a higher TDF content (SCF gen 1); a 
SCF prepared using similar production methods but that was spray dried (SCF spray-dried); 
and a SCF gen 1 that went through hydrogenation steps to form sugar alcohols (SCF 
hydrogenated). 
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A new process then was developed and eight second generation SCFs were 
produced.  The second generation SCFs included a set of  four carbohydrates where either 
phosphoric acid or hydrochloric acid alone were used as catalysts and that were produced in 
either a liquid (SCF phos (l) and SCF HCl (l)) or powder (SCF phos (p) and SCF HCl (p)) 
form.  A combination of phosphoric and hydrochloric acids was used as catalysts for the 
production of the last four SCFs in the second generation series.  They included a SCF that 
was evaporated to a greater extent than the SCFs in the previous generation and that 
contained 70% TDF and 15% sugar (SCF 2 B1).  Two other SCFs were produced using the 
same exact conditions but were made in different batches, one in liquid form (SCF 2 B2) 
and the other in powder form (SCF 2 B3).  Lastly, a lower sugar (80% TDF and 5% sugar) 
SCF was produced in this series (SCF low sugar). 
Chemical Analyses: 
Carbohydrates were analyzed for dry matter (DM) and organic matter (OM) 
according to AOAC (2000), and for free and hydrolyzed monosaccharide concentrations.  
Test carbohydrates were hydrolyzed using the procedure described by Hoebler et al. (1989) 
where carbohydrates were subjected to hydrolysis with H2SO4 acid.  Free sugars and 
hydrolyzed monosaccharides were quantified using a Dionex DX500 high performance 
liquid chromatography (HPLC) system (Dionex Corporation, Sunnyvale, CA).  Standards 
for quantification included inositol, fucose, arabinose, rhamnose, galactose, xylose, and 
mannose.  Free monosaccharides were injected at a volume of 25 L .  All assays were 
conducted using a CarboPac PA-1 column and guard column following methods cited by 
Smiricky et al. (2002).   
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In Vitro Hydrolytic Digestion: 
Approximately 200 mg of each carbohydrate were weighed in triplicate and 
incubated with 2 mL of a pepsin/hydrochloric acid solution and 2 mL of an enzyme solution 
consisting of amyloglucosidase and  -amylase to simulate gastric and small intestinal 
digestion (Muir et al., 1993).  The samples were analyzed for free released monosaccharides 
using HPLC (Smiricky et al., 2002) following the simulated hydrolytic digestion procedure. 
Data were analyzed as a completely randomized design using the Mixed Models 
procedure of SAS (SAS Institute, Inc., Cary, NC). The statistical model included the fixed 
effect of substrate.  Treatment least-squares means were reported and compared using a 
Tukey adjustment to ensure the overall protection level. Differences among means with a P-
value of less than 0.05 were considered significant. 
Glycemic/Insulinemic Responses:   
To determine postprandial glycemic and insulinemic responses to the test 
carbohydrates, five purpose-bred female dogs (Butler Farms, Clyde, NY) with hound 
bloodlines, a mean initial body weight of 25.1 ± 4.8 kg, and a mean age of 5.6 ± 2.4 years 
were used.  Dogs were housed individually in 1.2 x 2.4 m clean floor pens in a climate-
controlled room at the animal care facility of the Edward R. Madigan Laboratory on the 
University of Illinois campus. Dogs were provided with non-destructible toys (hard plastic 
balls, Nyla bones, etc.).  Pens allowed for nose-nose contact between dogs in adjacent runs 
and visual contact with all dogs in the room.  A 16-h light:8-h dark cycle was used. The 
University of Illinois Institutional Animal Care and Use Committee approved all procedures 
prior to animal experimentation. 
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Dogs consumed 25 g of carbohydrate (DM basis) in approximately 240 mL dd 
water.  In order to get carbohydrate sources into solution, water and carbohydrate were 
mixed using a stir plate.   Quantity to be dosed was measured using a disposable 60 cc 
syringe (without needle) and offered to dogs within a 10 min period.  During the trial, all 
dogs were fed the same commercial diet (Iams Weight Control
®
; The Iams Co., Lewisburg, 
OH).  Water was available ad libitum. 
Five by five Latin square experimental designs were used to evaluate test substrates. 
Maltodextrin served as the control, and in every Latin square conducted, the dogs were 
subjected to four test ingredients and the maltodextrin control. Glycemic tests were 3 h long 
and spaced 4 days apart.  At 1700 h on the evening before each glycemic test, any remaining 
food was removed and dogs were food-deprived for 15 h during which time they had access 
to water.  Dogs consumed their allotted treatment after the 15 h of food deprivation.   
On the morning of the glycemic test, a blood sample was obtained from dogs before 
being dosed to serve as the baseline value.  Dogs then were dosed with the appropriate 
carbohydrate, and additional blood samples were taken at 15, 30, 45, 60, 90, 120, 150, and 
180 min postprandially.  Approximately 3 mL of blood were collected in a syringe via 
jugular or radial venipuncture.  An aliquot of blood was taken immediately for glucose 
analysis.  The remaining blood was centrifuged at 1,240 x g for 10 min and serum stored at -
20 ºC for subsequent analysis of insulin. 
Immediately following collection, blood samples were assayed for glucose based on 
the glucose oxidase method using a Precision-G Blood Glucose Testing System (Medisense, 
Inc., Bedford, MA).  This system measures blood glucose concentrations from the electrical 
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current resulting  from electron transfer when the glucose oxidase on the test strip catalyzes 
the oxidation of glucose to gluconic acid (Cass et al., 1984).  Each glucometer was 
calibrated prior to each glycemic test according to manufacturer’s instructions.  Serum was 
analyzed for insulin using a Rat Insulin Enzyme Immunoassy kit (Cayman Chemical, Ann 
Arbor, MI) (Wisdom, 1976). 
The positive incremental area under the curve (AUC), ignoring any areas below the 
baseline, for blood glucose and insulin values was calculated according to the method of 
Wolever et. al. (1991) using GraphPad Prism 5 Software (GraphPad Software, Inc., San 
Diego, CA).  The relative glucose response (RGR) and relative insulinemic response (RIR) 
of the test carbohydrates were calculated for each individual dog according to the following 
formula: [(AUC for test carbohydrate) / (AUC for control)] x 100%.   
Data were analyzed by the Mixed models procedure of SAS (SAS Institute, Cary, 
NC).    The statistical model included the fixed effect of treatment and the random effects of 
animal nested within Latin square and test period nested within Latin square.  Treatment 
least-squares means were compared using single degree of freedom contrast statements to 
compare only the test ingredients of interest in the numerous Latin squares conducted.    A 
probability of P < 0.05 was accepted as being statistically significant.   
True Metabolizable Energy (TMEn): 
 Conventional Single Comb White Leghorn roosters were utilized in this study.  All 
birds were housed individually in cages with raised wire floors. They were kept in an 
environmentally controlled room and subjected to a 16 h light and 8 h dark photoperiod.  
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The University of Illinois Institutional Animal Care and Use Committee approved all 
procedures prior to animal experimentation. 
Roosters were deprived of feed for 24 h and then crop-intubated with approximately 
13 - 26 g of each carbohydrate using the precision-fed rooster assay (Sibbald, 1980; Parsons, 
1985). Each carbohydrate was fed to four roosters.  Following crop intubation, excreta 
(urine and feces) were collected for 48 h on plastic trays placed under each cage. Excreta 
samples then were lyophilized, weighed, and analyzed for gross energy using a bomb 
calorimeter (Parr Instrument Co., Moline, IL).  Endogenous corrections for energy were 
made using roosters that had been fasted for 48 h.  The nitrogen-corrected true 
metabolizable energy (TMEn) values, corrected for endogenous energy, were calculated 
using the following equation (Parsons et al., 1992): 
TMEn (kcal/g) =  
(g) intake Feed
(kcal) birds fastedby  excretedenergy   (kcal) birds fedby  excretedenergy   -(kcal) intakeEnergy 
 
Data were analyzed as a completely randomized design using the GLM procedure of 
SAS (SAS Institute, Inc., Cary, NC).  Differences among dietary treatments were 
determined using the least significant difference method.  A probability of P < 0.05 was 
accepted as being statistically significant. 
RESULTS AND DISCUSSION 
Free Sugar and Hydrolyzed Monosaccharide Concentrations: 
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Free sugar and hydrolyzed monosaccharide concentrations for the first generation 
SCFs are presented in Table 4-1.  All SCFs had low free sugar concentrations.  
Hydrogenated SCF  had the highest free sugar concentrations of all carbohydrates tested.  
Glucose was the major free sugar found in the SCFs except for SCF hydrogenated.  For  this 
substrate, little free glucose was present and sugars present in the highest concentration 
included fructose, sucrose, and sorbitol.   
 Hydrolyzed monosaccharide concentrations (Table 4-1) varied slightly among the 
first generation SCFs.  First generation SCF, SCF spray-dried, and SCF hydrogenated had 
high concentrations of hydrolyzed monosaccharides, while HCL corn syrup has a lower 
concentration.  Most of the hydrolyzed monosaccharides were glucose for all first 
generation SCF substrates.  Minor amounts of mannose were present in SCF gen 1, SCF 
spray-dried, and SCF hydrogenated.  An intermediate amount of sorbitol was present in SCF 
hydrogenated.  Sugars accounted for nearly all the dry matter in all SCFs except for HCl 
corn syrup where only 71% of the dry matter was accounted for. 
 Free sugar content (Table 4-2) varied slightly among second generation SCFs with a 
range of 2 to 14% of the carbohydrate content consisting of free sugars.  Low sugar SCF has 
the lowest free sugar content at 2.3% and generation 2 SCF had the highest with a 14.1% 
free sugar concentration.  Soluble corn fibers that were treated with phosphoric acid had 
higher free sugars (~11 %) than SCFs treated with hydrochloric acid (~ 6%).  Glucose was 
the major free sugar in all second generation SCFs. 
 Hydrolyzed monosaccharide concentrations (Table 4-2) were similar among the 
second generation SCFs except for SCF 2 B1 that had a considerably lower hydrolyzed 
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monosaccharide concentration (~49%).  The hydrolyzed monosaccharide assay destroys 
fructose so it not accounted for in the sugar analysis.  It is likely that SCF 2 B1 contained a 
major portion of bound fructose and, thus, its absence contributes to the low concentrations 
of hydrolyzed monosaccharides in this substrate.  Most of the hydrolyzed monosaccharide 
content was from glucose for all eight second generation SCFs.  A small amount of mannose 
was present in SCF 2 B3. 
 Quantification of the free sugar and hydrolyzed monosaccharide contents of novel 
carbohydrates is important if these substrates are to be considered for incorporation into 
foodstuffs.  Analyzing the free sugar content is important for carbohydrates that may be 
included in low glycemic foodstuffs.  Free sugars in carbohydrate substrates are rapidly 
available for digestion and, thus, have the ability to affect the glycemic response.  The 
hydrolyzed monosaccharides constitute the building blocks of the test substrate and the 
fraction of monosaccharides that are potentially available for digestion.  Free sugars and 
hydrolyzed monosaccharides provide an indication of how much and what monosaccharides 
may potentially affect the glycemic response and TME value. 
In Vitro Hydrolytic Digestion: 
 Monosaccharides released as a result of simulated hydrolytic digestion of the first 
generation SCFs are presented in Table 4-3.  All SCFs were found to have intermediate 
amounts of monosaccharides released, translating to a digestibility value of approximately 
50%. The SCF hydrogenated substrate resulted in the lowest (P<0.05) concentration of 
released glucose whereas the greatest glucose release occurred for HCl corn syrup.  
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Hydrogenated SCF resulted in the highest (P<0.05) concentrations of glucosamine and 
sorbitol release among the first generation SCFs.   
 Monosaccharides released as a result of simulated hydrolytic digestion of the second 
generation SCFs are presented in Table 4-4.  Low to intermediate amounts of 
monosaccharides were released after simulated digestion of all second generation SCFs.  
Low sugar SCF resulted in the lowest (P<0.05) monosaccharide release (~19% digested).  
The SCFs that were prepared by phosphoric acid catalyzation resulted in the highest 
(P<0.05) monosaccharide release, with SCF phos (p) being higher (P<0.05) than SCF phos 
(l).  Glucose was the major monosaccharide released for all second generation SCFs.  Low 
sugar SCF had the lowest glucose release and SCF phos (p) the highest (P<0.05).  All SCFs 
had low concentrations of fructose and galactose release during simulated hydrolytic 
digestion.  Sorbitol was released in small amounts for all SCFs except SCF low sugar, 
which had no released sorbitol.  The highest (P<0.05) concentration of released fructose, 
galactose, and sorbitol occurred for second generation SCF 2 B1. 
 First generation SCFs were approximately 50% digestible, higher than the 32% 
average digestibility of second generation SCFs.  Second generation SCFs were produced 
using more stringent processes that likely accounted for the decrease in digestibility.  
Differences in the acid catalyst used during the production process affected digestibility of 
the SCFs dramatically.  Using HCl as a catalyst appeared to create reversion products that 
were more resistant to enzymes used in hydrolytic digestion. 
   Resistance to hydrolytic digestion may be explained by the molecular structure of 
the carbohydrate.  The linkages that hold the monosaccharides together can make the 
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carbohydrate resistant to enzymatic digestion.  Enzyme resistance is due mainly to the 
presence of α-1,6 glycosidic linkages and inaccessibility of the α-1,4 linkages (Kendall et 
al., 2008).  During the production of the SCFs, different acid and enzyme combinations 
were utilized to form glycosidic linkages, predominantly α-1,6  linkages, among 
monosaccharides in the corn syrup in order to produce a more digestion-resistant 
carbohydrate.  Kendall et  al. (2008) evaluated the in vitro digestibility of a SCF that was 
similar to SCF 2 B1.  The SCF was calculated to be 14.5% digestible (13) which is lower 
than the 28% digestibility that was measured in the current study.  Sinaud et al. (2002) 
evaluated a novel low-dgestible carbohydrate produced using a starch in the presence of an 
acidic catalyst like the SCFs.  The low-digestible carbohydrate had an in vitro digestibility 
of 39.8% . A type III resistant starch evaluated by Brouns et al. (2007) had an in vitro 
digestion of 40.5% .  Both of the low-digestible carbohydrates evaluated above resulted in in 
vitro digestion values greater than the average 32.0% in vitro digestibility of the second 
generation SCFs.   Overall, the production processes implemented for second generation 
SCFs were very successful in producing low-digestible carbohydrates. 
Glycemic and Insulinemic Responses: 
 Incremental AUC data for glucose for the first generation SCFs are presented in 
Figure 4-1, and the corresponding values for AUC and relative glycemic response (RGR) 
are presented in Table 4-5.  Maltodextrin was used as a control for every set of glycemic 
response tests because it is highly digestible and rapidly absorbed, resulting in a consistently 
high glycemic response.  The carbohydrates were not all evaluated in the same period, so 
Malt was used in every period to serve as a control to calculate a relative response to the test 
carbohydrate in all periods.  Area under the curve for Malt was higher (P<0.05) than the 
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AUC values for all first generation SCFs.  Intermediate AUC values resulted for HCl corn 
syrup, SCF gen 1, and SCF spray-dried.  Hydrogenated SCF resulted in the lowest (P<0.05) 
AUC value. 
Since Malt served as the control to which all test carbohydrates were compared, it 
was assigned a RGR value of 100.  The RGR is a better value for interpretation of glycemic 
response because carbohydrates were run in a series of tests and were not all evaluated in 
the same period.  Relative glycemic responses are calculated from AUC values and directly 
related, so test carbohydrates with high AUC values will have correspondingly high RGR 
values.  The RGR values for first generation SCFs followed the same pattern as AUC 
values.  Maltodextrin had the highest RGR, followed by intermediate values for HCl corn 
syrup, SCF gen 1, and SCF spray-dried.  Hydrogenated SCF resulted in the lowest RGR 
values. 
A similar pattern in blood glucose response resulted from digestion of HCl corn 
syrup, SCF gen 1, and SCF spray-dried.  All three carbohydrates resulted in an intermediate 
peak at 30 min followed by a blunted response in blood glucose concentrations throughout 
the remainder of the glycemic response test.  Hydrogenated SCF peaked minimally at 30 
min and remained at or below basal blood glucose concentration throughout the glycemic 
response test.  These blood glucose patterns correspond well to sugar composition data.   
While SCF hydrogenated had a higher free sugar concentration than HCl corn syrup, SCF 
gen 1, and SCF spray-dried, it was due to higher concentrations of sorbitol and fructose that 
do not elicit a glycemic response.  Free sugar and released monosaccharide data show that 
HCl corn syrup, SCF gen 1, and SCF spray-dried have glucose available for digestion, and 
this was reflected in the intermediate blood glucose responses. 
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Incremental AUC data for insulin for the first generation SCFs are presented in 
Figure 4-2, and the corresponding values for AUC and RGR are presented in Table 4-5.  
Malt had a higher (P<0.05) AUC and RIR value than for all first generation SCFs.  
Hydrochloric acid-catalyzed corn syrup, SCF gen 1, and SCF spray-dried all resulted in 
intermediate RIR responses, approximately 50% of that of Malt.  Hydrogenated SCF 
resulted in the lowest (P<0.05) insulin response among the SCFs.   
Except for SCF hydrogenated, the first generation SCFs induced moderate peaks in 
insulin at the beginning of the response test before dropping to basal concentrations.  The 
peaks in insulin result from increased blood glucose concentrations elicited by the SCFs.  
Hydrogenated SCF resulted in a very low insulin response which is expected since the 
hydrogenation process leads to increased sorbitol, which does not elicit a glycemic or 
insulinemic response. 
Incremental AUC data for glucose for the second generation SCFs are presented in 
Figure 4-3, and the corresponding values for AUC and RGR are presented in Table 4-6.  
Maltodextrin had the highest (P<0.05) AUC, with all SCFs resulting in lower AUCs for 
blood glucose.  The powdered form of phosphoric-acid catalyzed SCF resulted in the 
highest AUC (P<0.05) among the SCFs.  All other second generation SCFs had intermediate 
AUC values.  The RGR data followed the same pattern, with Malt resulting in the highest 
(P<0.05) value and the SCFs resulting in intermediate values ( avg RGR of 44).  Kendall et  
al. (2008) evaluated the glycemic response in humans of a SCF that was similar to SCF 2 B1 
and incorporated into a beverage.  Authors reported an AUC of 28.5 mmol/L which was 
similar to the AUC (39.1 mmol/L) found in the current study.   A RGR value of 58.5 was 
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reported for a type III resistant starch (Brouns et al., 2007) which is similar to some of the 
SCFs evaluated. 
The majority of the second generation SCFs resulted in similar blood glucose 
response patterns except for phosphoric acid-catalyzed SCFs.  The SCFs that had similar 
glycemic responses showed a blood glucose pattern of small blunted peaks during the first 
60 min, then decreases to near basal concentrations for the remainder of the test.  The 
highest glycemic response among second generation SCFs occurred for SCF phos (p) that 
had a high peak in blood glucose concentration at 45 min, then a steady drop to baseline 
concentrations.  This higher glycemic response corresponded to higher free sugar and 
released monosaccharide values for SCF phos (p).  While SCF phos (l) also had higher free 
sugars and released monosaccharides from hydrolytic digestion, it resulted in one of the 
numerically lowest RGR values.  The lower RGR is due to the blood glucose pattern elicited 
by SCF phos (l).  The phosphoric acid-catalyzed SCF (l) peaked in blood glucose at the 
beginning of the glycemic response test but then decreased to below basal concentrations for 
the remainder of the test. 
Incremental AUC data for insulin for the second generation SCFs are presented in 
Figure 4-4, and the corresponding values for AUC and RGR are presented in Table 4-6.    
Area under the curve was highest (P<0.05) for Malt, with all other SCFs having similar but 
lower values.  The second generation values had low to intermidate RIR values with an 
average RIR of 35.5 which is lower than the average RIR of the first generation SCFs (RIR 
50.0, excluding SCF hydrogenated).  Yamada et al. (2005) evaluated the glycemic and 
insulinemic responses of a resistant starch produced using heat and de-branching enzymes.  
Lowered insulin, but not glucose, responses resulted upon consumption of bread containing 
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6 g of the resistant starch during a 2 h test (Yamada et al., 2005).  Brouns et al. (2007) 
reported the insulinemic response of a type III resistant starch to have a RIR of 24.8 which 
is similar to the average RIR for the second generation SCFs (RIR 35.5). 
The second generation SCFs, except the phosphoric acid catalyzed SCFs, had similar 
serum insulin patterns where insulin peaked at 15 min of the test and decreased to basal 
concentrations.  The higher RIR values for SCF phos (p) and SCF phos (l) results from a 
larger insulin response during the first 60 min of the response test, which corresponds to a 
higher peak in blood glucose concentrations during this time frame.  On average, SCFs 
resulting from a hydrochloric acid catalyst had lower glycemic and insulinemic responses 
(RGR 41, RIR 28) compared to SCFs from a phosphoric acid catalyst (RGR 51, RIR 50).  
Hydrochloric acid may form more digestion-resistant glycosidic bonds than phosphoric acid 
when used as a catalyst under these conditions.   
All SCFs from both generations had reduced glycemic and insulinemic responses.  
Second generation SCFs generally resulted in lower responses than did first generation 
SCFs.  The increased resistance to digestibility of these carbohydrates was likely because of 
increased glycosidic linkage formation resulting from different production methods.  
Reduced blood glucose and insulin responses have been shown to have several beneficial 
health effects, especially in diabetic patients (American Diabetes Association, 2007; Livesey 
et al., 2008; Riccardi et al., 2008).  Postprandial glucose and insulin responses can be 
reduced by decreasing available carbohydrate intake, which can be achieved by replacing 
available carbohydrates with low-digestible carbohydrates (Wolever, 2003).    Several of 
these SCF substrates may have utility in that regard. 
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True Metabolizable Energy (TMEn):  
 An increasing demand for reduced calorie foodstuffs is increasing the trend for 
production of low-calorie sweeteners and bulking agents.  A method for evaluating the 
caloric content of ingredients is the true metabolizable energy (TMEn) assay with roosters.  
This in vivo animal model assay allows for exposure of test substrates to actual digestive 
processes. 
 True metabolizable energy (TMEn) data for the first generation SCFs are presented 
in Table 4-7.  All SCFs had a lower (P<0.05) TMEn value compared to the Malt control.  
Among the SCFs, SCF hydrogenated had the highest (P<0.05) metabolizable energy, SCF 
gen 1 and SCF spray-dried had intermediate values, and HCl corn syrup had the lowest 
(P<0.05) TMEn value.  Hydrogenated SCF had the highest content (12%) of free sugars 
(sucrose, sorbitol, and fructose) readily available for digestion and leading to its higher 
energy value.   
 Maltodextrin had a higher (P<0.05) TMEn value compared to all second generation 
SCFs (Table 4-8).  Lower and similar TMEn values were found for the majority of the 
second generation SCFs, SCF phos (p) being statistically higher than all but SCF 2 B1.  The 
higher TMEn value of SCF phos (p) corroborates free sugar, released monosaccharide, and 
glycemic response data that show SCF phos (p) to be more digestible than the other SCFs.  
A low-digestible carbohydrate produced using acid catalysts was evaluated by Sinaud et al. 
(2002) and resulted in a metabolizable energy value of 3.37 kcal/g which is higher than the 
SCFs evaluated here, indicating that these production methods for SCFs were more 
successful in creating a less digestible ingredient. 
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 The TMEn assay is useful for evaluating the metabolizable energy content of novel 
carbohydrates alone, without the interferences from dietary matrix components.  This is 
important information when developing food products.  These substrates, especially the 
second generation SCFs, were shown to have low caloric content, making them potential 
candidates for inclusion in low calorie foodstuffs. 
 In conclusion, the SCFs evaluated varied widely in their sugar composition and 
physiological responses.  Overall, all SCFs exhibited varying degrees of resistance to 
hydrolytic digestion and, consequently, had attenuated glycemic responses and lower caloric 
content than the Malt control.  The second generation series of SCFs, on average, had lower 
digestibilities, glycemic responses, and TMEn values than did the SCFs from the first 
generation series. The variation noted among carbohydrates in physiological responses was 
due largely to the individual carbohydrate molecular structure and bonding pattern and was 
influenced greatly by the production methods used. Along with the beneficial characteristics 
evaluated above, it is important for ingredients to be well tolerated.  Stewart et al. (2010) 
found a SCF similar to SCF 2A to be well-tolerated when supplemented at 12 g/d. Low 
scores in bloating, cramping, flatulence, and stomach noises were observed when 
supplementing SCF (Stewart et al, 2010). Sanders et al. (2008) also reported SCF to be well 
tolerated at doses of 5, 15, and 25 g.   The beneficial physiological characteristics observed 
would make SCFs candidate ingredients for incorporation into reduced glycemic and caloric 
foodstuffs.   
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Table 4-1.  Free sugar and hydrolyzed monosaccharide concentrations of soluble corn fibers: 1
st
 generation series 
 
Test carbohydrate
1
 
Item HCl corn syrup SCF gen 1 SCF spray-dried SCF hydrogenated 
Free sugars, mg/g
2
 
    
Arabinose 0.03 0.44 0.05 5.55 
Fructose 0.58 0.00 0.00 36.49 
Galactose 0.00 0.00 0.00 8.73 
Glucose 67.93 36.72 27.47 4.58 
Mannose 0.00 0.49 0.00 0.00 
Rhamnose 0.49 0.00 0.53 0.00 
Sorbitol 0.02 0.04 0.02 25.21 
Sucrose 0.72 1.45 0.78 42.03 
Xylose 0.00 0.00 0.00 0.03 
Total, mg/g
3
 69.77 39.14 28.86 122.62 
 
    
Hydrolyzed 
monosaccharides, mg/g
2,4
     
Glucose 709.01 968.64 1,015.31 793.26 
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1  
Abbreviations: HCl corn syrup, product from hydrochloric acid-catalyzed condensation of corn syrup; SCF gen 1, generation 
1 soluble corn fiber; SCF spray-dried, spray-dried version of generation 1 soluble corn fiber; SCF hydrogenated, hydrogenated version 
of SCF spray-dried. 
2 
Values are expressed on a dry matter basis. 
3 
Values include water added when starches are broken down to monosaccharide units. 
4 
Values are corrected for free monosaccharide concentrations. 
 
 
 
Table 4-1 (con’t.) 
    
 
Mannose 
 
0.00 
 
5.03 
 
7.16 
 
3.96 
Sorbitol 0.00 0.00 0.00 177.27 
Total, mg/g
3
 709.01 973.67 1,022.48 974.48 
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Table 4-2.  Free sugar and hydrolyzed monosaccharide concentrations of soluble corn fibers: 2
nd
 generation series 
 
Test carbohydrate
1
 
Item SCF 2 
B1 
SCF low 
sugar 
SCF phos 
(l) 
SCF phos 
(p) 
SCF HCl 
(l) 
SCF HCl 
(p) 
SCF 2 B2 SCF 2 B3 
Free sugars, mg/g
2
 
        Arabinose 0.46 0.04 0.00 0.00 0.00 0.00 0.00 0.00
Fructose 11.93 0.70 7.25 5.06 4.39 4.87 4.40 7.96 
Galactose 0.09 0.00 0.00 0.00 0.00 0.00 0.11 0.15 
Glucose 127.19 21.22 92.01 114.48 54.56 58.32 90.10 53.32 
Mannose 0.72 0.00 0.45 0.46 0.41 0.46 0.59 0.65 
Rhamnose 0.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Sorbitol 1.00 0.17 0.32 0.28 0.00 0.11 0.73 0.22 
Sucrose 0.00 0.82 0.00 0.00 0.00 0.00 0.08 0.00 
Total, mg/g
3
 141.87 22.95 100.03 120.28 59.36 63.76 96.00 62.30 
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Table 4-2 (con’t.) 
        Hydrolyzed 
monosaccharides, 
mg/g
2,4
 
        Glucose 489.51 1,084.72 980.87 996.08 996.07 999.81 1,026.52 1,073.63
Mannose 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.01 
Total, mg/g
3
 489.51 1,084.72 980.87 996.08 996.07 999.81 1,026.52 1,074.64 
1  
Abbreviations: SCF 2 B1, generation 2 soluble corn fiber batch 1; SCF low sugar, low sugar version of generation 2 soluble 
corn fiber; SCF phos (1), phosphoric acid-catalyzed condensation of corn syrup liquid ; SCF phos (p), phosphoric acid-catalyzed 
condensation of corn syrup  powder; SCF HCl (l), hydrochloric acid-catalyzed condensation of corn syrup liquid; SCF HCl (p), 
hydrochloric acid-catalyzed condensation of corn syrup powder; SCF 2 B2, generation 2 soluble corn fiber batch 2; SCF 2 B3 
generation 2 soluble corn fiber batch 3. 
2 
Values are expressed on a dry matter basis. 
3 
Values include water added when starches are broken down to monosaccharide units. 
4 
Values are corrected for free monosaccharide concentrations. 
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Table 4-3.  Monosaccharides (including free monosaccharides) released after simulated hydrolytic digestion of soluble corn fibers: 1
st
 
generation series 
 
Released monosaccharides, 
mg/g
2
 
Test carbohydrate
1
  
HCL corn syrup SCF gen 1 SCF spray-dried 
SCF 
hydrogenated 
 
SEM 
 
Glucosamine 0.00
a
 0.36
b
 0.00
a
 5.52
c
 
 
0.05 
Glucose 515.36
c
 453.74
b
 484.19
bc
 395.56
a
 6.82 
Isomaltose 14.36
b
 20.23
c
 17.85
bc
 0.00
a
 0.81 
Sorbitol 0.00
a
 0.00
a
 0.00
a
 53.64
b
 0.50 
Total, mg/g
3  529.72
c
 474.33
ab
 502.04
bc
 454.72
a
 7.65 
1  
Abbreviations: HCl corn syrup, product from hydrochloric acid-catalyzed condensation of corn syrup; SCF gen 1, generation 1 soluble 
corn fiber; SCF spray-dried, spray-dried version of generation 1 soluble corn fiber; SCF hydrogenated, hydrogenated version of SCF spray-dried. 
2 
Values are expressed on a dry matter basis. 
3 
Values include water added when starches are broken down to monosaccharide units. 
abc 
Means in the same row with different superscript letters are different (P<0.05). 
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Table 4-4.  Monosaccharides (including free monosaccharides) released after simulated hydrolytic digestion of soluble corn fibers: 2
nd
 
 generation series 
 
 
Released 
monosaccharides, 
mg/g
2
 
Test carbohydrate
1
  
SCF 2 B1 
SCF 
low 
sugar 
SCF 
phos (l) 
SCF phos 
(p) 
SCF HCl 
(l) 
SCF HCl 
(p) 
SCF 2 B2 
SCF 2 
B3 
SEM 
Fructose 20.15
f
 10.53
a
 16.56
e
 12.78
bc
 13.43
c
 12.13
b
 14.93
d
 17.35
e
 
 
0.30 
Galactose 0.52
f
 0.05
a
 0.10
ab
 0.13
abc
 0.22
cde
 0.20
bcd
 0.29
de
 0.30
e
 0.02 
Glucose 264.27
cd
 177.09
a
 383.43
f
 513.77
g
 251.27
c
 276.72
d
 349.31
e
 231.62
b
 3.68 
Sorbitol 1.16
f
 0.00
a
 0.25
c
 0.24
c
 0.13
b
 0.17
b
 0.69
e
 0.40
d
 0.01 
Total, mg/g
3
 286.10
c
 187.66
a
 400.34
e
 526.93
f
 265.04
b
 289.21
c
 365.21
d
 249.68
b
 3.63 
1  
Abbreviations: SCF 2 B1, generation 2 soluble corn fiber batch 1; SCF low sugar, low sugar version of generation 2 soluble 
corn fiber; SCF phos (1), phosphoric acid-catalyzed condensation of corn syrup liquid ; SCF phos (p), phosphoric acid-catalyzed   
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condensation of corn syrup  powder; SCF HCl (l), hydrochloric acid-catalyzed condensation of corn syrup liquid; SCF HCl (p), 
hydrochloric acid-catalyzed condensation of corn syrup powder; SCF 2 B2, generation 2 soluble corn fiber batch 2; SCF 2 B3 
generation 2 soluble corn fiber batch 3. 
2 
Values are expressed on a dry matter basis. 
3 
Values include water added when starches are broken down to monosaccharide units. 
abcdefg 
Means in the same row with different superscript letters are different (P<0.05). 
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Table 4-5. Incremental area under the curve (AUC) for glucose and insulin, and relative glycemic response (RGR) and relative 
insulinemic response (RIR) of soluble corn fibers: 1
st
 generation series 
 Test carbohydrate
1
  
 
Item Malt 
HCL corn 
syrup 
SCF gen 1 
SCF spray-
dried 
SCF 
hydrogenated 
 
SEM
2 
 
 
AUC for glucose, 
mmol/L 
 
157.16
c 
 
121.15
b
 
 
98.20
b
 
 
98.90
b
 
 
34.04
a
 
 
18.15 
RGR, % 100.00
c 
80.94
b
 60.46
b
 62.79
b
 14.85
a
 10.20 
AUC for insulin, pmol/L 10,165.00
c
 4,758.15
b
 4,328.04
b
 4,241.59
b
 935.61
a
 1,640.88 
RIR, % 100.00
c
 58.33
b
 43.83
b
 48.55
b
 10.66
a
 8.96 
1 
Abbreviations: Malt, maltodextrin; HCl corn syrup, product from hydrochloric acid-catalyzed condensation of corn syrup; 
SCF gen 1, generation 1 soluble corn fiber; SCF spray-dried, spray-dried version of generation 1 soluble corn fiber; SCF  
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hydrogenated, hydrogenated version of SCF spray-dried. 
2 
Pooled standard error of the mean. 
abc
 Means in the same row with different superscript letters are different (P<0.05).  
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Table 4-6. Incremental area under the curve (AUC) for glucose and insulin, and relative glycemic response (RGR) and relative 
insulinemic response (RIR) of soluble corn fibers: 2
nd
  generation series 
 Test carbohydrate
1
  
 
Item Malt 
SCF 2 
B1 
SCF low 
sug 
SCF 
phos (l) 
SCF 
phos (p) 
SCF HCl 
(l) 
SCF HCl 
(p) 
SCF 2 
B2 
SCF 2 
B3 
 
SEM
2 
 
 
AUC for 
glucose, 
mmol/L 
 
 
157.25
d
 
 
 
39.10
a
 
 
 
75.32
b
 
 
 
59.25
ab
 
 
 
108.52
c
 
 
 
71.31
ab
 
 
 
71.49
ab
 
 
 
70.03
ab
 
 
 
57.42
ab
 
 
 
18.30 
RGR, % 100.00
d
 24.49
a
 50.15
bc
 33.33
ab
 68.35
c
 40.82
ab
 40.22
ab
 50.31
bc
 47.86
abc
 8.10 
AUC for 
insulin, 
pmol/L 
 
10,814.00
d
 
 
4,942.85
a
 
 
4,137.45
a
 
 
6,409.85
a
 
 
7,011.85
a
 
 
3,735.45
a
 
 
3,031.43
a
 
 
3,641.70
a
 
 
4,095.10
a
 
 
1,654.49 
 
RIR, % 
 
100.00
c
 
 
26.16
a
 
 
21.22
a
 
 
43.04
ab
 
 
56.52
b
 
 
31.03
ab
 
 
24.74
a
 
 
36.57
ab
 
 
44.47
ab
 
 
8.26 
1 
Abbreviations: SCF 2 B1, generation 2 soluble corn fiber batch 1; SCF low sugar, low sugar version of generation 2 soluble 
corn fiber; SCF phos (1), phosphoric acid-catalyzed condensation of corn syrup liquid ; SCF phos (p), phosphoric acid-catalyzed  
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condensation of corn syrup  powder; SCF HCl (l), hydrochloric acid-catalyzed condensation of corn syrup liquid; SCF HCl (p), 
hydrochloric acid-catalyzed condensation of corn syrup powder; SCF 2 B2, generation 2 soluble corn fiber batch 2; SCF 2 B3 
generation 2 soluble corn fiber batch 3. 
2 
Pooled standard error of the mean. 
abcd
 Means in the same row with different superscript letters are different (P<0.05).  
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Table 4-7.  True metabolizable energy (TMEn) values for soluble corn fibers: 1
st
 generation series 
Item 
Test carbohydrate
1
  
Malt 
HCL corn 
syrup 
SCF gen 1 
SCF spray-
dried 
SCF 
hydrogenated 
 
SEM
2
 
 
Grams dosed, dry 
matter basis 
 
14.3 
 
26.7 
 
13.3 
 
14.6 
 
14.7 
 
TMEn, kcal/g 4.06
d
 1.91
a
 2.35
b
 2.30
b
 3.03
c
 
 
0.10 
 
1 
Abbreviations: HCl corn syrup, product from hydrochloric acid-catalyzed condensation of corn syrup; SCF gen 1, generation 
1 soluble corn fiber; SCF spray-dried, spray-dried version of generation 1 soluble corn fiber; SCF hydrogenated, hydrogenated version 
of SCF spray-dried. 
2 
Pooled standard error of the mean. 
abcd
 Means in the same row with different superscript letters are different (P<0.05).  
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Table 4-8.  True metabolizable energy (TMEn) values for soluble corn fibers: 2
nd
 generation series. 
 
 
Item 
Test carbohydrate
1
  
Malt SCF 2 B1 
SCF low 
sug 
SCF 
phos (l) 
SCF 
phos (p) 
SCF 
HCl (l) 
SCF 
HCl (p) 
SCF 2 
B2 
SCF 2 
B3 
 
SEM 
 
Grams dosed, dry 
matter basis 
 
14.3 
 
26.8 
 
27.0 
 
25.6 
 
26.9 
 
25.4 
 
27.9 
 
23.9 
 
23.7 
 
TMEn, kcal/g 4.06
d
 1.96
bc
 1.58
ab
 1.75
b
 2.30
c
 1.82
b
 1.76
b
 1.85
b
 1.31
a
 0.10 
1 
Abbreviations: SCF 2 B1, generation 2 soluble corn fiber batch 1; SCF low sugar, low sugar version of generation 2 soluble 
corn fiber; SCF phos (1), phosphoric acid-catalyzed condensation of corn syrup liquid ; SCF phos (p), phosphoric acid-catalyzed 
condensation of corn syrup  powder; SCF HCl (l), hydrochloric acid-catalyzed condensation of corn syrup liquid; SCF HCl (p), 
hydrochloric acid-catalyzed condensation of corn syrup powder; SCF 2 B2, generation 2 soluble corn fiber batch 2; SCF 2 B3 
generation 2 soluble corn fiber batch 3. 
2 
Pooled standard error of the mean. 
abcd
 Means in the same row with different superscript letters are different (P<0.05).  
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Figure 4-1.  Incremental change from baseline in blood glucose response for dogs consuming 25 g of soluble corn fibers: 1
st
 
generation series.  Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (0.14), HCl corn syrup (0.32), 
SCF gen 1(0.34), SCF spray-dried (0.30), and SCF hydrogenated (0.27).  Abbreviations: HCl corn syrup, product from hydrochloric 
acid-catalyzed condensation of corn syrup; SCF gen 1, generation 1 soluble corn fiber; SCF spray-dried, spray-dried version of 
generation 1 soluble corn fiber; SCF hydrogenated, hydrogenated version of SCF spray-dried. 
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Figure 4-2. Incremental change from baseline in serum insulin response for dogs consuming 25 g of soluble corn fibers: 1
st
 generation 
series.  Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (13.36), HCl corn syrup (25.38), SCF gen 
1(25.38), SCF spray-dried (23.21), and SCF hydrogenated (25.38).  Abbreviations: HCl corn syrup, product from hydrochloric acid-catalyzed 
condensation of corn syrup; SCF gen 1, generation 1 soluble corn fiber; SCF spray-dried, spray-dried version of generation 1 soluble corn fiber; 
SCF hydrogenated, hydrogenated version of SCF spray-dried. 
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Figure 4-3.  Incremental change from baseline in blood glucose response for dogs consuming 25 g of soluble corn fibers: 2nd 
generation series.  Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (0.19), SCF 2A (0.28), SCF low 
sug (0.24), SCF phos (1) (0.33), SCF phos (p) (0.32), SCF HCl (l) (0.30), SCF HCl (p) (0.32), SCF 2B (l) (0.29), and SCF 2B (p) (0.29).  
Abbreviations: SCF 2 B1, generation 2 soluble corn fiber batch 1; SCF low sugar, low sugar version of generation 2 soluble corn fiber; SCF phos 
(1), phosphoric acid-catalyzed condensation of corn syrup liquid ; SCF phos (p), phosphoric acid-catalyzed condensation of corn syrup  powder; 
SCF HCl (l), hydrochloric acid-catalyzed condensation of corn syrup liquid; SCF HCl (p), hydrochloric acid-catalyzed condensation of corn syrup 
powder; SCF 2 B2, generation 2 soluble corn fiber batch 2; SCF 2 B3 generation 2 soluble corn fiber batch 3. 
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Figure 4-4.  Incremental change from baseline in serum insulin response for dogs consuming 25 g of soluble corn fibers: 2nd 
generation series.  Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (13.36), SCF 2A (23.21), SCF 
low sug (23.21), SCF phos (1) (23.21), SCF phos (p) (23.21), SCF HCl (l) (23.21), SCF HCl (p) (23.21), SCF 2B (l) (23.21), and SCF 2B (p) 
(23.21).  Abbreviations: SCF 2 B1, generation 2 soluble corn fiber batch 1; SCF low sugar, low sugar version of generation 2 soluble corn fiber; 
SCF phos (1), phosphoric acid-catalyzed condensation of corn syrup liquid ; SCF phos (p), phosphoric acid-catalyzed condensation of corn syrup  
powder; SCF HCl (l), hydrochloric acid-catalyzed condensation of corn syrup liquid; SCF HCl (p), hydrochloric acid-catalyzed condensation of 
corn syrup powder; SCF 2 B2, generation 2 soluble corn fiber batch 2; SCF 2 B3 generation 2 soluble corn fiber batch 3. 
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CHAPTER 5: BLENDING OF SOLUBLE CORN FIBER WITH PULLULAN, 
SORBITOL, OR FRUCTOSE ATTENUATES GLYCEMIC AND INSULINEMIC 
RESPONSES IN THE DOG AND AFFECTS HYDROLYTIC DIGESTION IN VITRO 
 
ABSTRACT: The objective of these experiments was to measure in vitro hydrolytic 
digestion and glycemic and insulinemic responses of select carbohydrate blends, all 
containing the novel carbohydrate, soluble corn fiber (SCF). Two SCFs that varied in their 
method of production were used to formulate the carbohydate blends. One set of blends 
contained a SCF that was spray-dried (SCFsd), then blended with different amounts of 
either pullulan (Pull), sorbitol (Sorb), or fructose (Fruct).  The other set of blends contained 
a SCF produced using a different production method (SCF), then blended with different 
ratios of Pull, Sorb, and Fruct (SCF:Pull:Sorb:Fruct blends).  All blends had low to 
intermediate free sugar concentrations except those with higher percentages of Fruct and 
Sorb.  The addition of higher amounts of Fruct and Sorb increased the free Fruct and Sorb 
concentrations of the blends.  Glucose was the primary bound monosaccharide in the blends.  
The SCFsd blends had intermediate to high amounts of monosaccharides released as a result 
of in vitro hydrolytic digestion.  The SCFsd:Pull blends were more digestible in vitro 
(~91%) than SCFsd:Fruct or SCFsd:Sorb.  Total released monosaccharides were higher in 
SCFsd blends containing either 50% Fruct or Sorb, but the combination resulted in lower 
concentrations of glucose released. The SCF:Pull:Sorb:Fruct blends also had intermediate to 
high released monosaccharides as a result of in vitro hydrolytic digestion.  The 30:30:20:20 
SCF:Pull:Sorb:Fruct blend was the most digestible (~85%), but also released the highest 
concentrations of Fruct and Sorb.  All SCF blends resulted in low glycemic and insulinemic 
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responses compared to the maltodextrin (Malt) control.  Blends containing Fruct and Sorb 
were most effective in attenuating the glycemic and insulinemic responses.  The blending of 
SCFs with Pull, Fruct, and Sorb resulted in mixtures varying in degree of resistance to 
digestion, but all blends were successful in attenuating postprandial glucose and insulin 
concentrations.  These blends may prove beneficial as components of low glycemic 
foodstuffs. 
INTRODUCTION 
Metabolic disorders such as type 2 diabetes, obesity, hypertension, cardiovascular disease, 
and cancer are major global health problems today.  In the United States alone, diabetes is 
estimated to affect 7% of the population (Blonde, 2007).  Controlling postprandial glycemia 
has been shown to be of great importance in the management of diabetes (American 
Diabetes Association, 2009).  Low glycemic diets have been shown to help control 
postprandial glucose and insulin concentrations in diabetics (Livesey et al., 2008; Riccardi 
et al., 2008).  Decreasing the glycemic response also may play a role in improving risk 
factors associated with heart disease and diabetes (Livesey et al., 2008; Riccardi et al., 
2008).  This has led to a demand for the development of novel carbohydrates that have the 
ability to attenuate glycemic and insulinemic responses and that may be incorporated easily 
into a wide array of food matrices.     
A class of carbohydrates that has the potential to improve glycemic control is low-
digestible carbohydrates.  Low-digestible carbohydrates represent a heterogeneous group of 
compounds that are partially unavailable to digestive enzymes so are either incompletely or 
not absorbed from the small intestine (Murphy, 2001; Scheppach et al., 2001; Grabitske et 
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al., 2008).  Low-digestible carbohydrates include polyols, resistant starch, 
fructooligosaccharides, and other oligosaccharides (Marteau and Flourie, 2001; Murphy, 
2001; Scheppach et al., 2001; Grabitske et al., 2008).  Factors restricting digestion and 
absorption of low-digestible carbohydrates are the impaired hydrolysis of constitutive bonds 
by enzymes and the degree of absorption in the small intestine (Marteau and Flourie, 2001).   
Soluble corn fibers (SCF) are types of novel, low-digestible carbohydrates. The 
different processes used to produce SCFs result in fractions with varying degrees of 
digestion resistance due to increased α-1,6 glycosidic bonds formed during their production. 
Research conducted on various forms of SCF found them to have low free sugar 
concentrations, increased resistance to in vitro hydrolytic digestion, and low true 
metabolizable energy values (Knapp et al. unpublished data).   
Pullulan is a naturally occurring fermentation product produced by Aureobasidium 
pullulans, a black yeast found widely throughout nature (Wolf et al., 2003; Shingel, 2004). 
Pullulans are linear polysaccharides consisting of three  -(1-4) linked glucose molecules 
that are repeatedly polymerized by  -(1-6) linkages on the terminal glucose, resulting in a 
stair-step structure (Kimoto et al., 1997; Leathers, 2003). The stair-step structure resulting 
from glycosidic linkages in Pull hinders hydrolysis by enzymes, making them low-digestible 
carbohydrates (Wolf et al., 2003).   
Fructose is a naturally occurring sugar and is the sweetest of all the natural sugars.  
Fructose is a six-carbon monosaccharide similar to that of glucose.  Fructose differs from 
glucose by the presence of a keto group attached to carbon 2 of the molecule, while glucose 
has an aldehyde group at carbon 1.  Fructose exhibits a synergy with other sweeteners 
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present in a formulation and allows for a product to have a higher total level of sweetness 
without increasing the total level of sweetener (Hanover and White, 1993).  Energy 
reduction, simple-sugar reduction, and flavor profile enhancement are three popular 
formulation trends that fructose can impact favorably (Hanover and White, 1993).  Fructose 
also is widely used in food products for diabetics as it is rapidly removed from the portal 
blood by the liver and enters the peripheral circulation in only small amounts.  The active 
hepatic enzyme system extracts fructose into the liver. This process is insulin-independent 
(White and Osberger, 2001).  Sorbitol is a sugar found in many natural sources including 
fruits such as plums, cherries, apples, and numerous other plants.   
Sorbitol is a six-carbon alcohol approximately 60% as sweet as sucrose and is 
soluble in water (Le and Mulderrig, 2001).  Sorbitol is slowly absorbed into the body from 
the gastrointestinal tract and is metabolized by the liver, largely as fructose.  Sorbitol is 
absorbed and metabolized in the liver by a pathway located entirely in the cytoplasmic 
compartment (Le and Mulderrig, 2001).  Ingestion of sorbitol does not usually result in an 
immediate demand for extra insulin and the initial steps in the metabolism of sorbitol in the 
liver, uptake by the liver cells, and conversion to glucose are independent of insulin (Le and 
Mulderrig, 2001). 
Evaluation of glycemic and insulinemic responses to individual carbohydrates is 
beneficial as it allows for a precise understanding of their potential effects without the 
interference of other dietary components.  Soluble corn fibers have a lower digestbility and 
attenuated glycemic and insulinemic responses (Knapp et al. unpublished data), but 
blending SCFs with other carbohydrates that resist digestion and (or) do not elicit a 
glycemic response, such as Pull, Fruct, and Sorb, have the potential to further attenuate 
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glycemic and insulinemic responses.  As the concentrations of these carbohydrate increase 
in the blend, glycemic and insulinemic responses would be expected to drop in order to 
create ideal low-glycemic carbohydrate blends.  The objective of the study was to evaluate 
select blends of SCFs with Pull, Fruct, and Sorb for in vitro hydrolytic digestion as well as 
glycemic and insulinemic responses using a dog model. 
MATERIALS AND METHODS 
Substrates:   
 Carbohydrate blends incorporating SCFs were evaluated.  The production of SCFs 
involves isolating an oligosaccharide-rich fraction from corn syrup.  During cornstarch 
hydrolysis, an aqueous stream comprised of dextrose, fructose, and a mixture of 
oligosaccharides results (Harrison and Hoffman, 2007).  The aqueous solution is 
nanofiltered, resulting in a monosaccharide and an oligosaccharide-rich stream.  Once 
oligosaccharide-rich syrup has been formed, it can be treated with an isomerization enzyme 
such that some of the dextrose present in the syrup is converted to fructose, producing an 
isomerized oligosaccharide-rich stream (Harrison and Hoffman, 2007).  The syrup is 
subjected to a catalyst(s) that creates reversion products where the residual monosaccharides 
in the syrup become covalently bonded to oligosaccharides or other monosaccharides 
present in the syrup, thus increasing α-1,6 glycosidic bond formation  in the structure 
(Harrison and Hoffman, 2007).  The last steps in the production process include 
decolorization of the syrup and evaporation and drying to produce a powder.   
Two sets of blends containing different SCFs were evaluated.   The SCFs used in the 
blends evaluated were produced using the basic steps outlined above, but differed in specific 
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production steps.  One set included a SCF that was spray-dried (SCFsd).  The other included 
a SCF that was produced using a process involving longer evaporation times than occurred 
for SCFsd (SCF).  The carbohydrates blended with SCFsd and SCF included fructose 
(Fruct), sorbitol (Sorb), and pullulan (Pull).   
  Seven blends were formulated using SCFsd with different percentages of Pull, 
Fruct, or Sorb. The SCFsd blends included four with varying percentages of Fruct: SCFsd 
with 5% Fruct (95:5 SCFsd:Fruct), SCFsd with 15% Fruct (85:15 SCFsd:Fruct), SCFsd with 
30% Fruct (70:30 SCFsd:Fruct), and SCFsd with 50% Fruct (50:50 SCFsd:Fruct). Two 
blends included SCFsd and Pull: SCFsd with 30% Pull (70:30 SCFsd:Pull) and SCFsd with 
50% Pull (50:50 SCFsd:Pull).  One blend was SCFsd with 50% Sorb (50:50 SCFsd:Sorb). 
The second set of blends consisted of four blends using SCF with different ratios of 
Pull, Sorb, and Fruct: SCF blended with 10% Pull, 10% Sorb, and 10% Fruct (70:10:10:10 
SCF:Pull:Sorb:Fruct), SCF blended with 20% Pull, 10% Sorb, and 10% Fruct (60:20:10:10 
SCF:Pull:Sorb:Fruct), SCF blended with 30% Pull, 10% Sorb, and 10% Fruct (50:30:10:10 
SCF:Pull:Sorb:Fruct), and SCF blended with 30% Pull, 20% Sorb, and 20% Fruct 
(30:30:20:20 SCF:Pull:Sorb:Fruct).  The Pull used in the blends had a molecular weight 
(MW) of 250,000 and was produced by Hayashibara Company Ltd. (Okayama, Japan).  
Soluble corn fibers, sorbitol, and fructose were produced by Tate and Lyle (Decatur, IL).  
All blends were formulated and prepared by Tate & Lyle (Decatur, IL).      
Chemical Analyses:   
Carbohydrates were analyzed for dry matter (DM) and organic matter (OM) 
according to AOAC (2000), and for free and hydrolyzed monosaccharide concentrations.  
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Test carbohydrates were hydrolyzed using the procedure described by Hoebler et al. (1989) 
where carbohydrates were subjected to hydrolysis with H2SO4.  Free sugars and hydrolyzed 
monosaccharides were quantified using a Dionex DX500 high performance liquid 
chromatography (HPLC) system (Dionex Corporation, Sunnyvale, CA).  Standards for 
quantification included inositol, fucose, arabinose, rhamnose, galactose, xylose, and 
mannose.  Free monosaccharides were injected at a volume of 25 L .  All assays were 
conducted using a CarboPac PA-1 column and guard column following methods cited by 
Smiricky et al. (2002).   
In Vitro Hydrolytic Digestion:   
Approximately 200 mg of each carbohydrate or carbohydrate blend were weighed in 
triplicate and incubated with 2 mL of a pepsin/hydrochloric acid solution and 2 mL of an 
enzyme solution consisting of amyloglucosidase and  -amylase to simulate gastric and 
small intestinal digestion (Muir et al., 1993).  The samples were analyzed for free released 
monosaccharides using HPLC (Smiricky et al., 2002) following the simulated hydrolytic 
digestion procedure. 
Data were analyzed as a completely randomized design using the Mixed Models 
procedure of SAS (SAS Institute, Inc., Cary, NC). The statistical model included the fixed 
effect of substrate.  Treatment least-squares means were reported and compared using a 
Tukey adjustment to ensure the overall protection level. Differences among means with a P-
value of less than 0.05 were considered significant. 
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Glycemic/Insulinemic Responses:   
To determine postprandial glycemic and insulinemic responses to the test 
carbohydrates, five purpose-bred female dogs (Butler Farms, Clyde, NY) with hound 
bloodlines, a mean initial body weight of 25.1 ± 4.8 kg, and a mean age of 5.6 ± 2.4 years 
were used.  Dogs were housed individually in 1.2 x 2.4 m clean floor pens in a climate-
controlled room at the animal care facility of the Edward R. Madigan Laboratory on the 
University of Illinois campus. Dogs were provided with non-destructible toys (hard plastic 
balls, Nyla bones, etc.).  Pens allowed for nose-nose contact between dogs in adjacent runs 
and visual contact with all dogs in the room.  A 16-h light:8-h dark cycle was used. The 
University of Illinois Institutional Animal Care and Use Committee approved all procedures 
prior to animal experimentation. 
Dogs consumed 25 g of carbohydrate (DM basis) in approximately 240 mL dd 
water.  In order to get carbohydrate sources into solution, water and carbohydrate were 
mixed using a stir plate.   Quantity to be dosed was measured using a disposable 60 cc 
syringe (without needle) and offered to dogs within a 10 min period.  During the trial, all 
dogs were fed the same commercial diet (Iams Weight Control
®
; The Iams Co., Lewisburg, 
OH).  Water was available ad libitum. 
Five by five Latin square experimental designs were used to evaluate test substrates. 
Maltodextrin served as the control, and in every Latin square conducted, the dogs were 
subjected to four test ingredients and the Malt control. Glycemic tests were 3 h long and 
spaced 4 days apart.  At 1700 h on the evening before each glycemic test, any remaining 
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food was removed and dogs were food-deprived for 15 h during which time they had access 
to water.  Dogs consumed their allotted treatment after the 15 h of food deprivation.   
On the morning of the glycemic test, a blood sample was obtained from dogs before 
being dosed to serve as the baseline value.  Dogs then were dosed with the appropriate 
carbohydrate, and additional blood samples were taken at 15, 30, 45, 60, 90, 120, 150, and 
180 min postprandially.  Approximately 3 mL of blood were collected in a syringe via 
jugular or radial venipuncture.  An aliquot of blood was taken immediately for glucose 
analysis.  The remaining blood was centrifuged at 1,240 x g for 10 min and serum stored at -
20 ºC for subsequent analysis of insulin. 
Immediately following collection, blood samples were assayed for glucose based on 
the glucose oxidase method using a Precision-G Blood Glucose Testing System (Medisense, 
Inc., Bedford, MA).  This system measures blood glucose concentrations from the electrical 
current resulting  from electron transfer when the glucose oxidase on the test strip catalyzes 
the oxidation of glucose to gluconic acid (Cass et al., 1984).  Each glucometer was 
calibrated prior to each glycemic test according to manufacturer’s instructions.  Serum was 
analyzed for insulin using a Rat Insulin Enzyme Immunoassy kit (Cayman Chemical, Ann 
Arbor, MI) (Wisdom, 1976). 
The positive incremental area under the curve (AUC), ignoring any areas below the 
baseline, for blood glucose and insulin values was calculated according to the method of 
Wolever et al. (1991) using GraphPad Prism 5 Software (GraphPad Software, Inc., San 
Diego, CA).  The relative glucose response (RGR) and relative insulinemic response (RIR) 
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of the test carbohydrates were calculated for each individual dog according to the following 
formula: [(AUC for test carbohydrate) / (AUC for control)] x 100%.   
Data were analyzed by the Mixed models procedure of SAS (SAS Institute, Cary, 
NC).    The statistical model included the fixed effect of treatment and the random effect of 
animal nested within Latin square and test period nested within Latin square.  Treatment 
least-squares means were compared using single degree of freedom contrast statements to 
compare only the test ingredients of interest in the numerous Latin squares conducted.  A 
probability of P < 0.05 was accepted as being statistically significant.   
RESULTS AND DISCUSSION 
Free Sugar and Hydrolyzed Monosaccharide Concentrations: 
 Free sugar and hydrolyzed monosaccharide concentrations for the SCFsd blends are 
presented in Table 5-1.  Free sugar concentrations varied among the blends, ranging from 
approximately 1 to 50%.  The two Pull blends (70:30 SCFsd:Pull and 50:50 SCFsd:Pull) 
had the lowest free sugar concentrations of all the blends tested and were similar in free 
sugar concentrations to SCFsd alone.  The blends with 50% Fruct and 50% Sorb had the 
highest free sugar concentrations (43-53%)  The SCFsd blends with 5, 15, and 30% Fruct 
had 11-23%  free sugar concentrations. 
 Fructose and glucose were the major free sugars found in SCFsd blends with the 
exception of the 50:50 SCFsd:Sorb blend where sorbitol was the primary free sugar present.  
Glucose was the primary free sugar for substrates 70:30 SCFsd:Pull, 50:50 SCFsd:Pull, and 
SCFsd, but the concentrations were low (~2.3%).  In blends where Fruct was added to 
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SCFsd, Fruct was the free sugar found in highest concentration, and concentrations 
increased in proportion to the percentage of Fruct added. 
 Hydrolyzed monosaccharide concentrations (Table 5-1) varied slightly among the 
SCFsd blends. The majority of the blends were completely hydrolyzed to their 
monosaccharide components.  The blends with higher percentages of Fruct or Sorb had 
lower hydrolyzed monosaccharide concentrations due to their higher free sugar 
concentrations.  Glucose accounted for most of the hydrolyzed monosaccharides for SCFsd 
and all the SCFsd blends. 
 Free sugar content (Table 5-2) was similar among the SCF:Pull:Sorb:Fruct blends 
except the 30:30:20:20 SCF:Pull:Sorb:Fruct blend that had the highest Fruct, Sorb, and total 
free sugar concentrations.  Free Fruct and Sorb increased and glucose decreased with 
addition of Sorb and Fruct to SCF.   
 Hydrolyzed monosaccharide concentrations (Table 5-2) for the SCF:Pull:Sorb:Fruct 
blends followed similar trends to the SCFsd blends where higher percentages of Fruct and 
Sorb resulted in lower hydrolyzed monosaccharide concentrations.  Soluble corn fiber had a 
low hydrolyzed monosaccharide concentration along with a low free sugar concentration.  It 
is likely that SCF contained a major portion of bound Fruct that would account for the low 
hydrolyzed monosaccharide concentration.  The hydrolyzed monosaccharide assay destroys 
fructose so it not included in the total hydrolyzed monosaccharide value.  The main 
monosaccharide found in SCF and all the blends was glucose.  Minor amounts of Sorb were 
present in three of the SCF:Pull:Sorb:Fruct blends. 
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 Free sugar and hydrolyzed monosaccharide data are important in an evaluation of 
substrates that may be included in glycemic foodstuffs.  The free sugars found in these 
substrates will be rapidly digested upon consumption and, thus, may have a major impact on 
the postprandial glycemic response.  Overall, the free sugar concentrations found in the 
individual SCFsd and SCF substrates were low, but varied.  Soluble corn fiber spray-dried 
had a lower free sugar concentration compared to SCF (2.8 vs 14.2%).  Glucose was the 
main free sugar found in both SCFsd and SCF, but at different concentrations (2.7 vs 12.7%, 
respectively).  Fructose was present in SCF, whereas no free fructose was found in SCFsd. 
 The 50:50 SCFsd:Pull blend resulted in a higher glucose and total free sugar 
concentration compared to the 70:30 SCFsd:Pull blend due to the small amounts of free 
glucose associated with Pull. The addition of Pull to the SCF:Pull:Sorb:Fruct blends resulted 
in lower free glucose concentrations compared to SCF alone.  As the percentage of Pull 
increased and replaced SCF in the SCF:Pull:Sorb:Fruct blends, glucose concentrations 
decreased. Overall, addition of Pull, even at high concentrations, did not significantly 
increase free sugar values.  Pullulan has been reported to contain very low free sugar 
concentrations (Knapp et al., 2010).    
  Increased amounts of Fruct and Sorb decreased the free glucose concentrations in the 
SCFsd blends while increasing free sugar concentrations of Fruct and Sorb.  The increased 
Fruct and Sorb concentrations resulted in increased total free sugar concentrations.  This 
same trend was noted for the SCF:Pull:Sorb:Fruct blends.  Increased concentrations of Fruct 
and Sorb (from 10 to 20%) decreased free glucose while increasing free Fruct and Sorb.  
The Fruct and Sorb added to the blends were available as free sugars and could have a major 
impact on glycemic response.   
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  The hydrolyzed monosaccharides constitute the building blocks of carbohydrate 
polymers and provide an indication of what sugars are potentially available for digestion.  
The hydrolyzed monosaccharide concentration (especially glucose) of SCF was lower 
compared to SCFsd.  Data indicate that SCF has a much greater concentration of bound 
Fruct than SCFsd.  The bound Fruct could have a major impact on the glycemic and 
insulinemic responses of these substrates.  This difference in carbohydrate content is likely 
due to production method used.  
 The SCFsd:Pull blends are high in bound glucose.  The SCFsd:Fruct and 
SCFsd:Sorb blends are lower in hydrolyzed monosaccharide concentrations due to higher 
concentrations of free Fruct and Sorb.  The different concentrations of Pull in the 
SCF:Pull:Sorb:Fruct blends had little impact on hydrolyzed monosaccharide values.  
Addition of Pull at 10, 20, or 30% resulted in similarly high hydrolyzed monosaccharide 
values.  As noted for the SCFsd blends, higher concentrations of Sorb and Fruct decreased 
hydrolyzed monosaccharide values.  Depending on their digestibility, glucose monomers 
may become available and have an impact on the glycemic response. 
In Vitro Hydrolytic Digestion: 
 Monosaccharides released as a result of simulated hydrolytic digestion of the SCFsd 
blends are presented in Table 5-3.  Soluble corn fiber spray-dried had an approximate 
monosaccharide digestibility value of 50%. The blends with the lowest percentages of Fruct 
added (95:5 SCFsd and 85:15 SCFsd:Fruct) had similar monosaccharide digestibility values 
as SCFsd.  The blends containing 30 and 50% Fruct or Sorb had higher (P<0.05) 
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monosaccharide digestibility values (~ 75%).  The Pull blends, 70:30 SCFsd:Pull and 50:50 
SCFsd:Pull, had similar but higher (P<0.05) digestibility values (~ 91%). 
 Glucose was the sugar released in the greatest concentration except for the blends 
that had 50% Fruct or 50% Sorb added.  Released glucose concentrations were increased 
(P<0.05) by  addition of 30 or 50% Pull to SCFsd and had the highest (P<0.05) glucose 
concentrations among all blends.  Fructose was found to be released in all the blends.  As 
the percentage of Fruct was increased in the blends, the concentration of Fruct released 
increased, with the 50:50 SCFsd:Fruct blend having the highest (P<0.05) amount of Fruct 
released.  The 50:50 SCFsd:Sorb was the only blend with a significant amount of Sorb 
released (~43% of released sugars); all other blends had little to no sorbitol released. 
Isomaltose was released in low concentrations in SCFsd, 85:15 SCFsd:Fruct, and 50:50 
SCFsd:Fruct. 
 Data reporting released monosaccharide values from simulated hydrolytic digestion 
of the SCF:Pull:Sorb:Fruct blends are presented in Table 5-4. Soluble corn fiber had the 
lowest (P<0.05) amount of monosaccharides released after simulated digestion (~29%).  The 
30:30:20:20 SCF:Pull:Sorb:Fruct blend had the highest (P<0.05) concentration of released 
monosaccharides (~85%).  The remaining blends were intermediate (~60%) in digestibility.  
Total released monosaccharide concentrations increased as the percentage of SCF decreased 
in the blends. 
 The major monosaccharide released from SCF and all the SCF:Pull:Sorb:Fruct 
blends was glucose.  Soluble corn fiber had the lowest (P<0.05) concentration of glucose 
released.  The concentrations of glucose released increased as the percentage of Pull 
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increased in the blends.  Released Fruct was similar among blends except for the 
30:30:20:20 SCF:Pull:Sorb:Fruct blend that had the highest (P<0.05) concentration of 
released Fruct. This same trend was noted for the concentrations of released Sorb. 
 The SCFs used in both sets of blends demonstrated a resistance to hydrolytic 
digestion, with SCF having an increased resistance compared to SCFsd (29 vs 50% 
digestible, respectively).  Kendall et al. (2008) evaluated a SCF similar to the ones used in 
the blends and reported the in vitro digestibility was 14.5% which is lower than either of the 
SCFs tested in the current study.  Differences in production methods likely affected 
digestibility of the different SCFs evaluated.  The ability of the SCFs to resist hydrolytic 
digestion was due, in part, to the linkages found in their molecular structure.  The presence 
of α-1,6 glycosidic linkages and inaccessibility of the α-1,4 linkages increase digestive 
enzymatic resistance in SCFs (Kendall et al., 2008). 
 Blending Pull with either of the SCFs resulted in increased released monosaccharide 
concentrations, especially glucose.  In both sets of blends, the higher the percentage of Pull 
in the blend, the higher the digestibility compared to SCF alone.  These data indicate that 
Pull was digestible by hydrolytic enzymes and resulted in glucose release.  Knapp et al. 
(2010) and Wolf et al. (2003) found pullulans of different molecular weights to be 
extensively hydrolyzed in vitro.  However, Wolf et al. (2003) found the hydrolysis to occur 
slowly over time and concluded that Pull was a slowly digestible carbohydrate with the 
potential to positively impact glycemic response. 
 Fructose and Sorb blended with the SCFs increased total released monosaccharide 
concentrations after hydrolytic digestion, especially when added at 30 or 50% 
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concentrations.  This increase occurred because the Fruct and Sorb added are completely 
available as free sugars.  However, the concentration of released glucose decreased as Fruct 
or Sorb concentration in the blend increased. 
Glycemic and Insulinemic Responses: 
 Incremental AUC data for glucose for the SCFsd blends are presented in Figure 5-1, 
and the corresponding values for AUC and relative glycemic response (RGR) are presented 
in Table 5-5.  Maltodextrin was used as a control for every set of glycemic response tests 
because it is highly digestible and rapidly absorbed, resulting in a consistently high 
glycemic response.  The carbohydrates were not all evaluated in the same period, so Malt 
was used in every period to serve as a control to calculate a relative response to the test 
carbohydrate in all periods.   
Maltodextrin served as the control to which all test carbohydrates were compared 
and was assigned a RGR value of 100.  Relative glycemic response values are calculated 
from AUC values and are directly related, so test carbohydrates with high AUC values will 
likely have correspondingly high RGR values.  The RGR values allow for an easier, more 
accurate interpretation of the glycemic response as it is a percentage of the Malt response 
and because carbohydrates were run in a series of tests and not all evaluated in the same 
period.  
All the SCFsd blends had lower (P<0.05) AUC and RGR values than did Malt.  Only 
the blends with 30 and 50% Fruct or sorbitol were able to lower (P<0.05) the AUC 
compared to SCFsd.  All other blends resulted in similar AUCs compared to SCFsd.  The 
RGR value of SCFsd was 63%, and all blends except the 70:30 SCFsd:Pull blend resulted in 
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lower (P<0.05) RGR values.  Blends with 30 or 50% Pull had lower (P<0.05) RGRs (avg 
RGR value of 38) compared to both SCFsd and Malt.  A similar RGR (avg RGR value of 
33) resulted from the addition of only 5 or 15% Fruct in the blends.  The lowest (P<0.05) 
RGR values resulted from the 70:30 SCFsd:Fruct, 50:50 SCFsd:Fruct, and 50:50 
SCFsd:Sorb blends.  The average RGR of these blends was only 4.8% compared to that of 
Malt. 
The majority of the SCFsd blends resulted in similar blood glucose response 
patterns.  The blends resulted in small to intermediate peaks during the first 30 min of the 
glycemic response test.  All of these peaks were greatly attenuated compared to the high 
peak produced by the Malt control.  Most of the SCFsd blends also showed attenuated peaks 
during the first 30 min compared SCFsd.  After 30 min into the glycemic response test, the 
blends decreased to near basal blood glucose concentrations for the remainder of the test.  
The 70:30 SCFsd:Fruct, 50:50 SCFsd:Fruct, and 50:50 SCFsd:Sorb blends had blood 
glucose patterns different from the other blends.  These blends did not result in any major 
peaks and attenuated the glycemic response to basal or below basal levels throughout the 
entire glycemic test. 
Incremental AUC data for insulin for the SCFsd blends are presented in Figure 5-2, 
and the corresponding values for AUC and RIR are presented in Table 5-5.  Maltodextrin 
had higher (P<0.05) AUC and RIR values than did SCFsd and all the SCFsd blends.  Trends 
in the insulinemic response were similar to those observed in the glycemic response for the 
SCFsd blends. All the SCFsd blends had similar AUC values to SCFsd.  The RIR value of 
SCFsd was approximately 49 and was similar to all SCFsd blends except the SCFsd blends 
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with 30 or 50% Fruct and Sorb.  These blends had lower (P<0.05) RIR values than did 
SCFsd, with an average RIR value of 10. 
Serum insulin patterns for SCFsd and the SCFsd blends were similar to blood 
glucose patterns.  All the SCFsd blends resulted in an attenuated peak insulin response 
compared to Malt.  The 70:30 SCFsd:Fruct, 50:50 SCFsd:Fruct, and 50:50 SCFsd:Sorb 
blends resulted in concentrations near or below basal insulin concentrations throughout the 
entire response test.  The remaining SCFsd blends all resulted in small peaks during the first 
30 min of the response test that dropped rapidly to near basal concentrations for the 
remainder of the test.  The attenuated insulin response of the SCFsd blends resulted from 
their blunted glycemic response. 
Incremental AUC data for glucose for the SCF:Pull:Sorb:Fruct blends are presented 
in Figure 5-3, and the corresponding values for AUC and RGR are presented in Table 5-6.  
Maltodextrin had the highest (P<0.05) AUC, with SCF and all SCF:Pull:Sorb:Fruct blends 
resulting in similar but low AUCs for blood glucose.  Numerically, the 60:20:10:10 
SCF:Pull:Sorb:Fruct and 30:30:20:20 SCF:Pull:Sorb:Fruct treatments resulted in the lowest 
RGR values (avg RGR value of 6), but were not significantly lower than for SCF (RGR 
value of 24). 
The SCF:Pull:Sorb:Fruct blends resulted in similar blood glucose patterns.  All the 
blends had a small blunted peak at 15 min of the glycemic response test that was attenuated 
compared with the peak resulting from either Malt or SCF.  After the short blunted peak at 
15 min, the SCF:Pull:Sorb:Fruct blends resulted in near or below basal concentrations until 
150 min into the response test.  At this point, all the blends except the 30:30:20:20 
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SCF:Pull:Sorb:Fruct began to show increasing blood glucose concentrations.  The increased 
concentrations of free Sorb and Fruct in the 30:30:20:20 SCF:Pull:Sorb:Fruct blend resulted 
in below basal blood glucose concentrations from 45 min into the response test. 
Incremental AUC data for insulin for the SCF:Pull:Sorb:Fruct blends are presented 
in Figure 5-4, and the corresponding values for AUC and RIR are presented in Table 5-6.  
Malt had a higher (P<0.05) AUC and RIR value than did SCF and all the 
SCF:Pull:Sorb:Fruct blends.  The SCF:Pull:Sorb:Fruct blends resulted in low but similar 
RIR values (avg RIR value of 20) that were not different from the SCF value.  These low 
insulin response values corresponded to the lower glycemic responses elicited by the 
SCF:Pull:Sorb:Fruct blends. 
Serum insulin patterns were similar among the SCF:Pull:Sorb:Fruct blends.  All the 
blends, except 50:30:10:10 SCF:Pull:Sorb:Fruct, had a small insulin peak at 15 min of the 
test that then decreased to basal concentrations.  The 50:30:10:10 SCF:Pull:Sorb:Fruct blend 
had a similar small peak, but at 30 min of the response test, before decreasing to basal 
concentrations.  Even though the AUC and RIR values were similar for SCF and the 
SCF:Pull:Sorb:Fruct blends, the blends showed an attenuated peak in serum insulin at the 
beginning of the response test compared to SCF. 
The SCFs used in both sets of blends partially resisted hydrolytic digestion and 
attenuated blood glucose concentrations upon consumption.  Soluble corn fiber had a lower 
glycemic response than did SCFsd.  Sugar composition and hydrolytic digestion data found 
SCF to be comprised of less glucose and more fructose and less digestible than SCFsd.  
These factors likely contributed to SCFs ability to attenuate blood glucose concentrations 
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more than SCFsd.   Kendall et al. (2008) evaluated the glycemic response in humans of SCF 
incorporated into a beverage.  Authors reported an AUC of 28.5 mmol/L which was similar 
to the AUC (39.1 mmol/L) of SCF reported in the current study.   Along with low free sugar 
concentrations, the reduced glycemic response obtained with SCFs is due to the increased 
resistance to digestibility from increased glycosidic linkage formation resulting from SCF 
production methods.   
Even though in vitro hydrolytic digestion studies have shown Pull to be nearly 
completely digested, this novel carbohydrate can attenuate the glycemic response due to its 
property of being slowly digestible.  Wolf et al. (2003) evaluated the glycemic response of a 
Pull (MW 100,000) in humans and found that it lowered (P<0.01) the AUC for glucose by 
50% compared to Malt.  Knapp et al. (2010) evaluated a set of pullulans of different MWs 
in dogs and found lower (P<0.05) RGR and RIR values compared to Malt.  Also, these 
pullulans successfully blunted the glucose and insulin curves throughout the response test.  
The addition of Pull reduced the glycemic response compared to Malt at all concentrations, 
but only 50:50 SCFsd:Pull resulted in a lowering of the glycemic response compared to 
SCFsd alone. 
The addition of Fruct and Sorb in the blends had the greatest impact on glycemic and 
insulinemic responses. Fructose and Sorb do not acutely raise blood glucose, nor stimulate 
insulin secretion.  Even at concentrations as low as 5% of the blend, Fruct reduced glycemic 
and insulinemic responses.  Several studies in humans and rats have shown that small doses 
of Fruct are effective in decreasing the glycemic response when supplemented with glucose 
(Moore et al., 2000; Wolf et al., 2002).  Possible reasons for the decreased glycemic 
response caused by Fruct include fructose-induced malabsorption of carbohydrate or 
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enhancement of blood glucose uptake by the liver due to the ability of  Fruct to stimulate 
hepatic glucokinase activity (Heacock et al., 2002; Shiota et al., 2002; Segal et al., 2007).  
This attenuation in blood glucose and serum insulin responses was greatest when Fruct and 
Sorb were added to the blends at 30 and 50% concentrations.  However, consumption of 
large doses of Fruct and Sorb may have adverse effects as they are incompletely absorbed in 
the small intestine and their malabsorption can lead to abdominal pains and development of 
diarrhea (Fernandez-Banares et al., 2009).  Consumption of high concentrations of Fruct 
also have been attributed to other adverse effects such as hypertriglyceridemia and 
hypercholesterolemia (Wolf et al., 2002; Segal et al., 2007). 
  In summary, carbohydrate blends tested in this study varied in sugar composition 
and in degree of resistance to simulated hydrolytic digestion.  However, even considering 
these differences, all SCF blends attenuated glycemic and insulinemic responses.  
Attenuation of glycemic and insulinemic responses was achieved using a slowly digestible 
carbohydrate like Pull or sugars such as Fruct and Sorb that do not elicit a glycemic 
response.  Reduced blood glucose and insulin responses have been shown to have several 
beneficial health effects, especially in diabetic patients (American Diabetes Association, 
2007; Livesey et al., 2008; Riccardi et al., 2008). These SCF blends could be utilized to 
lower postprandial glucose and insulin responses by replacing available carbohydrates in 
foods with low-digestible carbohydrates (Wolever, 2003).  
 
 
 
 154 
 
LITERATURE CITED 
American Diabetes Association. Nutrition recommendations and interventions for diabetes: 
A position statement of the American Diabetes Association. Diabetes Care. 
2007;30:S48-S65. 
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 
2009;32:S13-S61. 
AOAC, Official methods of analysis. In Association of Official Analytical Chemists, 17
th
 
ed.; Washington, DC, 2000. 
Blonde L. State of diabetes care in the United States. Am J Manag Care. 2007;13:S36-S40. 
Cass AEG, Davis G, Francis GD, Hill HAO, Aston WJ, Higgins IJ, Plotkin EV, Scott LDL, 
Turner APF. Ferrocene-mediated enzyme electrode for amperometric determination 
of glucose. Anal Chem. 1984;56:667-671. 
Fernandez-Banares F, Esteve M, Viver JM. Fructose-sorbitol malabsorption. Curr 
Gastroenterol Rep. 2009;11:368-374. 
Grabitske HA, Slavin JL. Low digestible carbohydrates in practice. J Amer Diet Assoc. 
2008;108:1677-1681. 
Hanover LM, White JS. Manufacturing, composition, and applications of fructose. Am J 
Clin Nutr. 1993;58:724S-732S. 
 155 
 
Harrison MD, Hoffman AJ, inventors. Food products comprising a slowly digestible or 
digestion resistant carbohydrate composition. US patent 2007/0172511 A1. July 26, 
2007. 
Heacock PM, Hertzler SR, Wolf BW. Fructose prefeeding reduces the glycemic response to 
a high-glycemic index, starchy food in humans. J Nutr. 2002;132:2601-2604. 
Hoebler C, Barry JL, David A, Delort-Laval J. Rapid acid hydrolysis of plant cell wall 
polysaccharides and simplified quantitative determination of their neutral 
monosaccharides by gas-liquid chromatography. J Agric Food Chem. 1989;37:360-
367. 
Kendall CWC, Esfahani A, Hoffman AJ, Evans A, Sanders LM, Josse AR, Vidgen E, Potter 
SM. Effect of novel maize-based dietary fibers on postprandial glycemia and 
insulinemia. J Am Coll Nutr. 2008;27:711-718. 
Kimoto T, Shibuya T, Shiobara S. Safety studies of a novel starch, pullulan: Chronic 
toxicity in rats and bacterial mutagenicity. Food Chem Toxicol. 1997;35:323-329. 
Knapp BK, Parsons CM, Bauer LL, Swanson KS, Fahey GC. Soluble fiber dextrins and 
pulluans vary in extent of hydrolytic digestion in vitro and in energy value and 
attenuate glycemic and insulinemic responses in dogs. J Agric Food Chem. 
2010;58:11355-11363. 
Le AS, Mulderrig KB. Sorbitol and mannitol. In: Nabors L, editor. Alternative Sweeteners. 
New York: Marcel Dekker; 2001. p. 317-334. 
 156 
 
Leathers T. Biotechnological production and applications of pullulan. Appl Microbiol 
Biotechnol. 2003;62:468-473. 
Livesey G, Taylor R, Hulshof T, Howlett J. Glycemic response and health - a systematic 
review and meta-analysis: Relations between dietary glycemic properties and health 
outcomes. Am J Clin Nutr. 2008;87:258S-268S. 
Marteau P, Flourie B. Tolerance to low-digestible carbohydrates: Symptomatology and 
methods. Br J Nutr. 2001;85:S17-S21. 
Moore MC, Cherrington AD, Mann SL, Davis SN. Acute fructose administration decreases 
the glycemic response to an oral glucose tolerance test in normal adults. J Clin 
Endocrinol Metab. 2000;85:4515-4519. 
Muir JG, O’Dea K. Validation of an in vitro assay for predicting the amount of starch that 
escapes digestion in the small intestine of humans. Am J Clin Nutr. 1993;57:540-
546. 
Murphy O. Non-polyol low-digestible carbohydrates: Food application and functional 
benefits. Br J Nutr. 2001;85:S47-S53. 
Riccardi G, Rivellese AA, Giacco R. Role of glycemic index and glycemic load in the 
healthy state, in prediabetes, and in diabetes. Am J Clin Nutr. 2008;87:269S-274S. 
Scheppach W, Luehrs H, Menzel T. Beneficial health effects of low-digestible carbohydrate 
consumption. Br J Nutr. 2001;85:S23-S30. 
Segal MS, Gollub E, Johnson RJ. Is the fructose index more relevant with regards to 
cardiovascular disease than the glycemic index? Eur J Nutr. 2007;46:406-417. 
 157 
 
Shingel KI. Current knowledge on biosynthesis, biological activity, and chemical 
modification of the exopolysaccharide, pullulan. Carbohydr Res. 2004;339:447-460. 
Shiota M, Moore MC, Galassetti P, Monohan M, Neal DW, Shulman GI, Cherrington AD. 
Inclusion of low amounts of fructose with an intraduodenal glucose load markedly 
reduces postprandial hyperglycemia and hyperinsulinemia in the conscious dog. 
Diabetes. 2002;51:469-478. 
Smiricky MR, Grieshop CM, Albin DM, Wubben JE, Gabert VM, Fahey Jr. GC. The 
influence of soy oligosaccharides on apparent and true ileal amino acid digestibility 
and fecal consistency in growing pigs. J Anim Sci. 2002;80:2433-2441. 
Wisdom GB. Enzyme-immunoassay. Clin Chem. 1976;22:1243-1255. 
White JS, Osberger TF. Crystalline fructose. In: Nabors L, editor. Alternative Sweeteners. 
New York: Marcel Dekker; 2001. p. 367-390. 
Wolever TMS. Carbohydrate and the regulation of blood glucose and metabolism. Nutr 
Rev. 2003;61:S40-S48. 
Wolever T, Jenkins D, Jenkins AL, Josse RG. The glycemic index: Methodology and 
clinical implications. Am J Clin Nutr. 1991;54:846-854. 
Wolf BW, Garleb KA, Choe YS, Humphrey PM, Maki KC. Pullulan is a slowly digested 
carbohydrate in humans. J Nutr. 2003;133:1051-1055. 
Wolf BW, Humphrey PM, Hadley CW, Maharry KS, Garleb KA, Firkins JL. Supplemental 
fructose attenuates postprandial glycemia in Zucker fatty fa/fa rats. J Nutr. 
2002;132:1219-1223. 
 158 
 
Table 5-1.  Free sugar and hydrolyzed monosaccharide concentrations of soluble corn fiber spray-dried blends 
 
Test carbohydrate
1
 
Item SCFsd 
95:5 
SCFsd:Fruct 
85:15 
SCFsd:Fruct 
70:30 
SCFsd:Fruct 
50:50 
SCFsd: 
Fruct 
70:30 
SCFsd:Pull 
50:50 
SCFsd:Pull 
50:50 
SCFsd:Sorb 
 
Free sugars, 
mg/g
2
 
 
 
    
  
Arabinose 0.05 0.26 0.14 0.16 0.08 0.00 0.21 0.00 
Fructose 0.00 62.30 171.47 210.44 415.68 0.91 0.23 0.51 
Glucose 27.47 42.60 37.37 18.17 10.98 12.57 30.76 18.25 
Mannose 0.00 0.05 0.17 0.00 0.00 0.08 0.11 0.00 
Rhamnose 0.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Sorbitol 0.02 0.62 0.53 0.02 0.05 0.42 0.68 508.54 
Sucrose 0.78 0.39 0.74 0.00 0.00 0.00 0.27 0.25 
Total, mg/g
3
 28.86 106.22 213.42 228.79 426.79 13.98 32.26 527.55 
 
 
       
 
 
       
 
 
       
 159 
 
Table 5-1 (con’t.) 
 
       
 
Hydrolyzed 
monosaccharides, 
mg/g
2,4
 
 
       
Glucose 1,015.31 1,070.98 957.50 814.04 526.54 1,130.19 1,115.24 595.03 
Mannose 7.16 0.00 0.00 4.89 6.62 0.00 0.00 0.00 
Sorbitol 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Total, mg/g
3
 1,022.48 1,070.98 957.50 818.93 533.16 1,130.19 1,115.24 595.03 
  
       
  
1 
Abbreviations: SCFsd, spray-dried soluble corn fiber; 95:5 SCFsd:Fruct, blend of 95% SCFsd:5% fructose; 85:15 
SCFsd:Fruct, blend of 85% SCFsd:15% fructose; 70:30 SCFsd:Fruct, blend of 70% SCFsd:30% fructose; 50:50 SCFsd:Fruct, blend of 
50% SCFsd:50%  fructose; 70:30 SCFsd:Pull, blend of 70%SCFsd:30% pullulan; 50:50 SCFsd:Pull, blend of 50% SCFsd:50% 
pullulan; 50:50 SCFsd:Sorb, blend of 50% SCFsd:50% sorbitol. 
2 
Values are expressed on a dry matter basis. 
3 
Values include water added when starches are broken down to monosaccharide units. 
4 
Values are corrected for free monosaccharide concentrations. 
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Table 5-2.  Free sugar and hydrolyzed monosaccharide concentrations of soluble corn fiber:pullulan:sorbitol:fructose blends 
 
Test carbohydrate
1
 
Item SCF   
70:10:10:10 
SCF:Pull:Sorb:Fruct 
60:20:10:10 
SCF:Pull:Sorb:Fruct 
50:30:10:10 
SCF:Pull:Sorb:Fruct 
30:30:20:20 
SCF:Pull:Sorb:Fruct 
 
Free sugars, mg/g
2
 
     Arabinose 0.46 0.00 0.00 0.00 0.00 
Fructose 11.93 99.89 84.45 101.50 192.05 
Galactose 0.09 0.00 0.05 0.00 0.00 
Glucose 127.19 42.92 36.63 31.69 20.61 
Mannose 0.72 0.00 0.32 0.00 0.00 
Rhamnose 0.49 0.00 0.00 0.00 0.00 
Sorbitol 1.00 78.52 79.39 87.03 155.82 
Sucrose 0.00 0.00 0.00 0.00 0.00 
Total, mg/g
3
 141.87 221.33 200.84 220.22 368.48 
      Hydrolyzed 
monosaccharides, mg/g
2,4
      
Glucose 489.51 833.10 855.60 820.40 501.71 
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Table 5-2 (con’t.) 
     
 
Sorbitol 
 
0.00 
 
23.41 
 
19.60 
 
0.00 
 
8.26 
Total, mg/g
3
 489.51 856.52 875.20 820.40 509.97 
1 
Abbreviations: SCF, soluble corn fiber; 70:10:10:10 SCF:Pull:Sorb:Fruct, blend of 70% SCF:10% pullulan:10% sorbitol:10% 
fructose; 60:20:10:10 SCF:Pull:Sorb:Fruct, blend of 60% SCF:20% pullulan:10% sorbitol:10% fructose; 50:30:10:10 
SCF:Pull:Sorb:Fruct, blend of 50% SCF:30% pullulan:10% sorb:10% fructose; 30:30:20:20 SCF:Pull:Sorb:Fruct, blend of 30% 
SCF:30% pullulan:20% sorbitol:20% fructose. 
2 
Values are expressed on a dry matter basis. 
3 
Values include water added when starches are broken down to monosaccharide units. 
4 
Values are corrected for free monosaccharide concentrations. 
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Table 5-3.  Monosaccharides (including free monosaccharides) released after simulated hydrolytic digestion of soluble corn fiber 
spray-dried blends 
 
Released 
monosaccharides, 
mg/g
2
 
Test carbohydrate
1
  
SCFsd 
95:5 
SCFsd: 
Fruct 
85:15 
SCFsd: 
Fruct 
70:30 
SCFsd: 
Fruct 
50:50 
SCFsd: 
Fruct 
70:30 
SCFsd: 
Pull 
50:50 
SCFsd: 
Pull 
50:50 
SCFsd: 
Sorb 
SEM 
Fructose 0.00
a
 49.83
a
 138.71
b
 273.12
c
 420.36
d
 7.90
a
 7.12
a
 7.19
a
 
 
11.26 
Glucose 484.19
d
 483.37
d
 422.61
c
 454.77
cd
 351.55
b
 927.86
f
 882.80
e
 298.68
a
 10.25 
Isomaltose 17.85
d
 0.00
a
 0.00
a
 12.92
c
 5.20
b
 0.00
a
 0.00
a
 0.00
a
 0.57 
Sorbitol 0.00
a
 0.41
a
 0.53
a
 0.00
a
 0.00
a
 0.33
a
 0.68
a
 430.90
b
 2.78 
Total
3
 502.04
a
 533.61
a
 561.86
a
 740.81
bc
 775.38
c
 936.09
d
 890.60
d
 736.77
bc
 13.94 
1 
Abbreviations: SCFsd, spray-dried soluble corn fiber; 95:5 SCFsd:Fruct, blend of 95% SCFsd:5% fructose; 85:15 
SCFsd:Fruct, blend of 85% SCFsd:15% fructose; 70:30 SCFsd:Fruct, blend of 70% SCFsd:30% fructose; 50:50 SCFsd:Fruct, blend of 
50% SCFsd:50%  fructose; 70:30 SCFsd:Pull, blend of 70%SCFsd:30% pullulan; 50:50 SCFsd:Pull, blend of 50% SCFsd:50% 
pullulan; 50:50 SCFsd:Sorb, blend of 50% SCFsd:50% sorbitol. 
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2 
Values are expressed on a dry matter basis. 
3 
Values include water added when starches are broken down to monosaccharide units. 
abcd 
Means in the same row with different superscript letters are different (P<0.05). 
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Table 5-4.  Monosaccharides (including free monosaccharides) released after simulated hydrolytic digestion of soluble corn 
fiber:pullulan:sorbitol:fructose blends 
 
Released 
monosaccharides, 
mg/g
2
 
Test carbohydrate
1
 
SCF   
70:10:10:10 
SCF:Pull:Sorb:Fruct 
60:20:10:10 
SCF:Pull:Sorb:Fruct 
50:30:10:10 
SCF:Pull:Sorb:Fruct 
30:30:20:20 
SCF:Pull:Sorb:Fruct 
 
SEM 
Fructose 
 
20.15
a
 
 
121.07
c
 
 
118.86
bc
 
 
110.11
b
 
 
234.83
d
 
 
2.19 
Galactose 0.52
b
 0.00
a
 0.00
a
 0.00
a
 0.00
a
 0.03 
Glucose 264.27
a
 317.58
b
 394.43
c
 489.27
e
 413.64
d
 3.80 
Sorbitol 1.16
a
 100.10
c
 98.41
c
 79.06
b
 198.05
d
 3.51 
Total
3  286.10
a
 538.76
b
 611.69
c
 652.16
c
 846.52
d
 13.68 
1 
Abbreviations: SCF, soluble corn fiber; 70:10:10:10 SCF:Pull:Sorb:Fruct, blend of 70% SCF:10% pullulan:10% sorbitol:10% 
fructose; 60:20:10:10 SCF:Pull:Sorb:Fruct, blend of 60% SCF:20% pullulan:10% sorbitol:10% fructose; 50:30:10:10 
SCF:Pull:Sorb:Fruct, blend of 50% SCF:30% pullulan:10% sorb:10% fructose; 30:30:20:20 SCF:Pull:Sorb:Fruct, blend of 30% 
SCF:30% pullulan:20% sorbitol:20% fructose. 
2 
Values are expressed on a dry matter basis. 
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3 
Values include water added when starches are broken down to monosaccharide units. 
abc 
Means in the same row with different superscript letters are different (P<0.05). 
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Table 5-5. Incremental area under the curve (AUC) for glucose and insulin, and relative glycemic response (RGR) and relative 
insulinemic response (RIR) of soluble corn fibers spray-dried blends 
 Test carbohydrate
1
  
 
Item 
Malt SCFsd 
95:5 
SCFsd: 
Fruct 
85:15 
SCFsd: 
Fruct 
70:30 
SCFsd: 
Fruct 
50:50 
SCFsd: 
Fruct 
70:30 
SCFsd:Pull 
50:50 
SCFsd:Pull 
50:50 
SCFsd: 
Sorb 
SEM
2 
 
AUC for 
glucose, 
mmol/L 
 
154.87
c
 
 
98.90
b
 
 
50.68
ab
 
 
49.56
ab
 
 
13.22
a
 
 
7.56
a
 
 
80.36
b
 
 
49.22
ab
 
 
4.79
a
 
 
16.14 
RGR, % 100.00
d
 62.79
c
 34.90
b
 30.27
b
 6.69
a
 2.06
a
 44.85
bc
 31.29
b
 5.79
a
 7.41 
AUC for 
insulin, 
pmol/L 
10,354.00
b
 4,241.59
a
 4,025.76
a
 2,444.32
a
 1,460.10
a
 818.41
a
 3,238.80
a
 4,201.47
a
 927.28
a
 1,610.24 
RIR, % 100.00
c
 48.55
b
 34.45
ab
 29.37
ab
 13.56
a
 7.73
a
 28.25
ab
 45.23
b
 9.46
a
 9.52 
1 
Abbreviations: SCFsd, spray-dried soluble corn fiber; 95:5 SCFsd:Fruct, blend of 95% SCFsd:5% fructose; 85:15 
SCFsd:Fruct, blend of 85% SCFsd:15% fructose; 70:30 SCFsd:Fruct, blend of 70% SCFsd:30% fructose; 50:50 SCFsd:Fruct, blend of 
50% SCFsd:50%  fructose; 70:30 SCFsd:Pull, blend of 70%SCFsd:30% pullulan; 50:50 SCFsd:Pull, blend of 50% SCFsd:50% 
pullulan; 50:50 SCFsd:Sorb, blend of 50% SCFsd:50% sorbitol. 
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2 
Pooled standard error of the mean. 
abcd
 Means in the same row with different superscript letters are different (P<0.05).  
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Table 5-6. Incremental area under the curve (AUC) for glucose and insulin, and relative glycemic response (RGR) and relative 
insulinemic response (RIR) of soluble corn fiber:pullulan:sorbitol:fructose blends 
 Test carbohydrate
1
 
Item Malt SCF 
70:10:10:10 
SCF:Pull:Sorb
:Fruct 
60:20:10:10 
SCF:Pull:Sorb
:Fruct 
50:30:10:10 
SCF:Pull:Sorb
:Fruct 
30:30:20:20 
SCF:Pull:Sorb
:Fruct 
SEM
2 
 
 
AUC for 
glucose, 
mmol/L 
 
210.40
b 
 
39.10
a
 
 
59.79
a
 
 
8.83
a
 
 
23.84
a
 
 
10.54
a
 
 
17.24 
RGR, % 
100.00
c 
24.49
ab
 38.64
b
 5.19
a
 25.76
ab
 7.05
a
 7.92 
AUC for 
insulin, 
pmol/L 
13,279.00
b
 4,942.85
a
 2,286.83
a
 2,593.40
a
 2,743.60
a
 1,605.94
a
 1,411.56 
RIR, % 
100.00
b
 26.16
a
 23.98
a
 23.65
a
 24.28
a
 9.32
a
 7.70 
1
Abbreviations: SCF, soluble corn fiber; 70:10:10:10 SCF:Pull:Sorb:Fruct, blend of 70% SCF:10% pullulan:10% sorbitol:10% 
fructose; 60:20:10:10 SCF:Pull:Sorb:Fruct, blend of 60% SCF:20% pullulan:10% sorbitol:10% fructose; 50:30:10:10 
SCF:Pull:Sorb:Fruct, blend of 50% SCF:30% pullulan:10% sorb:10% fructose; 30:30:20:20 SCF:Pull:Sorb:Fruct, blend of 30% 
SCF:30% pullulan:20% sorbitol:20% fructose. 
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2 
Pooled standard error of the mean. 
ab 
Means in the same row with different superscript letters are different (P<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 170 
 
Figure 5-1.  Incremental change from baseline in blood glucose response for dogs consuming 25 g of soluble corn fiber spray-dried 
blends.  Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (0.48), SCFsd (0.51), 95:5 SCFsd:Fruct 
(0.53), 85:15 SCFsd:Fruct (0.53), 70:30 SCFsd:Fruct (0.54), 50:50 SCFsd:Fruct (0.54), 70:30 SCFsd:Pull (0.53), 50:50 SCFsd:Pull 
(0.53), 50:50 SCFsd:Sorb (0.53).   Abbreviations: SCFsd, spray-dried soluble corn fiber; 95:5 SCFsd:Fruct, blend of 95% SCFsd:5% 
fructose; 85:15 SCFsd:Fruct, blend of 85% SCFsd:15% fructose; 70:30 SCFsd:Fruct, blend of 70% SCFsd:30% fructose; 50:50 
SCFsd:Fruct, blend of 50% SCFsd:50%  fructose; 70:30 SCFsd:Pull, blend of 70%SCFsd:30% pullulan; 50:50 SCFsd:Pull, blend of 
50% SCFsd:50% pullulan; 50:50 SCFsd:Sorb, blend of 50% SCFsd:50% sorbitol. 
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Figure 5-2. Incremental change from baseline in serum insulin response for dogs consuming 25 g of soluble corn fiber spray-dried 
blends.  Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (13.64), SCFsd (24.46) 95:5 
SCFsd:Fruct (25.60), 85:15 SCFsd:Fruct (23.00), 70:30 SCFsd:Fruct (23.00), 50:50 SCFsd:Fruct (23.62), 70:30 SCFsd:Pull (23.62), 
50:50 SCFsd:Pull (23.62), 50:50 SCFsd:Sorb (23.62).   Abbreviations: SCFsd, spray-dried soluble corn fiber; 95:5 SCFsd:Fruct, blend 
of 95% SCFsd:5% fructose; 85:15 SCFsd:Fruct, blend of 85% SCFsd:15% fructose; 70:30 SCFsd:Fruct, blend of 70% SCFsd:30% 
fructose; 50:50 SCFsd:Fruct, blend of 50% SCFsd:50%  fructose; 70:30 SCFsd:Pull, blend of 70%SCFsd:30% pullulan; 50:50 
SCFsd:Pull, blend of 50% SCFsd:50% pullulan; 50:50 SCFsd:Sorb, blend of 50% SCFsd:50% sorbitol. 
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Figure 5-3.  Incremental change from baseline in blood glucose response for dogs consuming 25 g of soluble corn 
fiber:pullulan:sorbitol:fructos blends.  Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (0.82), 
SCF (0.53), 70:10:10:10 SCF:Pull:Sorb:Fruct (0.82), 60:20:10:10 SCF:Pull:Sorb:Fruct (0.82), 50:30:10:10 SCF:Pull:Sorb:Fruct 
(0.82), 30:30:20:20 SCF:Pull:Sorb:Fruct (0.82).   Abbreviations: SCF, soluble corn fiber; 70:10:10:10 SCF:Pull:Sorb:Fruct, blend of 
70% SCF:10% pullulan:10% sorbitol:10% fructose; 60:20:10:10 SCF:Pull:Sorb:Fruct, blend of 60% SCF:20% pullulan:10% 
sorbitol:10% fructose; 50:30:10:10 SCF:Pull:Sorb:Fruct, blend of 50% SCF:30% pullulan:10% sorb:10% fructose; 30:30:20:20 
SCF:Pull:Sorb:Fruct, blend of 30% SCF:30% pullulan:20% sorbitol:20% fructose. 
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Figure 5-4.  Incremental change from baseline in serum insulin response for dogs consuming 25 g of soluble corn 
fiber:pullulan:sorbitol:fructos blends.  Pooled standard error of the mean (SEM) values for carbohydrates are: Maltodextrin (23.62), 
SCF (25.21), 70:10:10:10 SCF:Pull:Sorb:Fruct (23.62), 60:20:10:10 SCF:Pull:Sorb:Fruct (23.62), 50:30:10:10 SCF:Pull:Sorb:Fruct 
(23.62), 30:30:20:20 SCF:Pull:Sorb:Fruct (23.62).   Abbreviations: SCF, soluble corn fiber; 70:10:10:10 SCF:Pull:Sorb:Fruct, blend 
of 70% SCF:10% pullulan:10% sorbitol:10% fructose; 60:20:10:10 SCF:Pull:Sorb:Fruct, blend of 60% SCF:20% pullulan:10% 
sorbitol:10% fructose; 50:30:10:10 SCF:Pull:Sorb:Fruct, blend of 50% SCF:30% pullulan:10% sorb:10% fructose; 30:30:20:20 
SCF:Pull:Sorb:Fruct, blend of 30% SCF:30% pullulan:20% sorbitol:20% fructose. 
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CHAPTER 6: SOLUBLE FIBER DEXTRIN AND SOLUBLE CORN FIBER 
SUPPLEMENTATION MODIFY INDICES OF GASTROINTESTINAL HEALTH IN 
THE RAT 
 
ABSTRACT: The objective of this study was to evaluate gastrointestinal health 
outcomes resulting from supplementation of novel, low-digestible carbohydrates to rats.  
After a 7 d acclimation period, rats were randomly assigned to one of four treatment groups 
(n=10) for 21 d.  An AIN-93G diet with 5% cellulose served as the Control.  The 5% 
cellulose was replaced with either 5% pectin (Pectin, positive control), soluble fiber dextrin 
(SFD), or soluble corn fiber (SCF). Rats fed the Pectin diet had a higher average daily food 
intake, but no differences in final body weights or rates of gain among treatments were 
observed.  Consumption of SFD and SCF increased (P<0.05) cecal weight but not colon 
weight.  No differences were observed in short-chain fatty acid (SCFA) or branched-chain 
fatty acid (BCFA) concentrations (µmol/g) in the colon of rats fed either SFD or SCF. 
Pectin resulted in increased (P<0.05) BCFA in the colon.  On a per cecum basis, SFD and 
SCF increased (P<0.05) acetate, propionate, and total SCFA concentrations, with no effect 
on butyrate concentrations, compared to the Control diet. Cecal BCFA concentrations were 
decreased (P<0.05) by SFD and SCF, whereas Pectin increased (P<0.05) BCFA 
concentrations.  Supplementation of SFD and SCF did not have an effect on cecal microbial 
populations compared to the Control diet. Pectin tended to decrease (P<0.10) Escherichia 
coli concentrations.  Gut histomorphology was positively affected by SFD and SCF.  
Increased (P<0.05) crypt depth, goblet cell numbers, and acidic mucin were observed in 
both the cecum and colon of rats supplemented with SFD, SCF, and Pectin.  These novel, 
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low-digestible carbohydrates appear to be beneficial in modulating indices of 
gastrointestinal health when supplemented in the diet of rats.   
INTRODUCTION 
Dietary fiber as a promoter of healthy gut function and other health benefits is well 
recognized (Cummings et al., 1997).  However, most of the population of the United States 
consumes less than half of the recommended concentrations of dietary fiber daily (Anderson 
et al., 2009).  This has led to a demand for the development of novel carbohydrates that have 
functional properties similar to those of dietary fiber but that may be incorporated more 
easily into a wider array of solid and liquid food matrices.   
  One class of carbohydrates, low-digestible carbohydrates, are becoming popular as 
food ingredients, not only due to their potential to improve both the physical and chemical 
properties of foods, but also due to possible health benefits associated with their 
consumption that are similar in nature to those of dietary fiber (Murphy, 2001).  Low-
digestible carbohydrates are low molecular weight carbohydrates that resist hydrolytic 
activity of human digestive enzymes (Crittenden and Playne, 1996; Roberfroid and Slavin, 
2000; Mussatto and Mancilha, 2007).  They pass into the colon where they are substates for 
complete or partial fermentation by colonic microbiota.  Fermentation results in short-chain 
fatty acids (SCFA) that provide colonic cells with energy and lower the pH of luminal 
contents, stimulating a healthy environment for beneficial bacteria.  Low-digestible 
carbohydrates also may benefically impact the morphology of the gastrointestinal tract, 
especially throught modulation of the mucosal layer.  This layer is primarily composed of 
mucin glycoproteins synthesized and secreted by goblet cells that serve as a protective 
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barrier for the epithelial cells (Ito et al., 2009).  Modulation of the mucosal layer may 
positively or detrimentally affect this barrier and, thus, the health of the gastrointestinal 
tract. 
Two novel, low-digestible carbohydrates of interest are soluble fiber dextrin (SFD) 
and soluble corn fiber (SCF).  Soluble fiber dextrin is an indigestible dextrin produced when 
corn starch is treated with heat and acid, and SCF is produced by isolating an 
oligosaccharide-rich fraction from corn syrup.  Both of these novel, low-digestible 
carbohydrates are produced in such a way that branching and the number of α-1,6 glycosidic 
bonds are increased (Laurentin et al., 2003; Harrison and Hoffman, 2007).  Soluble fiber 
dextrin and SCF have been reported to have a decreased in vitro hydrolytic digestion.  Also, 
they attenuate glycemic and insulinemic responses and have reduced energy values (Knapp 
et al., 2010; Knapp et al., unpublished data).  However, little research exists regarding these 
novel, low-digestible carbohydrates on indices of gut health. 
The objective of this study was to determine the effects of supplementation of SFD 
and SCF on select indices of gut health. This was determined by measuring pH, SCFA 
concentrations, and microbial populations in the cecum and (or) colon of rats.  Cecum and 
colon mass and crypt and goblet cell measurements also were taken to determine the impact 
of these low-digestible carbohydrates on gut morphology. 
MATERIALS AND METHODS 
Animals: 
Forty male Sprague Dawley rats (average initial weight, 174 ± 11 g) were purchased 
from Harlan Laboratories Inc. (Indianapolis, IN).  Rats were housed individually in stainless 
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steel wire-bottom cages in a temperature and humidity controlled facility with 12 hour light 
and dark cycles.  Prior to the experiment, rats were fed for 7 d on an AIN-93G diet (Reeves 
et al., 1993).  Rats were given free access to water.  All animal care procedures were 
approved by the University of Illinois Institutional Animal Care and Use Committee before 
initiation of the experiment. 
Experimental design and treatments: 
Rats were randomly assigned to one of four dietary treatments (10 rats/treatment) 
after the adaptation period of 7 d.  Rats were given free access to pelleted diets.  Four 
dietary treatments were utilized in this study: a control diet that was the AIN-93G diet with 
5% cellulose (Control), a positive control that consisted of the AIN-93G diet with 5% pectin 
(high-methoxy pectin, TIC Gums, White Marsh, MD) substituted for cellulose (Pectin), a 
treatment that consisted of the AIN-93G diet with 5% soluble fiber dextrin (Nutriose, 
Roquette, Keokuk, IA) substituted for cellulose (SFD), and a treatment that consisted of the 
AIN-93G diet with 5% soluble corn fiber (Promitor, Tate & Lyle, Decatur, IL) substituted 
for cellulose (SCF). All diets were prepared by Research Diets Inc. (New Brunswick, NJ).  
The ingredient composition of the diets is listed in Table 6-1.  The duration of the study was 
21 d.  Food intake was determined daily and body weights were measured weekly. 
Sample collection: 
On day 21, rats were euthanized by placement in a CO2 chamber.  A ventral midline 
incision then was made and the cecum and colon were removed.  Immediately after 
removal, cecum and colon with contents were weighed to determine total weight.  pH of 
cecal and colonic contents was taken using a Beckman pH meter and electrode (Beckman 
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Instruments, Inc., Fullerton, CA.)  Aliquots of cecal and colon contents then were taken for 
DM, SCFA, and microbiota analysis.  The SCFA aliquots were acidified with 5 mL 2N HCl 
before storing at  -20˚C.  The aliquot for microbial analysis was sealed in a sterile cryovial, 
snap frozen in liquid nitrogen, and stored at -80˚C.  No colonic contents were collected for 
microbiota analysis due to insufficient amounts of colonic digesta.   
 Following removal of the appropriate samples, the tissues were cleaned with water, 
blotted dry, and weighed to determine empty cecum and colon weights.  Total cecal and 
colonic contents were calculated as total tissue weight with contents minus empty tissue 
weight.  Cecal and colonic tissue from rats was collected and fixed in phosphate buffered 
formalin for histomorphological analysis. 
Chemical analysis: 
 Diet samples were analyzed for dry matter (DM), organic matter (OM) (AOAC 
2000), Leco N (AOAC 2000), acid hydrolyzed fat (AHF; Budde 1952; AACC 1983), and 
gross energy (GE) (Parr Instrument Co., Moline, IL; Parr Instrument Manuals).  Diet 
samples also were analyzed for total dietary fiber (TDF) content (Prosky et al., 1992).  All 
procedures were performed in duplicate.  To maintain quality control during chemical 
analysis, the error between duplicate samples was determined and, if it exceeded 5%, the 
assay was repeated.  Fresh cecal and colonic contents were analyzed for DM and pH (as 
indicated above), and SCFA using gas chromatography (Erwin et al., 1961).  Briefly, 
acetate, propionate, butyrate, isobutyrate, isovalerate, and valerate concentrations were 
determined on the supernatant of acidified cecal and colonic contents using a Hewlett-
Packard 5890A Series II gas chromatograph (Palo Alto, CA) and a glass column packed 
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with 10% SP-1200/1% H3PO4 on 80/100+ mesh Chromosorb WAW (Supelco, Bellefonte, 
PA). 
Microbial analysis:  
 Microbial populations were analyzed using methods described by Middelbos et al. 
(2007) with minor modifications.  Cecal DNA was extracted from freshly collected samples 
that had been stored at -80˚C until analysis, using the repeated bead beater method described 
by Yu and Morrison (2004) followed by a QIAamp DNA stool mini kit (Qiagen, Valencia, 
CA) according to manufacturer’s instructions.  Extracted DNA was quantified using a 
NanoDrop ND-1000 spectrophotometer (Nano-Drop Technologies, Wilmington, DE).  
Escherichia coli, the Bifidobacterium genus, and the Lactobacillus genus were quantified 
using quantitative polymerase chain reaction (qPCR) specific primers. Amplification was 
performed for each bacterial group within each sample according to the procedures of 
Deplancke et al. (2002). For amplification, 10 µL final volume containing 5 µL of 2 × 
SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA), 15 pmol of the 
forward and reverse primers of the bacteria of interest, and 5 ng of extracted cecal DNA 
were used.  Pure cultures of each bacterium were used to create serial dilutions in triplicate 
of the targeted bacterial genus to obtain standard curves.  Bacterial DNA was extracted from 
each dilution and amplified along with cecal DNA samples using a Taqman ABI PRISM 
7900HT Sequence Detection System (Applied BioSystems).  Colony forming units (cfu) of 
each standard curve serial dilution was determined previously by plating on specific agars.  
E. coli was grown on Luria-Bertani medium, Lactobacillus on Difco Lactobacilli MRS 
broth (Becton, Dickenson, and Co., Sparks, MD), and Bifidobacterium on Difco Reinforced 
Clostridial Medium (Becton, Dickenson, and Co.).  Cycle threshold values were plotted 
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against the standard curves for quantification (cfu/g cecal contents) of the targeted bacterial 
DNA from cecal samples. 
Cecal and colonic histomorphology: 
 Cecal and colonic sections from each rat were embedded in a paraffin block, sliced 
into 5 µm thick sections using a microtome, and stained.  One set of slides was stained with 
alcian blue (AB) and periodic acid Shiff and counterstained with hematoxylin for 
determining crypt depth, goblet cell numbers, and mucin (acidic and neutral) components.  
Another set of slides was stained with high iron diamine (HID) and AB to determine 
sulfated and sialylated mucins.  Slides were prepared and stained at the University of Illinois 
Department of Veterinary Biosciences Histology Laboratory.  Crypt depth, goblet cell 
counts, and mucin composition measurements were attempted on a minimum of 15 crypts 
per section. Digital images of tissues and measurements were taken using Axiovision LE 
software and an AxioCam MRc5 (Zeiss, Oberkochen, Germany). 
Statistical analyses: 
 Data were analyzed as a completely randomized design using the Mixed Models 
procedure of SAS (SAS Institute, Inc., Cary, NC).  The model contained the fixed effect of 
diet and the random effect of rat.  Differences among treatments were determined using a 
Fisher-protected least significant difference test with a Tukey adjustment to control for 
experiment-wise error.  Reported pooled standard errors of the mean (SEM) were 
determined according to the Mixed Models procedure of SAS.  Significant differences were 
accepted at a probability of P<0.05 and a probability of P<0.10 was considered a trend.   
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RESULTS AND DISCUSSION 
Diet composition: 
 The chemical composition of the experimental diets is presented in Table 6-2.  
Dietary treatments were similar in DM, OM, CP, AHF, and GE composition.  Total dietary 
fiber concentrations were lower for the SFD and SCF diets because the particular TDF 
method used does not fully quantify low-molecular weight dietary fibers like SFD and SCF.  
The complete carbohydrate composition of SFD and SCF is presented in Knapp et al. (2010) 
and Knapp et al. (unpublished data).   
Body weight and food intake:  
Daily food intake values, final body weights, and rate of gain are presented in Table 
6-3.  Initial body weights of the rats were similar among the groups (avg 178.44 g) and after 
21 d on the experimental diets, the final body weights and rate of gain did not differ 
significantly.  Daily food intake was approximately 16.5 g/d, with rats fed the Pectin diet 
having a higher (P<0.05) daily food intake.  Rats consuming the SCF diet developed 
diarrhea soon after starting the treatment, but did not significantly decrease their food intake 
or lose weight.  Consumption of the Pectin and SFD diets also resulted in looser stools by 
the end of the study, but not to the extent experienced by rats fed the SCF diet.  Weaver et 
al. (2010) supplemented SCF and SFD to rats at 10% of the diet and found that they also 
developed loose stools.  The test carbohydrates then were reduced to 5% dietary 
concentration and loose stools persisted as was the case in the current study.  Low-digestible 
carbohydrates such as SCF and SFD can have tolerance problems such as diarrhea when 
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consumed for a period of time (Livesey, 2001; Marteau and Flourie, 2001; Grabitske and 
Salvin, 2008). 
Short-chain fatty acids: 
 Fermentative end-product concentrations in cecal and colonic contents are presented 
in Tables 6-4 and 6-5, respectively.  Pectin resulted in increased (P<0.05) acetate 
concentrations in cecal contents compared to the other treatments.  Propionate 
concentrations were highest (P<0.05) for SFD, with SCF and Pectin having lower (P<0.05) 
but similar concentrations.  Cecal concentrations of butyrate were lowest (P<0.05) for the 
SFD and SCF diets.  Pectin supplementation resulted in the highest (P<0.05) total cecal 
SCFA concentration among treatments.  Supplementation of SFD and SCF resulted in 
similar total SCFA concentrations as the Control.   
 Colonic SCFA concentrations (Table 6-5) were lower compared to those in cecal 
contents.  Acetate and total SCFA concentrations were higher (P<0.05) for the Pectin diet 
compared to the SCF diet.  Soluble fiber dextrin resulted in higher (P<0.05) propionate 
concentrations compared to the Control diet.  Similarly to cecal SCFA, butyrate 
concentrations were higher (P<0.05) for the Pectin and Control diets compared to the SFD 
and SCF diets.   
 The lack of difference between the SFD and SCF diets as regards cecal SCFA 
compared to the Control diet may be due to the increased cecal volume of rats consuming 
the SFD and SCF diets, thus leading to a dilution effect for SCFA in the cecal contents.  
When cecal SCFA were expressed as µmol/cecum (Table 6-4), SCFA were altered 
considerably due to SFD and SCF supplementation.  Acetate concentration increased 
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(P<0.05) in the SCF, SFD, and Pectin diets compared to the Control, with Pectin having the 
highest (P<0.05) concentration. Similar to acetate, propionate and total SCFA 
concentrations in cecal contents were increased (P<0.05) with supplementation of Pectin, 
SFD, and SCF.  Butyrate concentrations for SFD and SCF treatments were not increased 
compared with the Control treatment, even when expressed on a per cecum basis.   
 Colonic SCFA were expressed as µmol/colon (Table 6-5).  Small but similar 
amounts of colonic contents were found for all dietary treatments; thus, few differences 
among treatments were observed.  The Control diet resulted in higher (P<0.05) butyrate 
concentrations compared to the SFD and SCF diets.   
 Neither of the novel, low-digestible carbohydrates were butyrogenic.  Weaver et al. 
(2010) found a similar response to SCF and SFD in cecal SCFA concentrations in rats.  The 
supplemented SCF and SFD did not increase butyrate concentrations compared to a 
cellulose control when supplemented at 4% of the diet.  Stewart et al. (2010) found that 
supplementation of 12 g/d SFD and SCF to human subjects resulted in no differences in 
fecal SCFA concentrations compared with a maltodextrin control.  Soluble corn fiber has 
been supplemented at 21 g/d to human subjects and, similar to results with rats, fecal 
butyrate concentrations were not increased compared with the non-fiber control (Vester 
Boler et al., unpublished data).   
 Cecal isobutyrate, valerate, and total BCFA concentrations were lower (P<0.05) with 
supplementation of both SFD and SCF compared to either the Control or Pectin treatments.  
Isovalerate concentrations were lower (P<0.05) for the SFD and SCF diets compared to 
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Pectin.  Pectin resulted in the highest (P<0.05) cecal concentrations of all BCFA except 
isovalerate for all dietary treatments.   
Concentrations of BCFA were expressed on a per cecum basis (Table 6-5).  No 
differences among treatements were noted in isobutyrate concentration.  Isovalerate 
concentrations were higher (P<0.05) for the SFD and SCF diets compared to the Control, 
but not when compared to the Pectin diet.  Pectin resulted in the highest (P<0.05) 
concentrations of valerate and total BCFA.  
Concentrations of BCFA were lower in the colon compared to concentrations in the 
cecum.  Pectin resulted in higher (P<0.05) concentrations of isobutyrate than did SFD.  
Isovalerate concentrations were higher (P<0.05) for Pectin compared to the Control and the 
SCF diets.  Pectin resulted in the highest (P<0.05) concentrations of valerate and total 
BCFA, and the Control, SFD, and SCF diets resulted in lower (P<0.05) but similar 
concentrations.  
Concentrations of BCFA on a per colon basis are presented in Table 6-6.  No 
differences in isovalerate concentration were noted among dietary treatements.  As was 
noted when concentrations were expressed on a DM basis, Pectin tended to result in higher 
concentrations of BCFA compared to SFD and SCF, but not when compared to the Control 
diet.  Higher concentrations for the Control diet were noted for BCFA when expressed on a 
per colon basis because rats fed this diet had more colonic contents than did rats fed the 
other treatments. 
In general, colonic BCFA concentrations for the Control rats were similar to those 
for rats fed SFD and SCF. However, as regards cecal BCFA concentrations, the Control 
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tended to result in higher concentrations than did the SFD and SCF diets.  Overall, for both 
cecal and colonic BCFA, Pectin tended to have higher values than did the other dietary 
treatments.  Pectin increases the viscosity of digesta which could decrease crude protein 
digestion, resulting in higher quantities of protein reaching the cecum and colon where they 
would be fermented, thus producing BCFA (Brunsgaard et al., 1995; Burazewska et al., 
2007) 
Large bowel weight and pH: 
Total weight, empty weight, and pH values of the cecum and colon are presented in 
Table 6-6.  Total weight of the cecum was dramatically increased (P<0.05) as a result of 
consumption of SFD and SCF.  However, this effect was not noted in the colon where all 
treatments resulted in a similar total colon weight.  In some rats fed Pectin, SFD, and SCF 
diets, the colon was empty upon removal.  Empty cecal weight was increased (P<0.05) 
compared with the Control as a result of Pectin, SFD, and SCF consumption, with values for 
the latter two fibers being higher than that for Pectin.  Empty colonic weight was unaffected 
by diet.  Cecal and colonic pH values were lowered (P<0.05) by the SFD and SCF 
treatments. 
Weaver et al. (2010) also found that supplementation with SCF, SFD, and other 
novel fibers increased cecum weight compared to cellulose. In that study, supplementation 
of 4% SCF and SFD resulted in a cecum weight of 5.58 g, similar to what was found in the 
current study (cecal weight of 6.15 g and 6.72 g, respectively).  Other research has 
demonstrated that ingestion of low-digestible carbohydrates resulted in increased cecum 
weights of rats (Levrat et al., 1991; Campbell et al., 1997; Lu et al., 2000; Kim, 2002).  The 
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increased cecal weight likely is due to increased epithelial cell proliferation from the trophic 
effects of SCFA (Frankel et al., 1994).  The major differences in organ weights were noted 
only for the cecum and not the colon.  This is probably due to the fact that the major site of 
fermentation for rodents is the cecum and not the colon as in humans.  The decreased cecal 
pH is probably due to increased SCFA production at that site. 
Microbial concentrations: 
 Cecal microbial data are presented in Table 6-7.  Supplementation of SFD or SCF 
did not beneficially modulate microbial populations in the rat cecum.  Cecal concentrations 
of Bifidobacterium spp. and Lactobacillus spp. were not increased compared with the 
Control treatment.  Also, decreased concentrations of Escherichia coli were not observed 
with supplementation of SFD and SCF.  The only dietary treatment with an effect on cecal 
microbial concentrations was Pectin that tended (P<0.10) to decrease Escherichia coli 
concentrations with no effect on Bifidobacterium spp or Lactobacillus spp concentrations. 
  Soluble corn fiber has been shown to affect microbial concentrations in vitro.  
Maathuis et al. (2009) reported a 2-fold increase in Bifidobacterium spp. using SCF in a 
validated dynamic computer-controlled in vitro model of the human proximal large intestine 
(TIM-2).  A bifidogenic response also was found in a human in vivo study where healthy 
men were supplemented with 21 g/d of SCF (Vester Boler et al., unpublished data).  This 
dose of SCF was found to increase (P<0.05) fecal concentratons of Bifidobacterium spp. 
compared with the non-fiber control (from 6.9 log10 cfu/g to 8.2 log10 cfu/g), but did not 
have any effect on Lactobacillus spp. or Escherichia coli populations.  Pasman et al. (2006) 
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found that neither 30 nor 45 g/d of SFD increased Lactobacillus spp in feces compared with 
a maltodextrin control in a human study. 
Histomorphology: 
 Histomorphology data collected on cecum and colon of rats are presented in Table 6-
8.  Crypt depth in both the cecum and colon was increased (P<0.05) compared with the 
Control treatment with supplementation of Pectin, SFD, and SCF.  A similar pattern for 
goblet cell number was noted.  In both cecum and colon, supplementation of Pectin, SFD, 
and SCF increased (P<0.05) goblet cell numbers compared to the Control treatment.  
The majority of goblet cells found in both cecum and colon crypts was found to be 
comprised of acidic mucin, and increased (P<0.05) acidic mucins were found in rats fed the 
Pectin, SFD, and SCF diets.  These were found concentrated towards the bottom of the 
crypts.  No goblet cells composed of only neutral mucin were observed in the cecal or 
colonic crypts for any treatment; however, goblet cells comprised of a mixture of both 
acidic and neutral mucins were observed.  These cells stained purple, indicating that both 
types of mucins were present (Filipe, 1979).  No differences between cecum and colon or 
among dietary treatements were observed for mixed goblet cells.   
Acidic mucin can be classified as sulfomucins or sialomucins.  Both types of acidic 
mucins were found in both the cecal and colonic crypts.  In the cecum, no differences 
among dietary treatments were observed.  However, for the colonic crypts, diets 
supplemented with Pectin, SFD, and SCF had higher numbers of sulfomucins compared 
with the Control treatment.   
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 Increased crypt depth as a result of dietary supplementation of low-digestible 
carbohydrates is a beneficial morphological effect.  The crypts contain intestinal stem cells, 
the principal site of cell proliferation in the intestinal mucosa, and increased depth is 
associated with increased rate of turnover of intestinal mucosal cells (Jin et al., 1994; 
Kleessen et al., 2003).  Several studies have shown that pectin and other dietary fibers 
increase crypt depth throughout the intestinal tract (Jacobs, 1983; Lupton and Kurtz, 1993; 
Kleessen et al., 2003).  However, pectin has been reported to simultaneously increase crypt 
depth and decrease villus height of the small intestine (Jacobs, 1983). 
 The increase in goblet cells per crypt may have a positive impact on gut health by 
increasing the thickness of the mucous layer of the large bowel.  Other studies have reported 
increased goblet cell numbers in rats fed fermentable fibers including fructans and 
galactooligosaccharides (Satchithanandam et al., 1990; Meslin et al., 1993; Fontaine et al., 
1996; Schmidt-Wittig et al., 1996; Kim, 2002).  Acidification of large intestinal contents is 
postulated to stimulate mucus synthesis and secretion (Meslin et al., 1999) and could 
perhaps explain the increased numbers of goblet cells with the dietary treatments tested in 
this experiment. It has been suggested that acidic mucins protect against bacterial 
translocation because sulfated mucins (sulfomucins) in particular appear to be less 
degradable by bacterial glycosidases and host proteases (Deplancke and Gaskins, 2001).  
Rats fed diets supplemented with low-digestible, inulin-type fructans have been shown to 
modulate mucins in the intestinal tract by increasing acidic mucins, especially the protective 
sulfomucins (Fontaine et al., 1996; Delzenne, 2003; Kleessen et al., 2003).  Alterations in 
the mucosal architecture and amounts of sulfomucins and sialomucins could have important 
effects on the gut mucosal barrier and health maintenance of the gut.   
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 In summary, SFD and SCF both resulted in extensive fermentation in the cecum of 
rats and had positive results on indices of gut health.  Dietary supplementation at the 5% 
level of the diet resulted in tolerance issues (diarrhea) for the Pectin, SFD, and SCF 
treatments, but this did not affect food intake, body weight, or rate of gain.  Pectin resulted 
in higher cecal SCFA concentrations than did SFD or SCF, except for propionate 
concentrations where SFD resulted in higher concentrations.  However, on a per cecum 
basis, SFD and SCF resulted in total SCFA concentrations more similar to those of Pectin.  
Pectin and SFD treatments tended to have higher colonic SCFA concentrations compared to 
SCF, except for butyrate.  The trend for lower butyrate production from the SFD and SCF 
treatments was not noted for both cecal and colonic contents, when expressed on a DM basis 
and a total contents basis.  In general, Pectin resulted in higher concentrations of BCFA in 
cecal and colonic contents compared to SFD and SCF.  The only dietary treatment that had 
an effect on cecal microbial concentrations was Pectin that tended to decrease Escherichia 
coli concentrations.  Even though SFD and SCF did not result in increased butyrate 
conconcentration as did Pectin, they nevertheless resulted in increased total SCFA 
concentrations that had positive effects on cecal and colonic histomorphology.   
 In conclusion, the fermentative properties of SFD and SCF have the potential to 
beneficially impact large bowel health.  Both of these low-digestible carbohydrates 
increased cecal weight, increased cecal and colonic crypt depths, and had a positive effect 
on goblet cells and mucin composition.  Even though SFD and SCF do not appear to be 
butyrogenic or bifidogenic in the rat, sufficient positive outcomes were noted so as to make 
SFD and SCF carbohydrates of interest as regards modulation of indices of gut health.   
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Table 6-1. Ingredient composition of diets containing select dietary fibers and fed to rats 
Ingredient Control Pectin SFD
1
 SCF
2
 
 ------------------------------------% of diet--------------------------------- 
Casein 20.00 20.00 20.00 20.00 
L-Cystine 0.30 0.30 0.30 0.30 
Cornstarch 39.75 39.75 39.75 39.75 
Maltodextrin 13.20 13.20 13.20 13.20 
Sucrose 10.00 10.00 10.00 10.00 
Cellulose 5.00 0.00 0.00 0.00 
Pectin 0.00 5.00 0.00 0.00 
SFD 0.00 0.00 5.00 0.00 
SCF 0.00 0.00 0.00 5.00 
Soybean oil 7.00 7.00 7.00 7.00 
t-Butylhydroquinone 0.0014 0.0014 0.0014 0.0014 
Mineral mix
3
 3.50 3.50 3.50 3.50 
Vitamin mix
4
 1.00 1.00 1.00 1.00 
Choline bitartrate 0.25 0.25 0.25 0.25 
Dye 0.005 0.005 0.005 0.005 
1
 Soluble fiber dextrin. 
2
 Soluble corn fiber. 
3
 Mineral mix = AIN-93G-MX. Mineral (g/kg):  Calcium carbonate, 357.00; 
Potassium phosphate, 196.00; Potassium citrate, 70.78; Sodium chloride, 74.00; Potassium 
sulfate, 46.60; Magnesium oxide, 24.00; Ferric citrate, 6.06; Zinc carbonate, 1.65; Sodium 
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meta-silicate, 1.45; Manganous carbonate, 0.63; Cupric carbonate, 0.30; Chromium 
potassium sulfate, 0.28; Boric acid, 0.08; Sodium fluoride, 0.06; Nickel carbonate, 0.03; 
Lithium chloride, 0.02; Sodium selenate, 0.01; Potassium iodate, 0.01; Ammonium 
paramolybdate, 0.008; Ammonium vanadate, 0.007; Powdered sucrose, 221.03. 
4
 Vitamin mix = AIN-93G-VX. Vitamin (mg/kg) (except as noted): Nicotinic acid, 
3.00; Ca pantothenate, 1.60; Pyridoxine, 0.70; Thiamin, 0.60; Riboflavin, 0.60; Folic acid, 
0.20; Biotin, 0.02; Vitamin B12, 2.50; Vitamin E (500 IU/g), 15.00; Vitamin A (500,000 
IU/g), 0.80; Vitamin D3 (400,000 IU/g), 0.25; Vitamin K, 0.08; Powdered sucrose, 974.65. 
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Table 6-2. Chemical composition of diets containing select dietary fibers and fed to rats 
 Treatment 
Item Control Pectin SFD
1
 SCF
2
 
Dry matter (DM) 90.59 90.36 89.08 89.55 
 ------------------------------------------------------------% DM basis----------------------------------------------------- 
Organic matter 97.38 97.32 97.38 97.38 
Crude protein 18.69 19.51 19.32 19.21 
Total dietary fiber 5.88 5.30 2.01 2.19 
Acid hydrolyzed fat 6.91 6.92 7.01 6.99 
Gross energy, kcal/g 4.73 4.71 4.74 4.73 
1
 Soluble fiber dextrin. 
2
 Soluble corn fiber. 
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Table 6-3.  Daily food intake, rate of weight gain, and final body weights of rats fed select dietary fibers 
 
Treatment  
Item Control Pectin SFD
1
 SCF
2
 SEM
3
 
Food intake, g/d 16.5
a
 17.4
b
 16.1
a
 15.9
a
 0.26 
Initial body weight, g 178.21 178.80 179.33 177.42 2.09 
Final body weight, g 314.6 323.8 327.4 318.5 6.01 
Rate of gain, g/d 4.56 4.86 4.98 4.51 0.22 
1
 Soluble fiber dextrin. 
2
 Soluble corn fiber. 
3
Pooled SEM. 
ab
 Means in the same row with different superscript letters are different (P<0.05). 
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Table 6-4. Concentrations of short-chain fatty acids (SCFA) and branched-chain fatty acids (BCFA) in cecal contents of rats fed select 
dietary fibers 
 Treatment  
Item Control Pectin SFD
1
 SCF
2
 SEM
3
 
 
Cecal SCFA, µmol/g
4
 
     
Acetate 192.34
a
 460.93
b
 206.77
a
 171.64
a
 20.46 
Propionate 53.03
a
 88.05
b
 113.54
c
 90.39
b
 6.33 
Butyrate 52.80
b
 60.16
b
 13.59
a
 13.97
a
 5.15 
Total SCFA 298.17
a
 609.15
b
 333.91
a
 276.01
a
 26.17 
      
Cecal SCFA, µmol/cecum      
Acetate 452.33
a
 1,260.25
c
 1,052.11
bc
 827.32
b
 71.32 
Propionate 115.18
a
 234.37
b
 584.95
d
 422.51
c
 23.89 
Butyrate 99.79
a
 163.12
b
 70.12
a
 67.75
a
 14.09 
Total SCFA 628.52
a
 1,662.95
b
 1,719.61
b
 1,330.36
b
 93.81 
      
Cecal BCFA, µmol/g
4
      
Isobutyrate 4.53
b
 5.29
b
 2.73
a
 2.19
a
 0.44 
Isovalerate 4.57
ab
 5.63
b
 3.99
a
 3.53
a
 0.35 
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Table 6-4 (con’t.)      
 
Valerate 
 
4.98
b
 
 
8.05
c
 
 
1.47
a
 
 
1.88
a
 
 
0.41 
Total BCFA 14.07
b
 18.97
c
 8.20
a
 7.60
a
 1.04 
      
Cecal BCFA, µmol/cecum       
Isobutyrate 10.14 14.45 14.07 10.55 1.80 
Isovalerate 10.15
a
 15.37
ab
 20.55
b
 16.99
b
 1.37 
Valerate 11.34
a
 21.97
b
 7.59
a
 9.08
a
 1.56 
Total BCFA 31.62
a
 51.78
b
 42.23
ab
 36.63
ab
 4.10 
1
 Soluble fiber dextrin. 
2
 Soluble corn fiber. 
3 
Pooled SEM. 
  
4 
Values are expressed on a dry matter basis. 
abcd
 Means in the same row with different superscript letters are different (P<0.05). 
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Table 6-5. Concentrations of short-chain fatty acids (SCFA) and branched-chain fatty acids (BCFA) in colonic contents of rats fed 
select dietary fibers 
 Treatment  
Item Control Pectin SFD
1
 SCF
2
 SEM
3 
 
Colonic SCFA, µmol/g
4
 
     
Acetate 118.11
ab
 214.90
b
 100.65
ab
 81.68
a
 29.94 
Propionate 29.66
a
 50.78
ab
 73.94
b
 34.11
ab
 11.09 
Butyrate 30.32
b
 43.56
b
 6.69
a
 6.33
a
 5.86 
Total SCFA 178.79
ab
 309.09
b
 180.89
ab
 121.74
a
 42.70 
      
Colonic SCFA, µmol/colon      
Acetate 112.91 132.73 42.70 46.14 28.93 
Propionate 27.19 29.19 30.16 19.40 5.95 
Butyrate 29.78
b
 25.27
ab
 2.74
a
 3.61
a
 6.76 
Total SCFA 169.87 181.11 75.78 70.33 41.66 
      
Colonic BCFA, µmol/g
4
      
Isobutyrate 2.30
ab
 3.32
b
 1.21
a
 1.57
ab
 0.45 
Isovalerate 2.26
a
 4.54
b
 2.95
ab
 2.19
a
 0.54 
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Table 6-5 (con’t.)      
 
Valerate 
 
2.35
a
 
 
4.91
b
 
 
0.86
a
 
 
1.25
a
 
 
0.55 
Total BCFA 6.89
a
 12.78
b
 5.01
a
 5.03
a
 1.43 
      
Colonic BCFA, µmol/colon      
Isobutyrate 2.18
c
 1.92
bc
 0.49
a
 0.89
ab
 0.35 
Isovalerate 2.11 2.62 1.19 1.24 0.47 
Valerate 2.21
b
 2.85
b
 0.35
a
 0.71
a
 0.38 
Total BCFA 6.47
bc
 7.40
c
 2.05
a
 2.86
ab
 1.26 
1
 Soluble fiber dextrin. 
2
 Soluble corn fiber. 
3 
Pooled SEM. 
 
4 
Values are expressed on a dry matter basis. 
abc
 Means in the same row with different superscript letters are different (P<0.05). 
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Table 6-6. Cecal and colonic total and empty weights, and pH values in rats fed select dietary fibers 
 Treatment  
Item Control Pectin SFD
1
 SCF
2
 SEM
3
 
 
Total weight, g 
     
Cecum 3.12
a
 3.96
a
 6.73
b
 6.15
b
 0.38 
Colon 1.81 1.46 1.28 1.49 0.16 
      
 
Empty weight, g 
     
Cecum 0.94
a
 1.23
b
 1.58
c
 1.33
c
 0.08 
Colon 0.87 0.88 0.87 0.92 0.07 
      
Cecal pH 6.85
b
 6.68
b
 5.88
a
 6.00
a
 0.10 
Colon pH 
 
6.90
b
 6.88
b
 6.16
a
 6.06
a
 0.14 
1
 Soluble fiber dextrin. 
2
 Soluble corn fiber. 
3 
Pooled SEM. 
abc
 Means in the same row with different superscript letters are different (P<0.05). 
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Table 6-7. Cecal concentrations of microbiota for rats fed select dietary fibers 
Treatment 
Item Control Pectin SFD
1
 SCF
2
 SEM
3 
--------log10 cfu/g cecal DM-------- 
Bifidobacterium spp. 9.14 9.99 9.70 9.81 0.52 
 
Escherichia coli 11.37
a
 10.86
b
 11.58
a
 11.62
a
 0.32 
 
Lactobacillus spp. 11.59 12.20 11.33 11.52 0.33 
1
 Soluble fiber dextrin. 
2
 Soluble corn fiber. 
3 
Pooled SEM. 
ab 
Means in the same row with different superscript letters tend to be different (P<0.10). 
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Table 6-8. Effect of select dietary fibers on cecum and colon histomorphology of rats 
 Treatment  
Item Control Pectin SFD
1
 SCF
2
 SEM
3
 
 
Cecum 
     
Crypt depth, µm 164.58
a
 210.61
b
 208.81
b
 201.48
b
 5.46 
Goblet cells (n) per crypt      
     Total  12.6
a
 20.1
b
 19.8
b
 19.3
b
 1.48 
     Acidic mucin  7.1
a
 14.2
b
 13.9
b
 12.5
b
 1.22 
     Mixed (acidic/neutral) 5.7 7.5 6.9 6.9 0.41 
     Mucin(n) per crypt      
          Sulfomucins  6.8 8.2 7.8 8.1 0.68 
          Sialomucins  5.9 6.2 6.7 6.0 0.44 
      
Colon      
Crypt depth, µm 216.45
a
 257.54
b
 245.43
b
 242.71
b
 7.94 
Goblet cells (n) per crypt      
     Total  15.8
a
 25.0
b
 23.9
b
 24.3
b
 1.36 
     Acidic mucin  11.5
a
 21.4
b
 19.4
b
 20.1
b
 1.28 
     Mixed (acidic/neutral) 3.8 4.5 5.2 4.9 0.32 
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Table 6-8 (con’t.)      
     
 Mucin(n) per crypt 
     
          Sulfomucins  6.6
a
 13.3
b
 10.5
b
 10.9
b
 1.00 
          Sialomucins  10.7 10.2 9.9 10.2 0.92 
1
 Soluble fiber dextrin. 
2
 Soluble corn fiber. 
3 
Pooled SEM. 
ab
 Means in the same row with different superscript letters are different (P<0.05). 
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CHAPTER 7: SUMMARY 
Dietary fiber represents a complex group of carbohydrates that have a variety of 
beneficial physiological and nutritional properties (Crittenden and Playne, 1996; Cummings et 
al., 1997; Van Loo et al., 1999).  Evidence that dietary fiber consumption may positively affect 
risk factors associated with diseases such as obesity, non-insulin dependent diabetes mellitus, 
hyperlipidemia, hypertension, and cardiovascular disease continues to grow (Scheppach et al., 
2001).  This has led to a demand for the development of novel carbohydrates that have functional 
properties similar to those of dietary fiber but that may be incorporated more easily into a wider 
array of solid and liquid food matrices.  Novel carbohydrates usually are relatively pure 
compared to natural fibers such as brans and those in whole grains. 
A class of carbohydrate that is becoming popular as a proxy for commodity dietary fibers 
is low-digestible carbohydrates.  These are a heterogeneous group of oligosaccharides that are 
partially unavailable to digestive enzymes so are either incompletely or not at all absorbed from 
the small intestine (Murphy, 2001; Scheppach et al., 2001; Grabitske and Slavin, 2008).  The 
relative non-digestibility of these carbohydrates is due to the anomeric C atom of the 
monosaccharide unit having a configuration that makes linkages unable to be hydrolyzed by 
digestive enzymes.  Low-digestible carbohydrates pass into the colon where they are substrates 
for either complete or partial fermentation by the colonic microbiota.    
Evidence for the potential physiological and health benefits associated with low-
digestible carbohydrate consumption is substantial and has led to an increased awareness among 
consumers (Murphy, 2001).  Many benefits of low-digestible carbohydrate consumption exist 
including positive effects on mineral bioavailability and lipid metabolism in addition to their 
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anti-carcinogenic properties, but of major interest is their effect on energy content, glycemic 
response, fermentation characteristics, and indices of gastrointestinal tract health. 
The objective of this research was to evaluate select novel, low-digestible carbohydrates - 
pullulans (Pull), soluble fiber dextrins (SFD), and soluble corn fibers (SCF) - for properties that 
could positively impact health outcomes. Monosaccharide composition (free, bound), simulated 
hydrolytic digestion, glycemic and insulinemic responses, true metabolizable energy content, 
fermentation characteristics, microbiota populations, and gut morphological characteristics were 
evaluated using in vitro, canine, avian, and rodent models.  
The objective of the first study was to determine in vitro hydrolytic digestion 
characteristics, glycemic and insulinemic responses using a dog model, and true metabolizable 
energy (TMEn) content using an avian model, of select SFDs and Pulls.  Carbohydrates studied 
included six soluble fiber dextrins (SFDs) and three pullulans.  Soluble fiber dextrins were 
evaluated and were produced using two different starch sources, corn and tapioca.  Pullulans 
evaluated were of varying molecular weight.     
All SFDs and Pulls had low free sugar and high hydrolyzed monosaccharide 
concentrations, with glucose being the primary free and bound sugar present in all substrates.   
Hydrolytic digestibility values were higher for the tapioca-based SFDs (50%) than for the corn-
based SFDs (20%).  All Pulls were found to be nearly completely digested to glucose.  Overall, 
the SFDs exhibited varying degrees of resistance to digestion, thus resulting in attenuated 
glycemic responses compared to maltodextrin (Malt). The corn-based SFDs had relative 
glycemic responses (RGR) ranging from 27 to 100%. All three tapioca-based SFDs had similar 
RGR values averaging ~50% of the Malt control.  Despite the differences in RGR, all SFDs 
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lowered the relative insulinemic response (RIR) compared to Malt. Pullulans resulted in low 
glycemic and insulinemic responses, with an average response value of ~24% for both RGR and 
RIR.  Soluble fiber dextrins had lowered TMEn values compared to Malt, with tapioca-based 
SFDs being numerically higher than for the corn-based SFDs.  Pullulans resulted in higher TMEn 
values, similar to the 4.0 kcal/g value for Malt.  
The SFDs varied in sugar composition and physiological responses, and demonstrated 
varying degrees of resistance to digestion.  The corn-based SFDs resulted in a lower content of 
released monosaccharides and lower energy content compared to the tapioca- based SFDs after 
simulated hydrolytic digestion.  Perhaps the corn-based SFDs had a higher degree of 
dextrinization, more branching, or a higher concentration of non-digestible linkages compared to 
the SFDs derived from tapioca, making them less susceptible to digestive enzymes.  Having a 
decreased hydrolytic digestibility enabled the SFDs to attenuate the glycemic and insulinemic 
responses, making them suitable candidates for reduced glycemic and low-calorie foodstuffs.  A 
portion of SFDs pass into the colon and perhaps promote health due to their fermentative 
properties.   
Even though the Pulls were nearly completely hydrolyzed after simulated digestion, they 
resulted in a significantly blunted glycemic curve, corroborating results showing that Pulls are 
slowly digestible carbohydrates.  Other research also has found Pulls to be extensively 
hydrolyzed in vitro, with hydrolysis occurring slowly over time, thus making them slowly 
digestible carbohydrates (Wolf et al., 2003).  Pullulans could be ideal candidates for 
incorporation into foodstuffs for diabetics as they result in low glycemic responses without 
eliciting large peaks in blood glucose or insulin. 
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The objective of the second study was to determine in vitro hydrolytic digestion 
characteristics, glycemic and insulinemic responses using a dog model, and TMEn content using 
an avian model of select soluble corn fibers (SCF).  Soluble corn fibers were obtained by 
isolating an oligosaccharide-rich component from partially hydrolyzed corn syrup.  During corn-
starch hydrolysis, an aqueous stream comprised of dextrose, fructose, and a mixture of 
oligosaccharides is formed (Harrison and Hoffman, 2007).  This stream undergoes several 
additional processes including nanofiltration and use of enzymes to create a product with 
increased α-1,6 glycosidic bonds (Harrison and Hoffman, 2007).  The last steps in the production 
process include decolorization of the syrup and evaporation and drying to produce a powder.  All 
the SCFs evaluated were produced using the basic steps outlined above, but procedures were 
modified to produce a variety of SCFs.  The SCFs evaluated were classified into first generation 
and second generation products.  Both generations of SCFs rely on the creation of reversion 
products using different combinations of acid catalysts and enzymes to increase the number of 
glycosidic bonds. 
Soluble corn fibers from both generations of product had low free sugar concentrations 
and were hydrolyzed completely to glucose.  One SCF had a substantial portion of bound 
fructose.  The first generation SCFs were found to have a digestibility value of approximately 
50% whereas second generation SCFs had digestibility values averaging 32%.  Differences in the 
acid catalyst used during the production process affected digestibility of the SCFs dramatically.  
Using hydrochloric acid as a catalyst appeared to create reversion products that were more 
resistant to the enzymes used in simulated hydrolytic digestion compared to reversion products 
made with phosphoric acid.  All SCFs from both generations resulted in reduced glycemic and 
insulinemic responses.  Second generation SCFs resulted in generally lower responses than did 
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first generation SCFs.  Second generation SCFs resulted in lower (avg 1.80 kcal/g) TMEn values 
than did first generation SCFs (avg 2.40 kcal/g).  
Overall, the production processes implemented for second generation SCFs were very 
successful in producing low-digestible carbohydrates.  The second generation series of SCFs, on 
average, had lower digestibilities, glycemic responses, and TMEn values than did the SCFs from 
the first generation series.  The increased resistance to digestibility of these carbohydrates was 
likely due to increased glycosidic bond formation resulting from different production methods. 
The objective of the third study was to measure in vitro hydrolytic digestion and 
glycemic and insulinemic responses of select carbohydrate blends containing the novel 
carbohydrate, SCF.  Two SCFs produced using different production methods were used in the 
formulation of these blends, SCF spray-dried (SCFsd) and SCF.  In the previous study, both 
SCFs were found to have a lower hydrolytic digestion, but nonetheless elicited a glycemic 
response (SCFsd, 63%; SCF, 25%).  Further attenuation of glycemic and insulinemic responses 
was achieved by blending SCF with carbohydrates that did not elicit blood glucose responses 
upon consumption such as Pull, sorbitol (Sorb), and fructose (Fruct).  One set of blends 
contained SCFsd blended with different concentrations of either Pull, Sorb, or Fruct (SCFsd 
blends).  The other set of blends contained SCF blended with different ratios of Pull, Sorb, and 
Fruct (SCF:Pull:Sorb:Fruct blends).   
All blends had low to intermediate free sugar concentrations except those with higher 
percentages of Fruct and Sorb.  The addition of Pull, even at high percentages, did not have a 
large impact on free sugar concentrations for either set of blends.  However, addition of Pull 
increased the hydrolyzed monosaccharide concentrations of the blends, especially by increasing 
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the concentration of glucose. Addition of higher amounts of Fruct and Sorb increased free Fruct 
and Sorb concentrations of the blends.  Blends with higher percentages of Fruct or Sorb had 
lower hydrolyzed monosaccharide concentrations due to their higher free sugar concentrations. 
Blends of SCFsd and Pull resulted in high digestibility values (~91%).  The digestibility values 
of SCFsd blends increased with added percentages of Fruct or Sorb; however, concentrations of 
released glucose decreased with higher percentages of Fruct or Sorb.  Total released 
monosaccharide concentrations increased as the percentage of SCF decreased in the 
SCF:Pull:Sorb:Fruct blend.  The concentrations of glucose released increased as the percentage 
of Pull increased in the blends.  As noted with the SCFsd blends, increased Fruct and Sorb in the 
SCF:Pull:Sorb:Fruct resulted in higher total released monosaccharides, with higher 
concentrations of Fruct and Sorb released.  All SCF blends resulted in low glycemic and 
insulinemic responses that were attenuated compared to Malt.  Blends containing Fruct and Sorb 
were most effective in attenuating glycemic and insulinemic responses.   
The SCFs used in both sets of blends partially resisted hydrolytic digestion and 
attenuated blood glucose concentrations upon consumption.  Soluble corn fiber had a lower 
glycemic response than SCFsd, likely due to increased number of digestion-resistant bonds and 
bound fructose.  Blending these SCFs with select carbohydrates was generally successful in 
further attenuating glycemic and insulinemic responses.  Even though in vitro hydrolytic 
digestion studies have shown Pull to be nearly completely digested, Pull attenuated the glycemic 
response due to its property of being slowly digestible.  Even at concentrations as low as 5% of 
the blend, Fruct reduced glycemic and insulinemic responses because Fruct and Sorb do not 
acutely raise blood glucose or stimulate insulin secretion.  These SCF blends could be utilized to 
lower postprandial glucose and insulin responses by replacing available carbohydrates in foods 
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with low-digestible carbohydrates, and be of potential help to diabetic patients in blood glucose 
management. 
The objective of the fourth study was to evaluate gastrointestinal health outcomes 
resulting from supplementation of the novel, low-digestible carbohydrates, SFD and SCF, to rats.  
Previous studies showed that SFD and SCF had decreased hydrolytic digestion in vitro, 
attenuated glycemic and insulinemic responses, and lower energy values.  These data point to the 
fact that SFD and SCF contain a fraction that resists digestion and passes to the colon for 
potential fermentation.  Indices of gastrointestinal health included digesta pH, short-chain fatty 
acid (SCFA) concentrations, microbial populations, large bowel mass, and histomorphology 
measurements in cecum and (or) colon.  Cellulose was included as a poorly fermentable negative 
control treatment and pectin as a highly fermentable positive control treatment.   
Consumption of SFD and SCF resulted in increased cecal weight but not colon weight. 
Decreased cecal and colonic pH values also resulted from dietary supplementation of SFD and 
SCF.   Cecal and colonic SCFA concentrations were not increased by SFD and SCF 
supplementation when expressed on a per gram digesta DM basis.  However, SFD- and SCF-fed 
rats had more cecal contents so when analyzed on a per cecum basis, increased cecal SCFA 
concentrations compared to the cellulose control resulted for both SFD and SCF. While acetate 
and propionate increased with SFD and SCF supplementation, neither resulted in increased 
butyrate concentration compared to the cellulose control.  In both the cecum and colon, SFD and 
SCF promoted less branched-chain fatty acid concentrations compared to pectin.  Treatment had 
little effect on microbiota concentrations in cecal contents.  No differences were noted in 
Bifidobacterium spp. or Lactobacillus spp. among treatments.  The only difference noted was for 
pectin that tended to promote lower Escherichia coli concentrations.  Soluble fiber dextrin and 
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SCF, in addition to pectin, were able to modulate cecal and colonic histomorphology.  These 
fermentable carbohydrates increased crypt depth and the number of goblet cells per crypt 
compared with the cellulose control.  Increased acidic mucins per crypt resulted from 
supplementation of SFD, SCF, and pectin.  Only in the colon did supplementation of SFD, SCF, 
and pectin increase sulfomucins per crypt. 
This study showed that SFD and SCF are, indeed, low-digestible, partially fermentable 
carbohydrates that positively impact gastrointestinal health outcomes.  Supplementation of these 
low-digestible carbohydrates resulted in increased SCFA concentrations, but not butyrate.  This 
also has been observed in other studies with SCF in particular.  Unlike other studies using in 
vitro methodologies or human subjects, SFD and SCF did not result in increased gut microbiota 
concentrations.  Perhaps longer-term studies or more dramatic changes in diet are necessary to  
elicit microbiota alterations. Since both SFD and SCF are somewhat digestible, perhaps larger 
dosages, too, are needed to demonstrate changes in microbial populations.  Although SFD and 
SCF were not butyrogenic or bifidogenic in the rat, their fermentative capacity had a positive 
effect on cecal and colonic morphology by increasing crypt depth, goblet cell numbers, and 
acidic mucins.  These outcomes positively impact gut health by increasing the mucous thickness 
and beneficially impacting the gut mucosal barrier.   
In conclusion, the research presented here clarifies that select novel carbohydrates are 
low-digestible, partially fermentable, and have the potential to beneficially impact health in 
several ways.  This research offers insight into the importance of evaluating monosaccharide 
composition and how it can impact outcomes such as hydrolytic digestion, glycemic and 
insulinemic responses, and energy values.  The data presented in this dissertation provide 
valuable information for food formulators and consumers wishing to incorporate ingredients with 
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advantageous physiological properties into foodstuffs and diets.  Future research is necessary to 
determine the impact of these supplemental low-digestible carbohydrates on health outcome in 
disease states using diabetic or immune-challenged models. 
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